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Abstract
The synthesis of biologically active small molecules is crucial for drug discovery and treatment of diseases.
Innovative C-C bond forming methods have the potential to revolutionize the synthesis of functionally
diverse small molecules in a timely fashion. Among all methodologies, transition metal catalyzed cross
coupling reaction is a reliable tool and has been widely used in both pharmaceuticals and industries nowadays.
Traditional cross coupling reactions, such as Suzuki, Negishi, Kumada, Stille and so on, require
prefunctionalized coupling partners (organoboron in Suzuki, organozinc in Negishi, Grignard reagents in
Kumada and organotin in Stille). The downside of such strategies is that prefunctionalization requires
significant effort and time. Thus, turning C-H bond directly into cross coupling partners without any
prefunctionalization is more efficient and atom-economical.
Much progress have been made the past two decades in C-H functionalization, including both sp2 and sp3
hybridized C-H bonds. Functionalization of sp2 hybridized C-H bonds has focused on arenes and
heteroarenes and has been well developed. In contrast, sp3 hybridized C-H bonds are more difficult to
functionalize. Early studies on sp3 hybridized C-H functionalization focused on C-H bond alpha to activating
groups such ketone, ester, amide and others. Another strategy to functionalize those unactivated C-H bonds
(pka>30) is to install directing groups to facilitate reactivity and selectivity. The addition and removal of
directing groups, however, may limit the utility of this strategy. To date, intermolecular cross-coupling
reactions of non- or weakly acidic C(sp3)-H bonds in the absence of directing group remains a challenge.
The Walsh group set out to develop methods to for C(sp3)–H functionalization using a strategy called
Deprotonative Cross Coupling Process (DCCP). DCCP takes advantage of reversible deprotonation under
the conditions of the reaction as a method to achieve functionalization of weakly acidic C(sp3)-H bond using
relatively mild condition. This dissertation describes two methods to functionalization of weakly acidic
C(sp3)-H bonds, allylic substitution and arylation, with success on both Pd or Ni as catalyst.
The first two chapters of the dissertation describe transition metal catalyzed allylic substitution with
diarylmethane pronucleophiles (pka up to 32.3). Diarylmethane are among the least acidic pronucleophiles
used to date in transition metal catalyzed allylic substitution reactions (Tsuji-Trost reaction). The widely
accepted paradigm for classifying the mode of attack of nucleophiles on palladium π-allyl intermediates in the
Tsuji−Trost reaction is based on the pKa of the pronucleophile: (1) stabilized or “soft” carbon nucleophiles
and heteroatom nucleophiles (e.g., pronucleophiles with pKa‘s < 25), and (2) unstabilized or “hard”
nucleophiles (those from pronucleophiles with pKa‘s > 25). One of the keys to the continuing development of
asymmetric allylic substitution processes remains broadening the scope of “soft” nucleophiles. In Chapter 1,
we successfully demonstrated the cut-off between soft and hard nucleophiles for Pd-catalyzed allylic
substitution should be raised from pKa of 25 to at least 32. This discovery expands the scope of soft
nucleophiles, and suggests the possibility of developing asymmetric allylic substitution for more weakly acidic
substrates.
In chapter 2, we further applied Ni catalyzed allylic substitution on diarylmethanes to develop a supplement
to the Pd version. We were able to prove the same nucleophile behaves as soft nucleophile in both Pd and Ni
catalyzed allylic substitution. More importantly, Ni has always been paired with hard nucleophiles to perform
asymmetric allylic substitution, but we were able to identify a chiral ligand SL-J204-1 to do asymmetric allylic
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substitution using Ni as catalyst with soft nucleophile (diarylmethane) and got up to 91% yield with 92% e.e.
This result suggests Ni catalyzed asymmetric allylic substitution can be done with both soft and hard
nucleophiles, which makes Ni an appealing choice other than Pd for transition metal catalyzed allylic
substitution.
The second part of the dissertation focus on the arylation of weakly acidic substrates such as carboxylate and
toluene (pKa = 44±1). The same strategy DCCP is applied to both types of substrates, through direct
metalation and subsequent cross coupling of benzylic C(sp3)-H bonds.
Chapter 3 describes alpha arylation of carboxylic acids. Significant works on alpha arylation have been done
on carbonyl group containing substrates such as ketone, aldehyde, ester and amide. However, examples on
alpha arylation of carboxylic acids remain scarce due to the difficulty of generating dienolate. We successfully
demonstrated the reversible deprotonation could be applied to benzyl carboxylic acids and identified a
catalyst system that could further cross couple dienolate with aryl chlorides and bromides.
Finally, chapter 4 describes a direct arylation of toluene derivatives benzylic C-H bond. We used an unique
catalyst with deprotonatable ligand NIXANTPHOS. The deprotonated ligand would carry the counter cation
(alkali metal) of the base through out the catalytic cycle. Previously, our group had developed an activation
strategy using η6-coordination of arenes to tricarbonylchromium to activate toluene benzylic C-H bond. In
this chapter, we developed a new strategy using η6-coordination of toluene to potassium to activate benzylic
C-H bond to perform DCCP. The mechanistic study showed the crucial role of potassium cation. The method
is valuable in two points: 1. Direct arylation of toluene derivatives provides a strong tool transforming cheap,
inert molecule to useful molecule diarylmethane. 2. The unique mechanism would inspire us to design more
heterobimetallic systems with deprotonatable ligands to activate different kind of molecules.
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ABSTRACT 
METAL-CATALYZED ALLYLIC SUBSTITUTION & 
ARYLATION 
WITH WEAKLY ACIDIC C(SP3)–H BONDS 
 
Sheng-Chun Sha 
 
Professor Patrick J. Walsh 
 
The synthesis of biologically active small molecules is crucial for drug 
discovery and treatment of diseases. Innovative C-C bond forming methods have 
the potential to revolutionize the synthesis of functionally diverse small 
molecules in a timely fashion. Among all methodologies, transition metal 
catalyzed cross coupling reaction is a reliable tool and has been widely used in 
both pharmaceuticals and industries nowadays.  
Traditional cross coupling reactions, such as Suzuki, Negishi, Kumada, 
Stille and so on, require prefunctionalized coupling partners (organoboron in 
Suzuki, organozinc in Negishi, Grignard reagents in Kumada and organotin in 
Stille). The downside of such strategies is that prefunctionalization requires 
significant effort and time. Thus, turning C-H bond directly into cross coupling 
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partners without any prefunctionalization is more efficient and atom-economical.  
 Much progress have been made the past two decades in C-H 
functionalization, including both sp2 and sp3 hybridized C-H bonds. 
Functionalization of sp2 hybridized C-H bonds has focused on arenes and 
heteroarenes and has been well developed. In contrast, sp3 hybridized C-H bonds 
are more difficult to functionalize. Early studies on sp3 hybridized C-H 
functionalization focused on C-H bond alpha to activating groups such ketone, 
ester, amide and others. Another strategy to functionalize those unactivated C-
H bonds (pka>30) is to install directing groups to facilitate reactivity and 
selectivity. The addition and removal of directing groups, however, may limit the 
utility of this strategy. To date, intermolecular cross-coupling reactions of non- 
or weakly acidic C(sp3)-H bonds in the absence of directing group remains a 
challenge. 
  The Walsh group set out to develop methods to for C(sp3)–H 
functionalization using a strategy called Deprotonative Cross Coupling Process 
(DCCP). DCCP takes advantage of reversible deprotonation under the conditions 
of the reaction as a method to achieve functionalization of weakly acidic C(sp3)-
H bond using relatively mild condition. This dissertation describes two methods 
to functionalization of weakly acidic C(sp3)-H bonds, allylic substitution and 
arylation, with success on both Pd or Ni as catalyst.  
 The first two chapters of the dissertation describe transition metal 
catalyzed allylic substitution with diarylmethane pronucleophiles (pka up to 32.3). 
Diarylmethane are among the least acidic pronucleophiles used to date in 
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transition metal catalyzed allylic substitution reactions (Tsuji-Trost reaction). 
The widely accepted paradigm for classifying the mode of attack of nucleophiles 
on palladium π-allyl intermediates in the Tsuji−Trost reaction is based on the pKa 
of the pronucleophile: (1) stabilized or “soft” carbon nucleophiles and 
heteroatom nucleophiles (e.g., pronucleophiles with pKa‘s < 25), and (2) 
unstabilized or “hard” nucleophiles (those from pronucleophiles with pKa‘s > 25). 
One of the keys to the continuing development of asymmetric allylic substitution 
processes remains broadening the scope of “soft” nucleophiles. In Chapter 1, we 
successfully demonstrated the cut-off between soft and hard nucleophiles for 
Pd-catalyzed allylic substitution should be raised from pKa of 25 to at least 32. 
This discovery expands the scope of soft nucleophiles, and suggests the 
possibility of developing asymmetric allylic substitution for more weakly acidic 
substrates.  
 In chapter 2, we further applied Ni catalyzed allylic substitution on 
diarylmethanes to develop a supplement to the Pd version. We were able to 
prove the same nucleophile behaves as soft nucleophile in both Pd and Ni 
catalyzed allylic substitution. More importantly, Ni has always been paired with 
hard nucleophiles to perform asymmetric allylic substitution, but we were able to 
identify a chiral ligand SL-J204-1 to do asymmetric allylic substitution using Ni 
as catalyst with soft nucleophile (diarylmethane) and got up to 91% yield with 
92% e.e. This result suggests Ni catalyzed asymmetric allylic substitution can be 
done with both soft and hard nucleophiles, which makes Ni an appealing choice 
other than Pd for transition metal catalyzed allylic substitution.  
 The second part of the dissertation focus on the arylation of weakly 
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acidic substrates such as carboxylate and toluene (pKa = 44±1). The same 
strategy DCCP is applied to both types of substrates, through direct metalation 
and subsequent cross coupling of benzylic C(sp3)-H bonds.   
 Chapter 3 describes alpha arylation of carboxylic acids. Significant works 
on alpha arylation have been done on carbonyl group containing substrates such 
as ketone, aldehyde, ester and amide.  However, examples on alpha arylation of 
carboxylic acids remain scarce due to the difficulty of generating dienolate. We 
successfully demonstrated the reversible deprotonation could be applied to 
benzyl carboxylic acids and identified a catalyst system that could further cross 
couple dienolate with aryl chlorides and bromides.  
 Finally, chapter 4 describes a direct arylation of toluene derivatives 
benzylic C-H bond. We used an unique catalyst with deprotonatable ligand 
NIXANTPHOS. The deprotonated ligand would carry the counter cation (alkali 
metal) of the base through out the catalytic cycle. Previously, our group had 
developed an activation strategy using η6-coordination of arenes to 
tricarbonylchromium to activate toluene benzylic C-H bond. In this chapter, we 
developed a new strategy using η6-coordination of toluene to potassium to 
activate benzylic C-H bond to perform DCCP. The mechanistic study showed the 
crucial role of potassium cation. The method is valuable in two points: 1. Direct 
arylation of toluene derivatives provides a strong tool transforming cheap, inert 
molecule to useful molecule diarylmethane. 2. The unique mechanism would 
inspire us to design more heterobimetallic systems with deprotonatable ligands 
to activate different kind of molecules.  
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Chapter 1 
Raising the pKa Limit of “Soft” Nucleophiles in 
Palladium-Catalyzed Allylic Substitutions:   
Application of Diarylmethane Pronucleophiles 
 
 
1.1. INTRODUCTION 
  Palladium-catalyzed C−C bond-forming reactions are among the most 
important and well-developed processes in modern organic chemistry.1-10 Of 
these, the Tsuji−Trost allylic substitution reaction provides a useful and efficient 
approach to construct C−C bonds between sp3-hybridized carbons.  As a result, 
it has been widely used to synthesize natural products and bioactive molecules. 
11-17 The widely accepted paradigm for classifying the mode of attack of 
nucleophiles on transition metal η3-π-allyl intermediates in the Tsuji−Trost 
reaction is based on the pKa of the pronucleophile.18 Nucleophiles are divided 
into two classes: 1) stabilized or “soft” carbon nucleophiles and heteroatom 
nucleophiles (e.g., enolates and those from pronucleophiles with pKa‘s < 25), and 
(2) unstabilized or “hard” nucleophiles (those from pronucleophiles with pKa‘s > 
25). The distinction between these two classes is “soft” nucleophiles directly 
attack the π-allyl moiety while “hard” nucleophiles first attack the metal center 
(via transmetallation) before bond formation with the allyl group.  Importantly, 
these two pathways lead to distinct stereochemical outcomes (soft nucleophiles 
result in net retention in the Tsuji−Trost allylic substitution whereas hard 
nucleophiles react by single inversion). The scope of “soft” nucleophiles has 
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received significant attention in asymmetric catalysis,11,13,14,19 although non-
enantioselective Pd-catalyzed allylic substitution with “hard” nucleophiles are 
also known.20-22  
  One of the keys to the continuing development of allylic substitution 
processes remains broadening the scope of “soft” nucleophiles. With this in 
mind, Trost and co-workers increased the reach of “soft” nucleophiles in the 
allylic substitution with use of 2-picoline-derived nucleophiles (pKa = 34)23. 
Essential to their success was to increase the acidity of the 2-picoline CH3. This 
was accomplished by BF3 coordination to the pyridine nitrogen to facilitate 
deprotonation. The resulting “softened” nucleophile was successfully employed 
in Pd-catalyzed asymmetric allylic alkylation (AAA, Scheme 1A).18,24 The same 
group later reported no such activation was necessary with more acidic 
heterocycles, including pyrazine, pyrimidine, pyridazine, quinoxaline, and 
benzimidazole derivatives. (Scheme 1B).25 
  Our group recently introduced a strategy to employ toluene derivatives 
(RC6H4−CH2R’, pKa ~ 44)26 as “soft” pronucleophiles in Pd-catalyzed allylic 
substitution reactions using Cr(CO)3 to increase the acidity of the benzylic C–H’s 
(Scheme 1C).27 The drawback of this approach is the stoichiometric use of 
chromium. We, therefore, set out to develop benzylic nucleophiles in the 
absence of chromium activating groups. 
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Scheme 1.1. Palladium-Catalyzed Benzylic Allylations 
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  Application of unactivated diarylmethane derivatives as pronucleophiles in 
Pd-catalyzed allylic substitution reactions are unknown, but would have 
significant potential in medicinal chemistry. Hundreds of bioactive drug-like 
molecules contain allylated diarylmethyl motifs (Figure 1), with applications in 
treatment of breast cancer28, inhibitor of HIV protease29, blocker of human T-
cells30 and antagonist of the thyroid hormone receptor,31 among others. Given 
these important applications, we set out to introduce diarylmethane-derived 
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nucleophiles for the Pd-catalyzed allylic substitution.  To achieve this objective, 
it is essential to find conditions to deprotonate diarylmethane derivatives that 
are compatible with the catalyst and substrates. Based on our previous studies 
on deprotonative cross-coupling processes (DCCP) using diarylmethane 
derivatives,32-35 we hypothesized that diarylmethane derivatives could be 
reversibly deprotonated in situ by MN(SiMe3)2 (M = Li, Na, K) under mild 
conditions.  These conditions would be more amenable to catalysis than 
deprotonation under traditional conditions with n-BuLi at low temperature.36 
Herein we report an approach to the room temperature Pd-catalyzed allylic 
substitution with diarylmethane derivatives (Scheme 1D). This method enables 
rapid access to a variety of allylated products, including heteroaryl-containing 
derivatives as well as molecules bearing quaternary centers. The mild reaction 
conditions that have been identified employ MN(SiMe3)2 at room temperature 
and a Pd catalyst based on van Leeuwen’s Xantphos ligand.37 Surprisingly, 
stereochemical studies indicate that nucleophiles derived from diarylmethane 
derivatives (pKa = 25–33)26,38 behave as “soft” nucleophiles, significantly 
extending the range of nucleophiles undergoing the double inversion mechanism 
in the Tsuji−Trost allylic substitution. 
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Figure 1.1. Selected bioactive compounds containing the allylated diarylmethyl 
motif. 
 
1.2. RESULTS AND DISCUSSION 
  As mentioned above, we recently disclosed a Pd−Xantphos catalyst 
system to promote the allylic substitution with Cr(CO)3-stabilized toluene-
derived nucleophiles (eq 1).27 We hypothesized the reaction conditions in eq 1 
would be a good starting point for allylic substitution with diarylmethanes and 
related pronucleophiles.  
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Cr(CO)3
CH3 +
OPiv 5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
3 equiv LiN(SiMe3)2
1 equiv NEt3
hv, air (1)
O
PPh2 PPh2
Xantphos
THF, 24 oC, 12h
 
1.2.1. Development and Optimization of Palladium-Catalyzed Allyl ic 
Substitution with Diarylmethanes.  
  Given the perceived challenge to the application of diphenylmethane (pKa 
= 32.2)39 in allylic substitutions, we initiated our studies with the more acidic 2-
benzylpyridine (1a, pKa = 28.2)38 under the reaction conditions in eq 1. The 
desired product 3aa was formed in 80% assay yield (Table 1, entry 1). 
Switching the base to NaN(SiMe3)2 led to 3aa in 99% assay yield (entry 2). The 
additive NEt3, which proved very useful in eq 1, was not necessary for the Pd-
catalyzed allylic substitution with 2-benzylpyridine (entry 3 vs 2). The allylic 
substitution product formed with 2-benzylpyridine was isolated in 99% yield.   
We next sought to increase the pKa of the pronucleophile. The less acidic 3-
benzylpyridine (1c) (pKa = 30.1),38 however, led to only 27% assay yield (entry 
4). We increased the assay yield of 3ca to 70% by using the more reactive 
base, KN(SiMe3)2 (entry 5). Unfortunately, further decreasing the acidity of the 
pronucleophile was challenging: using diphenylmethane (4aa, pKa = 32.3)39 gave 
desired product 5aa in only 10% assay yield (entry 6). We next set out to 
optimize the reaction conditions for Pd-catalyzed allylic substitution with 
pronucleophiles with pKa’s >30, such as diphenylmethane. 
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Table 1.1. Preliminary Results of Allylic Substitution Reactionsa 
Ph OBoc
5 mol % Pd(COD)Cl2 
7.5 mol % Xantphos
3 equiv base
THF, 24 oC, 12 h Ph
Entry
Ar/HetAr
Ar/HetAr
1d
Yieldb (%)
2a
80
Base
LiN(SiMe3)2
Pronuclephiles
N
1a
Product
3aa
N
2d (99c)NaN(SiMe3)2N
1a 3aa
N
3 (99c)NaN(SiMe3)2N 1a 3aa
N
4 27NaN(SiMe3)2
N
1c 3ca
N
5 70KN(SiMe3)2
N
1c 3ca
N
6 10KN(SiMe3)24a 5aa
+
1a, 1c, 4a 3aa, 3ca, 5aa
 
a Reaction conducted on a 0.1 mmol scale with 1 equiv of pronucleophile and 2 
equiv of 2a at 0.1 M. b Yield determined by 1H NMR spectroscopy of the crude 
reaction mixture. c Isolated yield after chromatographic purification. d 1 equiv of 
NEt3. 
 
  From the results in Table 1, we hypothesized that the generation of the 
deprotonated diphenylmethane was problematic, and that choice of base would 
significantly impact the conversion. Since the traditional protocols preparing 
allylated diarylmethanes require strong bases (such as n-BuLi) at low 
temperature36 or under other harsh reaction conditions40, we limited ourselves to 
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use of KN(SiMe3)2 as the strongest base in this study. We then screened 
different ethereal solvents (THF, 2-methyl THF, 1,4-dioxane, DME and CPME) and 
found that DME was the leading solvent of those examined (Table 2, entry 2, see 
the Supporting Information for details). Another important variable in optimizing 
Pd-catalyzed allylic substitution with diphenylmethane is the ratio of reagents. 
We observed decomposition of allyl tert-butyl carbonate 2a during the reaction. 
Increasing 2a to 3 equiv led to significant improvement in yield (entry 3). In 
addition, increasing the concentration of base led to higher concentrations of 
the nucleophile and improved yields (entries 4–5). Under these conditions, the 
allylic substitution product 5aa was obtained in 95% isolated yield in DME with 
diphenylmethane 4a as the limiting reagent, 5 equiv of KN(SiMe3)2 and 3 equiv 
of the allyl electrophile 2a. The yield dropped if the equivalence of 2a (entry 6) 
or the catalyst loading (entry 7) were decreased. With the optimized conditions 
in Tables 1 and 2, we examined various benzylic heterocycles and 
diarylmethanes as pronucleophiles in the allylic substitution. 
 
Table 1.2. Optimization of Allylic Substitution with Diphenylmethane 4aa 
+ OBoc
5 mol %  Pd(COD)Cl2
7.5 mol % Xantphos
KN(SiMe3)2
solvent, 24 oC, 12 h
Entry yieldb (%)
1
2
3
4
5
SolventRatio(4a:base:2a)
1:3:2 THF 10
6
7d
1:3:2
1:5:3
1:3:3
1:4:3
1:5:2
1:5:3
DME
DME
DME
DME
DME
DME
88
55
79
62
(95c)
68
4a 2a 5aa
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a Reaction conducted on a 0.1 mmol scale at 0.1 M. b Yield determined by 1H 
NMR spectroscopy of the crude reaction mixture. c Isolated yield after 
chromatographic purification. d 2.5 mol % Pd(COD)Cl2/3.75 mol % Xantphos. 
1.2.2. Scope of Heterocyclic Diarylmethanes in Palladium-Catalyzed 
Allyl ic Substitution. 
  Based on the optimization process above, we anticipated that the choice 
of base would be critical to expand the scope of pronucleophiles and that each 
substrate class might require reexamination of bases. We first evaluated the 
scope of heterocyclic diarylmethanes as pronucleophiles in Pd-catalyzed allylic 
substitution (Table 3). The diarylmethane derivatives containing heterocycles 
are interesting targets in medicinal chemistry.41-43 Our method provides a rapid 
access to the heteroaryl-containing allylated products in good to excellent yields 
using 1−5 mol % catalyst loading (80−99% yield). Silylamide bases, MN(SiMe3)2 
(M = Li, Na, K), were used to accommodate the wide range of pronucleophile 
pKa’s. In general, LiN(SiMe3)2 was used for the most acidic pronucleophiles (pKa < 
28), NaN(SiMe3)2 for moderately acidic (pKa = 28–31) and KN(SiMe3)2 for the 
least acidic (pKa > 31). The 2-, 4- and 3-benzylpyridines underwent allylation in 
91−99% yield (Table 3, entries 1−3). Xanthene (1d) derivatives are important 
components of dyes.44 Xanthene underwent monoallylation in 82% yield (entry 
4). Furan45 and thiophene46 derivatives are valuable building blocks in 
agrochemicals and pharmaceuticals. Under the reaction conditions with 
KN(SiMe3)2 as the base, we observed decomposition of 2-benzylfuran (1e). 
Under the same reaction conditions with NaN(SiMe3)2 as the base, the desired 
product 3ea was obtained in only 32% yield. Using NaN(SiMe3)2, in combination 
with 15-crown-5 (2.5 equiv), the allylic substitution reaction afforded the 
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desired product 3ea in 80% yield (entry 5). This result demonstrates that the 
use of additives, such as crown ethers, are useful in transition metal catalyzed 
processes other than deprotonative cross-coupling processes.32 With 2-
benzylthiophene (1f) the desired substitution product 3fa was isolated in 93% 
with NaN(SiMe3)2 (entry 6). Di(3-pyridyl)methane (1g) was applied to give 3ga 
in 85% yield (entry 7). To establish the scalability of this method, the allylation 
of 3-benzylpyridine (1c) was examined on a 10 mmol scale, affording the 
allylated product 3ca in 89% yield (eq 2). 
+ OBoc
3 equiv KN(SiMe3)2
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
N N
1c 2a 3ca
10 mmol 89%
1.85 g
(2)
 
Table 1.3. Scope of Heterocyclic Diarylmethanes in the Allylic Substitutiona 
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HetArPh + OBoc 3 equiv Base
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
HetArPh
N
N
N
O
S
O
1a-g 2a 3aa-3ga
Entry Pronucleophiles Base Yieldb (%)
1c
2c
3
4
5d
6
NaN(SiMe3)2
NaN(SiMe3)2
NaN(SiMe3)2
KN(SiMe3)2
LiN(SiMe3)2
NaN(SiMe3)2
3aa
3ea
3da
3ba
3ca
3fa
99
82
99
91
80
93
N
N
N
O
S
O
Products
1a
1e
1d
1b
1c
1f
N N
7 LiN(SiMe3)2 3ga 85
N N
1g
 
a Reaction conducted on a 0.1 mmol scale with 1 equiv of 1 and 2 equiv of 2a at 
0.1 M . b Isolated yield after chromatographic purification. c 1 mol % Pd(COD)Cl2, 
1.5 mol % Xantphos. d 2.5 equiv of NaN(SiMe3)2 and 2.5 equiv of 15-crown-5. 
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1.2.3. Scope of Diphenylmethane Derivatives in the Allyl ic 
Substitution 
  Diphenylmethane derivatives are more challenging pronucleophiles due to 
their higher pKa’s.39 To compensate for the less favorable equilibrium for 
deprotonation of these pronucleophiles, the amount of base was increased to 5 
equiv. With the optimized reaction conditions for 4a (Table 4, entry 1), we 
investigated 4-halogenated diphenylmethanes (entries 2−4). Compounds 
containing fluorine are important because of their bioactivities and uses in 
material science.47 The reaction with 4-fluoro diphenylmethane (4b) as 
pronucleophile afforded the desired product 5ba in 84% yield (entry 2). We 
then applied our reaction conditions to 4-bromo and 4-chloro diphenylmethanes 
(4c and 4d). A potential problem with these substrates lies in the competing 
oxidative addition of C–X (X = Cl, Br) bonds to the active Pd(0) species. We were 
pleased to find that Pd-catalyzed allylic substitution afforded the allylated 
products 5ca and 5da in 95% and 73% yield, respectively (entries 3 and 4). 
These results suggest that generation of the π-allyl palladium intermediate is 
significantly faster than the oxidative addition of C–X bonds to the Pd(0) species 
under our reaction conditions. Fluorene (4e) derivatives have interesting 
characteristics and can be used in organic light-emitting diodes.44 By using 1.5 
equiv LiN(SiMe3)2 and 1.1 equiv of 2a, 5ea was generated in 87% yield (entry 
5). 4-Cyano diphenylmethane (4fa) is potentially problematic because 
benzonitriles are known to undergo additions with strong bases and 
organometallic reagents.48 Nonetheless, this substrate provided the product 5fa 
in 90% yield (entry 6). As might be anticipated, pronucleophiles with electron 
donating groups are less acidic and, therefore, more difficult to deprotonate. We 
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found that 4-methyl diphenylmethane 4g underwent substitution to give 5ga in 
68% yield at 50 °C (entry 7). Notably, 2-methyl diphenylmethane (4h) reacted 
to provide 5ha in 70% yield at 50 °C (entry 8).  Unfortunately, 4-methoxy 
diphenylmethane did not react under these, or a variety of other conditions. 
 
Table 1.4. Scope of Diphenylmethane Derivatives in Allylic Substitution 
Reactionsa 
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4a-h 2a 5aa-5ha
Entry Pronucleophiles Yieldb (%)
1
2
3
4
5c
6d
7e, g
5aa
5ha
5da
5ba
5ga
5ca
95
73
84
68
95
70
+ OBoc
5 equiv KN(SiMe3)2
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
4a
4h
4d
4b
4g
4c
Products
F
Br
H3C
CH3
F
Br
H3C
CH3
Cl Cl
R R
5fa 904f
NC NC
8f, g
5ea 874e
 
a Reaction conducted on a 0.1 mmol scale with 1 equiv of 4 and 3 equiv of 2a 
at 0.1 M. b Isolated yield after chromatographic purification. c 1.5 equiv of 
LiN(SiMe3)2 and 1.1 equiv of 2a. d 1.5 equiv of KN(SiMe3)2 and 2 equiv of 2a. e 8 
equiv of KN(SiMe3)2. f 10 equiv of KN(SiMe3)2. g Reaction conducted at 50 °C. 
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1.2.4. Dial lylation with Heteroaryl Diarylmethanes 
  Having demonstrated the monoallylation of diarylmethanes and 
heteroaryl-containing derivatives, we next explored the possibility of adding a 
second allyl group to the allylated products prepared above. We were 
encouraged by the formation of small amounts of diallylation products with more 
acidic pronucleophiles (pKa < 30) in the monoallylation optimization process.  
We, therefore, reoptimized the conditions to enable allylation of the purified 
monoallylated products. By employing 5 equiv of KN(SiMe3)2 and 3 equiv of 2a 
with the monoallylated substrates (3aa–3ga, Table 3), we obtained the 
corresponding diallylation products (6aa–6ga, 70−95% yield). These results 
indicate that the allylation chemistry outlined here can be used to establish 
quaternary centers. 
  A more efficient method to prepare the diallylated products would be 
from the diarylmethane derivatives.   We, therefore, set out to develop a one-
pot diallylation protocol. We rationalized that the conditions mentioned above 
for the allylation of the mono-allylated diarylmethanes would be suitable for the 
one-pot diallylation. This approach proved fruitful: the yields for the double 
allylation ranged from 65 to 85% (Table 5, entries 1–5). The one-pot syntheses 
were not efficient for 2-benzylpyridine (1a) and 3-benzylpyridine (1c) as 
pronucleophiles, because the deprotonation events are more difficult for these 
substrates. Nonetheless, starting from monoallylation products 3aa and 3ca we 
obtained the bis-allylated products 6aa and 6ca in 84 and 80% yield (entries 6–
7). We were also able to use 1,1-diarylethane (e.g., 8a) as pronucleophile to 
install an allyl group to afford a quaternary stereocenter (entry 8). Notably, 
triphenylmethane (9a) was used as pronucleophile to give the sterically 
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congested 9aa in 90% yield (entry 9). To summarize, our method afforded 
diaryl- or triarylmethane products containing at least one allyl group on the 
quaternary carbon. Some of the products in Table 5 could presumably be 
employed in ring-closing metathesis reactions49 to prepare 1,1-diarylcyclopent-
3-ene or Pauson–Khand type [2+2+1] reactions50 to afford bicyclic scaffolds.    
 
Table 1.5. Diallylation with Diarylmethanesa 
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N
2a
Entry Pronucleophiles Yieldb (%)
1c, d
2
3e
4f
5e
6
6da
6ba
7ea
6ca
6fa
65
85
85
80
70
5 equiv KN(SiMe3)2
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
1d
1b
4e
3ca
1f
Products
N
PhAr
+ OBoc
Ar Ph
O
S
N
N
O
S
N
7 8aa 908a
N
CH3
8 9aa 909a
PhPh
H3C
R
R
N
6aa 843aa
N
R = Ar, Alkyl, H R = Ar, Alkyl
 
 a Reaction conducted on a 0.1 mmol scale with 1 equiv of pronucleophile and 3 
equiv of 2a at 0.1 M. b Isolated yield after chromatographic purification. c 
Reaction conducted at 0.066 M. d Reaction conducted at 50 °C. e 3 equiv of 
KN(SiMe3)2 and 2 equiv of 2a. f 8 equiv of KN(SiMe3)2. 
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1.2.5. Scope of Electrophiles in Palladium-Catalyzed Allyl ic 
Substitutions  
  Having demonstrated that the simplest allyl electrophile can be used with 
a variety of pronucleophiles, we turned our attention to the nature of the 
electrophilic partner. We chose the more acidic pronucleophile di(3-
pyridyl)methane (1g, Table 3, entry 7) and examined the influence of different 
leaving groups on Pd-catalyzed allylic substitution with cyclohexenyl 
electrophiles (2b, 2c). Both the Boc (2b) and benzoate ester (2c) derivatives 
gave similar yields of 10a (89 and 90% yield, entries 1–2). Changing the ring 
size of the electrophile from six to five (2d) resulted in 90% yield (entry 3) 
when the Boc analogue was used. The classic 1,3-diphenyl allyl precursor 2e 
afforded the allylic substitution product 10c in 87% yield with a 10:1 trans:cis 
ratio (entry 4).  
  Next, the less acidic diphenylmethane (4a) was employed as 
pronucleophile (entries 5–7). The Boc derived cyclohexenyl substrate 2b 
underwent reaction leading to the product in 85% yield (entry 5).  In contrast, 
the benzoate derivative 2c resulted in only 20% yield (entry 6). The low yield is 
likely due to attack of nucleophile on the ester carbonyl.  Changing the benzoate 
ester 2c to the pivalate ester 2f resulted in an increase in the yield to 70% 
(entry 7). Cyclopentenyl OBoc electrophile 2d underwent substitution in the 
presence of diphenylmethane in 94% yield (entry 8).  
  Many electrophilic partners used in allylic substitution reactions lead to 
unsymmetrical h3-allyl groups.  We, therefore, examined the regioselectivity with 
unsymmetrical linear Boc-protected electrophiles such as cinnamyl alcohol (2g), 
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geranyl alcohol (2h) and prenyl alcohol (2i) (Table 6, entries 9–11). It is well 
known that π-allyl palladium complexes are prone to react with carbon 
nucleophiles at the less substituted terminus of the π-allyl.51 For the Pd-
catalyzed allylic substitution with Boc-protected cinnamyl alcohol (2g), the 
linear product 10f was the major product, albeit with moderate regioselectivity 
(2.6:1, entry 9). The reduced regioselectivity in this case, relative to cases with 
less basic nucleophiles,27 is likely a manifestation of the high reactivity of the 4-
benzylpyridine-derived nucleophile.  Interestingly, the prenylation and 
geranylation exhibited opposite regioselectivities (entries 10–11). The Boc 
activated geranyl underwent reaction with 4-benzylpyridine slightly favoring the 
terminal substitution product (1.9:1.0, linear:branched).  In contrast, the 
prenylation afforded the branched product 10h’ with a linear:branched ratio of 
1.0:4.5 (entry 11). We hypothesize that the origin of the regioselectivity in the 
prenylation is a result of the non-bonded interaction between the bulky, wide-
bite angle Xantphos ligand and the more substituted carbon of the h3-allyl.  This 
interaction places a larger d+ partial change on the more substituted terminus 
and, therefore, nucleophilic attack at this position prevails.  The additional 
substituent (=R) on the h3-allyl in the geranylation causes this group to adopt a 
conformation positioning it anti to the bulky (Xantphos)Pd center (Figure 2).  
The substituent partially obstructs the nucleophilic attack at the more 
substituted terminus, resulting in a shift of the regioselectivity toward the less 
substituted carbon of the allyl.     
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CH3
R
Pd
P
P
Ph2
Ph2
H
H
prenylation, R = H
geranylation, R = CH2
Nu
 
Figure 1.2. Proposed conformational model to explain the reversal in 
regioselectivity between the prenylation and geranylation (Table 2, entries 10–
11).  When R=H nucleophilic attack is favored at the more substituted terminus 
(solid arrow).  When R=alkyl, attack follows the dashed arrow leading to the 
linear product. 
 
Table 1.6. Scope of Electrophiles in Allylic Substitution Reactionsa 
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2b-i 10a-10h'
Entry Electrophiles Yieldb (%)
1c
2c
3d
5f
6f
7f
Products
9e, h
10e, h
1b, 1g, 4a
Ar2Ar1 +
 Base
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
OPG
R R
Ar2Ar1
Pronucleophiles
PGO
PG = Boc
PG = Bz
BocO
2b
2c
2d
N N
N N
10a
PGO
PG = Boc
PG = Bz
PG = Piv
1g
1g
1g
4a
4a
4a
2b
2c
2f
10d
8f, g BocO 2d 10e4a
10b
4e
Ph Ph
OBoc N N
Ph Ph
2e 1g 10c
BocO
11e, h
2h 1b 10g
10g'
N
N
BocO Ph 2g
1b
N
H Ph
N
Ph
10f
10f'
BocO
2i 1b
N
N
10h
10h'
89
90
87
85
94
90
20
70
N N
N
(trans: cis = 10:1) i
91
(L:B=2.6:1)i
88
(L:B=1.9:1)i
93
(L:B=1:4.5)i
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a Reaction conducted on a 0.1 mmol scale at 0.1 M. b Isolated yield after 
chromatographic purification. c 3 equiv of NaN(SiMe3)2 and 2 equiv of 2. d 3 
equiv of KN(SiMe3)2 and 2 equiv of 2. e 3 equiv of LiN(SiMe3)2 and 2 equiv of 2. f 
5 equiv of KN(SiMe3)2 and 3 equiv of 2. g Reaction conducted at 50 °C. h 
Reaction conducted at 0 °C. i Ratio of trans:cis or linear:branched (L:B) 
determined by 1H NMR. 
 
1.2.6. Internal vs. External Attack of Diarylmethane on π-Allyl 
Palladium Intermediate 
  As outlined in the Introduction, nucleophiles in allylic substitutions can 
directly add to the π-allyl or to the metal in their reactions with [(η3-allyl)MLn]+ 
intermediates.  It is generally accepted that nucleophiles with conjugate acids of 
pKa < 25, classified as “soft” nucleophiles, undergo external attack on π-allyl 
palladium complexes.  Soft nucleophiles, therefore, result in stereoretentive 
allylic substitutions reactions (via double inversion).52 On the other hand, “hard” 
nucleophiles, those with pKa > 25 are proposed undergo attack on the metal 
center of the π-allyl palladium complexes (i.e., transmetallation) followed by 
reductive elimination to afford net inversion for the allylic substitution.53 
  To examine the mechanistic pathway of the reaction, di(3-
pyridyl)methane (1g) was reacted with cis-disubstituted stereoprobe 2j 
(Scheme 2A) and afforded cis-product 11a in 90% isolated yield as a single 
diastereomer (determined by 1H NMR spectroscopy). Reaction of the less acidic 
pronucleophile diphenylmethane (4a) (pKa = 32.3) with 2j (Scheme 2B) similarly 
furnished the cis-product 11b as a single diastereomer (determined by 1H NMR 
spectroscopy and single crystal X-ray diffraction) in 88% yield. The results 
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indicated both nucleophiles derived from di(3-pyridyl)methane (1g)  and 
diphenylmethane (4a) behave as “soft” nucleophiles and that the pKa limit for 
“soft” nucleophiles should be raised from 25 to 32, a change of 7 orders of 
magnitude.  
Scheme 1.2. Allylic Substitution with Retention of Configuration 
 3 equiv NaN(SiMe3)2
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
11a
90% yield
+
2j
N N
1g
BocO Ph
PhN
N
 5 equiv KN(SiMe3)2
DME, 24 oC, 12 h
5 mol % Pd(COD)Cl2
7.5 mol % Xantphos
11b
88% yield
+
2j4a
pKa = 32.3
BocO Ph
Ph
A. Pd-catalyzed allylic substitution of 1g with 2j
B. Pd-catalyzed allylic substitution of 4a with 2j
 
 
1.3. SUMMARY AND OUTLOOK 
  Herein we have developed a general method for Pd-catalyzed allylic 
substitution with diarylmethane derivatives at room temperature. The synthetic 
significance of the method is that it provides a rapid access to products 
containing allylated diarylmethanyl motifs. The method is general for a wide 
range of nucleophiles derived diarylmethanes and heteroaryl derivatives. A 
tandem procedure for the Pd-catalyzed allylic substitutions to afford diallylation 
products with quaternary centers is also described. With alkylated 
diarylmethanes and triarylmethanes, the method is also efficient to afford the 
corresponding allylated products. We anticipate that the described method will 
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be a valuable complement to the existing arsenal of nucleophiles in Pd-catalyzed 
allylic substitutions.  Mechanistic studies show that diarylmethane derivatives 
behave as “soft” or stabilized nucleophiles. The nucleophile derived from 
diphenylmethane undergoes external attack on π-allyl palladium species under 
our reaction conditions. The results of this study indicate that the cutoff 
between “soft” and “hard” nucleophiles should be raised from a pKa of 25 to at 
least 32.  
 
1.4. EXPERIMENTAL SECTION 
General Methods. All reactions were performed under nitrogen using oven-
dried glassware and standard Schlenk or vacuum line techniques. Air- and 
moisture-sensitive solutions were handled under nitrogen and transferred via 
syringe. The solvents (DME and THF) were sparged for 20 min with dry N2 and 
dried using a commercial two-column solvent purification system comprising 
columns packed with neutral alumina. Unless otherwise stated, reagents were 
commercially available and used as purchased without further purification. 
Chemicals were obtained from Sigma-Aldrich, Acros, TCI America, Strem 
Chemicals or Matrix Scientific, and solvents were purchased from Fisher 
Scientific. The progress of the reactions was monitored by thin-layer 
chromatography using Whatman Partisil K6F 250 μm precoated 60 Å silica gel 
plates and visualized by short-wavelength ultraviolet light as well as by 
treatment potassium permanganate (KMnO4) stain or iodine. Silica gel (230−400 
mesh, Silicycle) was used for flash chromatography. The 1H NMR and 13C{1H} 
NMR spectra were obtained using a Brüker AM-500 Fourier transform NMR 
spectrometer at 500 and 126 MHz, respectively. Chemical shifts are reported in 
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units of parts per million (ppm) downfield from tetramethylsilane (TMS), and all 
coupling constants are reported in hertz. The infrared spectra were obtained 
with KBr plates using a Perkin-Elmer Spectrum 100 Series FTIR spectrometer. 
High-resolution mass spectrometry (HRMS) data were obtained on a Waters 
LC−TOF mass spectrometer (model LCT-XE Premier) using chemical ionization 
(CI) or electrospray ionization (ESI) in positive or negative mode, depending on 
the analyte.  Melting points were determined on a Unimelt Thomas-Hoover 
melting point apparatus and are uncorrected. 
 
General Procedure A: Palladium-Catalyzed Allyl ic Substitution with 
Heterocyclic Diarylmethanes Under Room Temperature. An oven-dried 
10 mL reaction vial equipped with a stir bar was charged with NaN(SiMe3)2 (55 
mg, 0.30 mmol, 3 equiv) under a nitrogen atmosphere. A solution (from a stock 
solution) of Pd(COD)Cl2 (1.43 mg, 0.0050 mmol) and Xantphos (4.34 mg, 
0.0075 mmol) in 1 mL of dry DME was taken up by syringe and added to the 
reaction vial. After stirring for 5 min at 24 °C, 2-benzylpyridine 1a (16 μL, 0.1 
mmol, 1 equiv) was added to the reaction mixture followed by 2a (34 μL, 0.2 
mmol, 2 equiv). Note that the diarylmethanes or allyl-OBoc in a solid form was 
added to the reaction vial prior to NaN(SiMe3)2. The reaction mixture was stirred 
for 12 h at 24 °C, quenched with two drops of H2O, diluted with 3 mL of ethyl 
acetate and filtered over a pad of MgSO4 and silica. The pad was rinsed with 
additional ethyl acetate, and the solution was concentrated in vacuo. The crude 
material was loaded onto a silica gel column and purified by flash 
chromatography eluting with EtOAc/hexanes.  
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General Procedure B: Palladium-Catalyzed Allyl ic Substitution with 
Heterocyclic Diarylmethanes Under 50 °C. An oven-dried 10 mL reaction 
vial equipped with a stir bar was charged with KN(SiMe3)2 (160 mg, 0.80 mmol, 
8 equiv) under a nitrogen atmosphere. A solution (from a stock solution) of 
Pd(COD)Cl2 (1.43 mg, 0.0050 mmol) and Xantphos (4.34 mg, 0.0075 mmol) in 
1 mL of dry DME was taken up by syringe and added to the reaction vial. After 
stirring for 5 min at 24 °C, 4-methyl diphenylmethane 4g (18.5 μL, 0.1 mmol, 1 
equiv) was added to the reaction mixture followed by 2a (51 μL, 0.3 mmol, 3 
equiv). The reaction mixture was stirred for 12 h at 50 °C, quenched with two 
drops of H2O, diluted with 3 mL of ethyl acetate, and filtered over a pad of 
MgSO4 and silica. The pad was rinsed with additional ethyl acetate and the 
solution was concentrated in vacuo. The crude material was loaded onto a silica 
gel column and purified by flash chromatography eluting with EtOAc/hexanes. 
 
General Procedure C: Palladium-Catalyzed Allyl ic Substitution with 
Heterocyclic Diarylmethanes Under 0 °C. An oven-dried 10 mL reaction 
vial equipped with a stir bar was charged with LiN(SiMe3)2 (51 mg, 0.30 mmol, 3 
equiv) under a nitrogen atmosphere. A solution (from a stock solution) of 
Pd(COD)Cl2 (1.43 mg, 0.0050 mmol) and Xantphos (4.34 mg, 0.0075 mmol) in 
1 mL of dry DME was taken up by syringe and added to the reaction vial. After 
stirring for 5 min at 0 °C, 4-benzylpyridine 1b (16 μL, 0.1 mmol, 1 equiv) was 
added to the reaction mixture followed by Boc-protected cinnamyl alcohol 2g 
(46 μL, 0.2 mmol, 2 equiv). The reaction mixture was stirred for 12 h at 0 °C, 
quenched with two drops of H2O, diluted with 3 mL of ethyl acetate, and filtered 
over a pad of MgSO4 and silica. The pad was rinsed with additional ethyl acetate 
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and the solution was concentrated in vacuo. The crude material was loaded onto 
a silica gel column and purified by flash chromatography eluting with 
EtOAc/hexanes 
Preparation of Diarylmethanes. 
Compounds 1e54, 1f55, 1g56, 4f57, 8a58 were prepared according to literature 
procedures. 
 
Preparation of Allyl ic Electrophiles.  
Compounds 2a59, 2b60, 2c61, 2d60, 2e62, 2f63, 2g64, 2h65, 2i65, and 2j66 were prepared 
according to literature procedures. 
 
2-(1-phenylbut-3-en-1-yl)pyridine (1.3aa): The reaction was 
performed following General Procedure A with 1a (16 μL, 0.1 mmol), 
NaN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 10:90) to give the product (21 mg, 99% yield) 
as a yellow oil. Rf = 0.30 (EtOAc:hexanes = 10:90); 1H NMR (500 MHz, CDCl3): δ 8.57 (dt, 
J = 4.8, 0.9 Hz, 1H), 7.54 (td, J = 7.7, 1.8 Hz, 1H), 7.34-7.06 (m, 7H), 5.73 (dd, J = 
17.1, 10.2 Hz, 1H), 5.04-4.91 (m, 2H), 4.15 (t, J = 7.8 Hz, 1H), 3.06-2.82 (m, 2H) 
ppm; 13C {1H} NMR (126 MHz, CDCl3): δ 163.5, 149.5, 143.5, 136.9, 136.5, 128.7, 
128.3, 126.7, 123.1, 121.5, 116.5, 53.8, 39.4 ppm; IR (thin film): 3063, 3025, 3005, 
2975, 2917, 1639, 1589, 1568, 1493, 1471, 1432, 994, 913, 800, 746, 699 cm–1; 
HRMS calc’d for C15H16 N+ 210.1283, observed 210.1287 [MH]+. 
 
4-(1-phenylbut-3-en-1-yl)pyridine (1.3ba): The reaction was 
performed following General Procedure A with 1b (16 μL, 0.1 mmol), 
N
N
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LiN(SiMe3)2 (51 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes to EtOAc:hexanes = 
30:70) to give the product (21 mg, 99% yield) as a yellow oil. Rf = 0.30 (EtOAc:hexanes 
= 40:60); 1H NMR (500 MHz, CDCl3): δ 8.47 (dd, J = 4.5, 1.6 Hz, 2H), 7.30-7.12 (m, 
7H), 5.67 (d, J = 6.8 Hz, 1H), 5.04-4.95 (m, 2H), 3.97 (t, J = 7.9 Hz, 1H), 2.79 (ddd, J 
= 7.9, 6.7, 1.2 Hz, 2H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 153.2, 149.8, 142.5, 
135.7, 128.6, 127.9, 126.7, 123.2, 117.0, 50.5, 39.1 ppm; IR (thin film): 3064, 3026, 
2977, 2923, 1640, 1595, 1557, 1494, 1452, 1413, 994, 916, 813, 746, 700 cm–1; 
HRMS calc’d for C15H16 N+ 210.1283, observed 210.1292 [MH]+. 
 
3-(1-phenylbut-3-en-1-yl)pyridine (1.3ca): The reaction was 
performed following General Procedure A with 1c (17 mg, 0.1 mmol), 
KN(SiMe3)2 (60 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted 
with hexanes to EtOAc:hexanes = 30:70) to give the product (19 mg, 91% yield) as a 
yellow oil. Rf = 0.40 (EtOAc:hexanes = 40:60); 1H NMR (500 MHz, CDCl3): δ 8.50 (d, J = 
2.3 Hz, 1H), 8.40 (dd, J = 4.8, 1.6 Hz, 1H), 7.48 (dt, J = 7.9, 2.0 Hz, 1H), 7.48 (dt, J = 
7.9, 2.0 Hz, 1H), 7.28-7.15 (m, 6H), 5.67 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.03-4.93 
(m, 2H), 4.00 (t, J = 7.9 Hz, 1H), 2.86-2.74 (m, 2H) ppm;13C {1H} NMR (126 MHz, 
CDCl3): δ 149.7, 147.7, 143.3, 139.8, 136.0, 135.3, 128.7, 127.9, 126.6, 123.4, 
117.0, 48.8, 39.6 ppm; IR (thin film): 3061, 3027, 2977, 2925, 1640, 1601, 1574, 
1494, 1478, 1452, 1423, 1025, 994, 916, 813, 750, 714, 700 cm–1; HRMS calc’d for 
C15H16 N+ 210.1283, observed 210.1286 [MH]+. 
 
9-allyl-9H-xanthene (1.3da): The reaction was performed 
following General Procedure A with 1d (18.2 mg, 0.1 mmol), 
N
O
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NaN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to give the product 
(18 mg, 82% yield) as a colorless oil. Rf = 0.25 (hexanes); The NMR spectral data match 
the previously published data.67 
 
2-(1-phenylbut-3-en-1-yl)furan (1.3ea): The reaction was 
performed following General Procedure A with 1e (15 μL, 0.1 mmol), 
NaN(SiMe3)2 (45 mg, 0.25 mmol), 15-Crown-5 (50 μL, 0.25 mmol) 
and 2a (34 μL, 0.2 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (15.8 mg, 80% 
yield) as a colorless oil. Rf = 0.25 (hexanes); The NMR spectral data match the previously 
published data.68  
 
2-(1-phenylbut-3-en-1-yl)thiophene (1.3fa): The reaction was 
performed following General Procedure A with 1f (16 μL, 0.1 mmol), 
NaN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with hexanes) 
to give the product (20 mg, 93% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR 
spectral data match the previously published data.69 
 
3,3'-(but-3-ene-1,1-diyl)dipyridine (1.3ga): The reaction was 
performed following General Procedure A with 1g (17 mg, 0.1 mmol), 
LiN(SiMe3)2 (51 mg, 0.30 mmol) and 2a (34 μL, 0.2 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted 
with MeOH:DCM = 2.5:97.5) to give the product (18 mg, 85% yield) as a yellow oil. Rf = 
0.30 (MeOH:DCM = 2.5:97.5); 1H NMR (500 MHz, CDCl3): δ 8.54-8.44 (m, 4H), 7.49 (dt, 
J = 7.9, 1.8 Hz, 2H), 7.24-7.20 (m, 2H), 5.69-5.61 (m, 1H), 5.03-4.97 (m, 2H), 4.04 
O
S
N N
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(dd, J = 10.1, 5.7 Hz, 1H), 2.81 (t, J = 7.3 Hz, 2H) ppm;13C {1H}  NMR (126 MHz, CDCl3): 
δ 149.5, 148.1, 138.5, 135.14, 135.02, 123.5, 117.7, 46.2, 39.2.; IR (thin film): 3078, 
3032, 3001, 2978, 2852, 1641, 1589, 1575, 1479, 1423, 1178, 1132, 1047, 1025, 
994, 917, 803, 775, 715 cm–1; HRMS calc’d for C14H15 N2+ 211.1235, observed 
211.1238 [MH]+ 
 
but-3-ene-1,1-diyldibenzene (1.5aa): The reaction was 
performed following General Procedure A with 4a (17 μL, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a (51 μL, 0.3 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (20 mg, 95% yield) as a colorless oil. Rf = 
0.25 (hexanes); The NMR spectral data match the previously published data.70 
 
1-fluoro-4-(1-phenylbut-3-en-1-yl)benzene (1.5ba): The 
reaction was performed following General Procedure A with 4b (17 
μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a (51 μL, 
0.3 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (19 mg, 84% 
yield) as a colorless oil. Rf = 0.25 (hexanes); 1H NMR (500 MHz, CDCl3): δ 7.29-7.16 (m, 
9H), 6.97-6.93 (m, 2H), 5.69 (dd, J = 17.1, 10.2 Hz, 1H), 5.03-4.93 (m, 2H), 3.98 (t, J 
= 7.8 Hz, 1H), 2.80-2.76 (m, 2H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 161.3 (J = 
244 Hz), 144.3, 140.1 (J = 3.4 Hz), 136.5, 129.26 (J = 7.6 Hz), 128.4, 127.8, 126.3, 
116.4, 115.09 (J = 21.3 Hz), 50.4, 40.0 ppm; IR (thin film): 3063, 3027, 3003, 2977, 
2924, 2850, 1640, 1603, 1508, 1494, 994, 915, 833, 771, 698 cm–1; HRMS calc’d for 
C16H16 F+ 227.1236, observed 227.1232 [MH]+. 
 
F
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 1-chloro-4-(1-phenylbut-3-en-1-yl)benzene (1.5ca): The 
reaction was performed following General Procedure A with 4c 
(18 μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a (51 
μL, 0.3 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (23 mg, 95% 
yield) as a colorless oil. Rf = 0.25 (hexanes); The NMR spectral data match the previously 
published data.70 
 
1-bromo-4-(1-phenylbut-3-en-1-yl)benzene (1.5da): The 
reaction was performed following General Procedure A with 4d 
(18.5 μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a 
(51 μL, 0.3 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (21 mg, 73% 
yield) as a colorless oil. Rf = 0.25 (hexanes); 1H NMR (500 MHz, CDCl3): δ 7.42-7.10 (m, 
9H), 5.71 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.06-4.96 (m, 2H), 3.99 (t, J = 7.9 Hz, 1H), 
2.82-2.78 (m, 2H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 143.9, 143.5, 136.4, 131.5, 
129.8, 128.5, 127.9, 126.4, 120.0, 116.7, 50.7, 39.8 ppm; IR (thin film): 3076, 3062, 
3025, 3002, 2976, 2924, 2850, 1640, 1599, 1487, 1451, 1402, 1114, 1073, 1009, 
915, 815, 747, 699 cm–1; HRMS calc’d for C13H10Br+ 246.0044, observed 246.0163 [M-
C3H5]+. 
 
 9-allyl-9H-fluorene (1.5ea): The reaction was performed following 
General Procedure A with 4e (16.7 mg, 0.1 mmol), LiN(SiMe3)2 (25 mg, 
0.15 mmol) and 2a (19 μL, 0.11 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to 
give the product (18 mg, 87% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR 
spectral data match the previously published data.71 
Cl
Br
 32 
 
 4-(1-phenylbut-3-en-1-yl)benzonitri le (1.5fa): The 
reaction was performed following General Procedure A with 4f 
(19 mg, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2a (34 
μL, 0.2 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes to EtOAc:hexanes = 5:95) to give the 
product (21 mg, 90% yield) as a colorless oil. Rf = 0.25 (EtOAc:hexanes = 5:95); 1H NMR 
(500 MHz, CDCl3): δ 7.59-7.58 (m, 2H), 7.37-7.22 (m, 7H), 5.73-5.66 (m, 1H), 5.08-
4.99 (m, 2H), 4.09 (t, J = 7.9 Hz, 1H), 2.88-2.80 (m, 2H) ppm;13C {1H}  NMR (126 MHz, 
CDCl3): δ 150.0, 142.9, 135.7, 132.2, 128.75, 128.67, 127.8, 126.7, 118.9, 117.1, 
110.0, 51.1, 39.4 ppm; IR (thin film): 3063, 3027, 3003, 2977, 2925, 2227, 1641, 
1605, 1502, 1492, 1451, 1414, 1020, 994, 916, 862, 826, 765, 730, 700 cm–1; 
HRMS calc’d for C17H15NNa+ 256.1102, observed 256.1111 [M+Na]+ 
 
1-methyl-4-(1-phenylbut-3-en-1-yl)benzene 
(1.5ga):The reaction was performed following General 
Procedure B with 4g (18.5 μL, 0.1 mmol), KN(SiMe3)2 (160 mg, 
0.8 mmol) and 2a (51 μL, 0.3 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to give the product 
(15 mg, 68% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR spectral data match 
the previously published data.70 
 
1-methyl-2-(1-phenylbut-3-en-1-yl)benzene (1.5ha):The 
reaction was performed following General Procedure B with 4h (18.5 
μL, 0.1 mmol), KN(SiMe3)2 (200 mg, 1.0 mmol) and 2a (51 μL, 0.3 
mmol). The crude material was purified by flash chromatography on 
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silica gel (eluted with hexanes) to give the product (15.5 mg, 70% yield) as a colorless 
oil. Rf = 0.20 (hexanes); The NMR spectral data match the previously published data.72 
 
4-(4-phenylhepta-1,6-dien-4-yl)pyridine (1.6ba): The 
reaction was performed following General Procedure B with 1b (16 μL, 
0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol) 
at 0.066 M. The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 40:60) to give the product (21 mg, 85% yield) 
as a colorless oil. Rf = 0.25 (EtOAc:hexanes = 40:60); 1H NMR (500 MHz, CDCl3): δ 8.47 
(dd, J = 4.9, 1.2 Hz, 2H), 7.28-7.05 (m, 7H), 5.32-5.27 (m, 2H), 5.00-4.95 (m, 4H), 
2.83 (dd, J = 6.7, 3.4 Hz, 4H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 156.9, 149.4, 
145.9, 133.4, 128.1, 127.7, 126.3, 123.2, 118.6, 48.8, 41.3 ppm; IR (thin film): 3074, 
3024, 2978, 2931, 2853, 1638, 1594, 1551, 1494, 1445, 1411, 996, 916, 819, 773, 
749, 700, 664 cm–1; HRMS calc’d for C18H20N+ 250.1595, observed 250.1595 [MH]+. 
 
9,9-dial lyl-9H-xanthene (1.6da): The reaction was performed 
following General Procedure A with 1b (18.2 mg, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (17 mg, 65% yield) as a colorless oil. Rf = 0.25 
(hexanes); 1H NMR (500 MHz, CDCl3): δ 7.32-6.98 (m, 9H), 5.39-5.34 (m, 2H), 4.80-
4.76 (m, 4H), 2.74 (dd, J = 8.1, 1.0 Hz, 4H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 
151.7, 134.0, 127.5, 126.8, 124.7, 122.9, 117.9, 116.2, 48.0, 42.2 ppm; IR (thin film): 
3074, 3005, 2978, 2923, 2852, 1639, 1599, 1572, 1480, 1447, 1326, 1303, 1266, 
1232, 1130, 1098, 1042, 994, 916, 886, 749, 700, 665 cm–1; HRMS calc’d for C16H13+ 
221.0967, observed 221.0963 [M-C3H5]+. 
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9,9-diallyl-9H-fluorene (1.7ea): The reaction was performed 
following General Procedure A with 4e (16.7 mg, 0.1 mmol), 
KN(SiMe3)2 (60 mg, 0.3 mmol) and 2a (34 μL, 0.2 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with 
hexanes) to give the product (21 mg, 85% yield) as a colorless oil. Rf = 0.20 (hexanes); 
The NMR spectral data match the previously published data.73 
 
2-(4-phenylhepta-1,6-dien-4-yl)thiophene (1.6fa): The 
reaction was performed following General Procedure A with 1f (16 μL, 
0.1 mmol), KN(SiMe3)2 (160 mg, 0.8 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (18 mg, 70% yield) as a colorless oil. Rf = 
0.30 (hexanes); 1H NMR (500 MHz, CDCl3): δ 7.28-7.24 (m, 4H), 7.20-7.15 (m, 2H), 
6.91 (dd, J = 5.1, 3.6 Hz, 1H), 6.84 (dd, J = 3.6, 1.2 Hz, 1H), 5.44 (ddt, J = 17.2, 10.1, 
7.0 Hz, 2H), 5.04-4.97 (m, 4H), 2.90-2.87 (m, 4H) ppm;13C {1H}  NMR (126 MHz, CDCl3): 
δ 153.7, 147.0, 134.1, 127.9, 127.3, 126.3, 126.0, 124.3, 123.8, 118.2, 47.6, 43.5 
ppm; IR (thin film): 3073, 3007, 2977, 2929, 2853, 1638, 1597, 1494, 1443, 1414, 
1234, 997, 915, 849, 826, 771, 743, 695, 665 cm–1; HRMS calc’d for C14H14S+ 
214.0816, observed 214.0850 [M-C3H5]+. 
 
2-(4-phenylhepta-1,6-dien-4-yl)pyridine (1.6aa): The reaction 
was performed following General Procedure B with 3aa (21 μL, 0.1 
mmol), KN(SiMe3)2 (60 mg, 0.3 mmol) and 2a (34 μL, 0.2 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with hexanes to 
EtOAc:hexanes = 5:95) to give the product (21 mg, 84% yield) as a colorless oil. Rf = 
0.30 (EtOAc:hexanes = 5:95); 1H NMR (500 MHz, CDCl3): δ 8.61-8.53 (m, 1H), 7.52 
(ddd, J = 8.0, 7.5, 1.9 Hz, 1H), 7.28-7.02 (m, 8H), 5.36 (ddt, J = 17.2, 10.1, 7.1 Hz, 
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2H), 4.99-4.91 (m, 4H), 3.04-2.93 (m, 4H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 
166.3, 148.2, 146.7, 135.7, 134.4, 128.0, 127.6, 125.9, 123.1, 120.9, 117.8, 51.4, 
41.4 ppm; IR (thin film): 3073, 3005, 2977, 2926, 2854, 1638, 1586, 1566, 1495, 
1468, 1444, 1428, 1152, 994, 913, 798, 762, 748, 700, 666 cm–1; HRMS calc’d for 
C18H19N+ 249.1517, observed 249.1514 [M]+. 
 
3-(4-phenylhepta-1,6-dien-4-yl)pyridine (1.6ca): The reaction 
was performed following General Procedure A with 3ca (20 μL, 0.1 
mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 20:80) to give the product (20 mg, 80% yield) 
as a colorless oil. Rf = 0.20 (EtOAc:hexanes = 20:80); 1H NMR (500 MHz, CDCl3): δ 8.45-
8.41 (m, 2H), 7.41 (ddt, J = 8.0, 2.5, 1.3 Hz, 1H), 7.28-7.24 (m, 2H), 7.20-7.13 (m, 
4H), 5.36-5.29 (m, 2H), 4.99-4.96 (m, 4H), 2.87 (d, J = 7.0 Hz, 4H) ppm;13C {1H}  NMR 
(126 MHz, CDCl3): δ 149.5, 147.2, 146.4, 143.0, 135.5, 133.6, 128.1, 127.8, 126.2, 
122.7, 118.5, 47.8, 41.7 ppm; IR (thin film): 3074, 3029, 3007, 2977, 2930, 2853, 
1638, 1597, 1572, 1477, 1445, 1414, 1136, 1023, 997, 916, 809, 769, 740, 714, 
700, 666 cm–1; HRMS calc’d for C18H20N+ 250.1595, observed 210.1606 [MH]+ 
 
2-(2-phenylpent-4-en-2-yl)pyridine (1.8aa): The reaction was 
performed following General Procedure A with 8a (18 μL, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with hexanes to 
EtOAc:hexanes = 5:95) to give the product (20 mg, 90% yield) as a colorless oil. Rf = 
0.20 (EtOAc:hexanes = 5:95); 1H NMR (500 MHz, CDCl3): δ 8.51-8.49 (m, 1H), 7.46-
7.42 (m, 1H), 7.21-7.08 (m, 5H), 7.01-6.95 (m, 2H), 5.44-5.37 (m, 1H), 4.97-4.85 (m, 
2H), 3.04-2.85 (m, 2H), 1.60 (s, 3H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 167.6, 
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148.3, 147.9, 135.9, 135.2, 128.0, 127.1, 125.9, 122.4, 120.8, 117.5, 48.4, 45.4, 
26.1 ppm; IR (thin film): 3061, 3028, 2974, 2924, 1638, 1586, 1567, 1494, 1469, 
1444, 1427, 1374, 1152, 1091, 1028, 993, 913, 788, 759, 747, 700, 665 cm–1; 
HRMS calc’d for C16H18N+ 224.1439, observed 224.1436 [MH]+. 
 
but-3-ene-1,1,1-triyltribenzene (1.9aa): The reaction was 
performed following General Procedure A with 9a (24.4 mg, 0.1 
mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel (eluted with 
hexanes) to give the product (25.5 mg, 90% yield) as white solid. Rf = 0.20 (hexanes); 
The NMR spectral data match the previously published data. 74  
 
3,3'-(cyclohex-2-en-1-ylmethylene)dipyridine (1.10a): The 
reaction was performed following General Procedure A with 1g (17 
mg, 0.1 mmol), NaN(SiMe3)2 (55 mg, 0.3 mmol) and 2b (40 μL, 0.2 
mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with MeOH:DCM = 2.5:97.5) to give the product (22 mg, 89% yield) as 
a yellow oil. Rf = 0.25 (MeOH:DCM = 2.5:97.5); 1H NMR (500 MHz, CDCl3): δ 8.60 (dd, J 
= 14.6, 2.2, 2H), 8.49 (ddd, J = 6.5, 4.8, 1.6, 2H), 7.68-7.59 (m, 2H), 7.31-7.24 (m, 
2H), 5.78-5.75 (m, 1H), 5.44-5.41 (m, 1H), 3.72 (d, J = 11.1 Hz, 1H), 3.06-3.02 (m, 
1H), 2.05-2.02 (m, 2H), 1.79-1.74 (m, 1H), 1.68-1.54 (m, 2H), 1.33-1.23 (m, 1H) 
ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 150.0, 148.04, 138.0, 135.0, 129.4, 128.2, 
123.6, 52.8, 38.4, 28.0, 25.2, 21.1 ppm; IR (thin film): 3082, 3024, 2927, 2857, 
2836, 1719, 1587, 1574, 1478, 1174, 1138, 1045, 1024, 902, 860, 792, 721, 680, 
665 cm–1; HRMS calc’d for C17H19N2+ 251.1548, observed 251.1548 [MH]+. 
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3,3'-(cyclopent-2-en-1-ylmethylene)dipyridine (1.10b): The 
reaction was performed following General Procedure A with 1g (17 
mg, 0.1 mmol), KN(SiMe3)2 (60 mg, 0.3 mmol) and 2d (40 μL, 0.2 
mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with MeOH:DCM = 2.5:97.5) to give the product (21.2 mg, 90% yield) 
as a yellow oil. Rf = 0.25 (MeOH:DCM = 2.5:97.5); 1H NMR (500 MHz, CDCl3): δ 8.53 (dd, 
J = 10.8, 2.3 Hz, 2H), 8.41 (s, 2H), 7.55 (ddt, J = 12.5, 8.0, 2.1 Hz, 2H), 7.26-7.18 (m, 
2H), 5.78 (dq, J = 5.9, 2.1 Hz, 1H), 5.42 (dq, J = 5.8, 2.0 Hz, 1H), 3.68 (d, J = 10.8 Hz, 
1H), 3.56 (dtd, J = 8.4, 4.2, 2.2 Hz, 1H), 2.32-2.27 (m, 2H), 1.98 (dtd, J = 13.3, 8.1, 
5.3 Hz, 1H), 1.44 (ddt, J = 13.2, 8.7, 6.5 Hz, 1H) ppm;13C {1H}  NMR (126 MHz, CDCl3): 
δ 149.8, 148.1, 138.9, 135.4, 132.8, 132.3, 123.6, 52.9, 49.7, 32.0, 29.1 ppm; IR 
(thin film): 3051, 2928, 2849, 1574, 1478, 1421, 1177, 1105, 1025, 918, 862, 797, 
718, 665 cm–1; HRMS calc’d for C16H17N2+ 237.1391, observed 237.1391 [MH]+. 
 
(E)-3,3'-(2,4-diphenylbut-3-ene-1,1-diyl)dipyridine 
(1.10c): The reaction was performed following General Procedure 
A with 1g (17 mg, 0.1 mmol), LiN(SiMe3)2 (51 mg, 0.3 mmol) and 
2e (62 mg, 0.2 mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with MeOH:DCM = 2.5:97.5) to give the product (31.5 mg, 87% yield 
trans:cis= 10:1) as a yellow oil. Rf = 0.20 (MeOH:DCM = 2.5:97.5); 1H NMR (500 MHz, 
CDCl3): δ 8.66 (d, J = 2.2 Hz, 1H), 8.44 (d, J = 1.3 Hz, 1H), 8.39 (d, J = 2.2 Hz, 1H), 
8.29 (dd, J = 4.8, 1.4 Hz, 1H), 7.69 (dt, J = 8.0, 1.9 Hz, 1H), 7.46 (dt, J = 8.0, 1.9 Hz, 
1H), 7.26-7.04 (m, 12H), 6.29-6.22 (m, 2H), 4.45 (d, J = 11.5 Hz, 1H), 4.29 (dd, J = 
11.5, 6.2 Hz, 1H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 150.2, 148.3, 147.8, 141.5, 
137.5, 136.9, 135.9, 132.3, 131.2, 128.8, 128.2, 127.5, 126.8, 126.2, 123.6, 53.6, 
52.6 ppm; IR (thin film): 3081, 3026, 2926, 1575, 1479, 1423, 1372, 1175, 1129, 
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1105, 1076, 1025, 966, 912, 789, 761, 664 cm–1; HRMS calc’d for C26H23N2+ 
363.1861, observed 363.1861 [MH]+. 
 
 (cyclohex-2-en-1-ylmethylene)dibenzene (1.10d): The 
reaction was performed following General Procedure A with 4a (17 μL, 
0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2b (60 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (21 mg, 85% yield) as white solid. Rf = 0.20 
(hexanes), KMnO4 stained; The NMR spectral data match the previously published data.75 
 
 (cyclopent-2-en-1-ylmethylene)dibenzene (1.10e): The 
reaction was performed following General Procedure B with 4a (17 μL, 
0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2d (60 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (22 mg, 94% yield) as white solid. Rf = 0.20 
(hexanes), KMnO4 stained; The NMR spectral data match the previously published data.66 
 
(E)-4-(1,4-diphenylbut-3-en-1-yl)pyridine (1.10f): The 
reaction was performed following General Procedure C with 1b (16 
μL, 0.1 mmol), LiN(SiMe3)2 (51 mg, 0.3 mmol) and 2g (46 μL, 0.2 
mmol). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes to EtOAc:hexanes = 40:60) to give the product (26 mg, 91% yield 
linear:branched= 2.6:1) as a yellow oil. Rf = 0.30 (EtOAc:hexanes = 40:60); 1H NMR (500 
MHz, CDCl3): δ 8.50 (d, J = 4.8 Hz, 2H), 7.34-7.08 (m, 12H), 6.39 (dd, J = 15.8, 0.9 Hz, 
1H), 6.05 (dtd, J = 15.7, 7.1, 1.1 Hz, 1H), 4.06-4.03 (m, 1H), 2.98-2.90 (m, 2H) 
ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 153.2, 149.7, 142.5, 137.2, 132.2, 128.68, 
128.55, 128.43, 128.29, 128.16, 127.9, 127.4, 126.8, 126.0, 123.3, 50.9, 38.4 ppm; 
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IR (thin film): 3059, 3025, 2922, 2851, 1945, 1878, 1805, 1594, 1557, 1493, 1451, 
1413, 1279, 1072, 1029, 993, 967, 916, 810, 749, 699, 640 cm–1; HRMS calc’d for 
C21H20N+ 286.1595, observed 286.1591 [MH]+ 
 
 (E)-4-(4,8-dimethyl-1-phenylnona-3,7-dien-1-
yl)pyridine (1.10g): The reaction was performed following 
General Procedure C with 1b (16 μL, 0.1 mmol), LiN(SiMe3)2 
(51 mg, 0.3 mmol) and 2h (56 μL, 0.2 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with hexanes to 
EtOAc:hexanes = 40:60) to give the product (27 mg, 88% yield linear:branched= 1.9:1) 
as a yellow oil. Rf = 0.25 (EtOAc:hexanes = 40:60); 1H NMR (500 MHz, CDCl3): δ 8.49-
8.46 (m, 2H), 7.39-7.14 (m, 7H), 5.03-4.97 (m, 2H), 3.92 (t, J = 7.8 Hz, 1H), 2.75-
2.72 (m, 2H), 1.95 (td, J = 17.4, 10.3 Hz, 4H), 1.65 (d, J = 7.5 Hz, 3H), 1.55 (d, J = 
9.8 Hz, 6H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 153.8, 149.7, 143.2, 137.2, 131.4, 
130.1, 128.6, 126.7, 125.2, 124.1, 123.5, 62.6, 51.0, 39.7, 33.6, 26.5, 25.7, 16.2 
ppm; IR (thin film): 3058, 2917, 1593, 1493, 1451, 1413, 1028, 993, 699, 665 cm–1; 
HRMS calc’d for C22H28N+ 306.2221, observed 306.2220 [MH]+. 
 
 4-(2,2-dimethyl-1-phenylbut-3-en-1-yl)pyridine (1.10h’): 
The reaction was performed following General Procedure C with 1b 
(16 μL, 0.1 mmol), LiN(SiMe3)2 (51 mg, 0.3 mmol) and 2i (41 μL, 
0.2 mmol). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes to EtOAc:hexanes = 30:70) to give the product (22 mg, 93% yield 
linear:branched= 1:4.5) as a yellow oil. Rf = 0.30 (EtOAc:hexanes = 30:70); 1H NMR (500 
MHz, CDCl3): δ 8.45 (d, J = 5.8 Hz, 2H), 7.33-7.18 (m, 7H), 5.99 (dd, J = 17.5, 10.8 Hz, 
1H), 5.11-4.98 (m, 2H), 3.74 (s, 1H), 1.06 (s, 6H) ppm;13C {1H}  NMR (126 MHz, CDCl3): 
δ 151.3, 149.3, 144.8, 140.6, 129.8, 128.0, 126.7, 125.0, 113.0, 63.0, 40.2, 27.34, 
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27.26 ppm; IR (thin film): 3059, 3026, 2964, 2925, 2868, 1636, 1593, 1556, 1494, 
1453, 1415, 1379, 1363, 1221, 1166, 1072, 1012, 994, 916, 822, 746, 701, 640 
cm–1; HRMS calc’d for C17H19N+ 237.1517, observed 237.1525 [M]+. 
 
3,3'-(((1R ,3R)-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-
yl)methylene)dipyridine (1.11a): The reaction was 
performed following General Procedure A with 1g (17 mg, 0.1 
mmol), NaN(SiMe3)2 (55 mg, 0.3 mmol) and 2j (54 μL, 0.2 
mmol). The crude material was purified by flash chromatography on silica gel (eluted 
with MeOH:DCM = 2.5:97.5) to give the product (29.4 mg, 90% yield) as a white solid 
(m.p. = 104-105 °C). Rf = 0.20 (MeOH:DCM = 2.5:97.5); 1H NMR (500 MHz, CDCl3): δ 
8.61 (d, J = 2.1Hz, 1H), 8.56 (d, J = 2.1Hz, 1H), 8.49 (dd, J = 4.8, 1.6 Hz, 1H), 8.41 
(dd, J = 4.8, 1.6 Hz, 1H), 7.67 (dt, J = 7.9, 2.0 Hz, 1H), 7.56 (dt, J = 8.0, 2.0 Hz, 1H), 
7.28-7.25 (m, 3H), 7.19-7.13 (m, 3H), 5.83 (dq, J = 7.6, 2.6 Hz, 1H), 5.49 (ddd, J = 
10.2, 2.5, 1.3 Hz, 1H), 3.70 (d, J = 11.0 Hz, 1H), 3.29-3.23 (m, 1H), 2.90-2.84 (m, 
1H), 2.34-2.28 (m, 1H), 2.18-2.11 (m, 1H), 1.80-1.76 (m, 1H), 1.42 (td, J = 12.6, 
10.9 Hz, 1H) ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 150.1, 149.6, 148.2, 146.3, 
138.0, 135.5, 135.1, 129.1, 128.5, 128.1, 126.8, 126.3, 123.7, 53.2, 40.57, 40.45, 
36.2, 34.0 ppm; IR (thin film): 3026, 2906, 2852, 2836, 1733, 1649, 1574, 1492, 
1452, 1243, 1175, 1142, 1045, 1024, 909, 849, 794, 721, 701, 666 cm–1; HRMS 
calc’d for C23H23N2+ 327.1861, observed 327.1867 [MH]+ . 
Stereochemistry was assigned by 1H NMR analysis.66 
 
(1R ,3R)-3-benzhydryl-1,2,3,6-tetrahydro-1,1'-biphenyl 
(1.11b): The reaction was performed following General 
Procedure A with 4a (17 μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 
mmol) and 2j (81 μL, 0.3 mmol). The crude material was purified 
PhN
N
Ph
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by flash chromatography on silica gel (eluted with hexanes to EtOAc:hexanes = 2:98) to 
give the product (28.5 mg, 88% yield) as a white solid (m.p = 124-125 °C). Rf = 0.25 
(EtOAc:hexanes = 2:98); 1H NMR (500 MHz, CDCl3): δ 7.32-7.06 (m, 17H), 5.74-5.71 
(m, 1H), 5.52-5.50 (m, 1H), 3.58 (d, J = 11.3, 1H), 3.24-3.18 (m, 1H), 2.86-2.79 (m, 
1H), 2.27-2.22 (m, 1H), 2.13-2.05 (m, 1H), 1.80-1.76 (m, 1H), 1.40-1.33 (m, 1H) 
ppm;13C {1H}  NMR (126 MHz, CDCl3): δ 147.0, 143.83, 143.72, 129.8, 128.59, 128.53, 
128.38, 128.35, 127.89, 127.73, 126.9, 126.23, 126.17, 126.06, 58.4, 40.8, 36.2, 
34.3 ppm; IR (thin film): 3083, 3060, 3024, 2905, 1648, 1596, 1492, 1450, 1072, 
1028, 960, 906, 758, 745, 726, 698 cm–1; HRMS calc’d for C13H11+ 167.0860, 
observed 167.0863 [M-C12H13]+  
Stereochemistry was assigned by X-Ray structure determination and by 1H NMR 
analysis.66  
 
Screening Results of Ethereal Solventsa  
+ OBoc
5 mol % Pd(COD)Cl2 
7.5 mol %Xantphos
3 equiv KN(SiMe3)2
solvent, 12 h, rt
entry yield (%)bsolvent(4a:base:2a)
1 1:3:2 THF 10%
2 1:3:2 CPME 9%
3 1:3:2 Dioxane trace
4 1:3:2 2-Me THF 7%
5 1:3:2 DME 55%
4a 2a 5aa
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a Reaction conducted on a 0.1 mmol scale with 1 equiv of 4a and 2 equiv of 2a 
at 0.1M . b Yield determined by 1H NMR spectroscopy of the crude reaction 
mixture. 
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Chapter 2 
Nickel-Catalyzed Allylic Alkylation of  
Diarylmethane Derivatives and Mechanistic Insight. 
 
 
 
2.1. INTRODUCTION 
Metal-catalyzed allylic substitution reactions remain one of the most 
efficient approaches to construct carbon-carbon bond between sp3-hybridized 
carbons.1 Among the transition metals used in allylic substitution reactions, 
palladium has attracted the most attention and met with the greatest success.  
Many enantioselective catalysts have been developed and applied to the 
synthesis of natural products.1-6 
The mechanisms of allylic substitution reactions promoted by a variety of 
catalysts with different nucleophiles have been reported.1,2 From these studies, 
trends in reactivity and reaction pathways have emerged and are now well 
accepted.  Importantly, the reaction pathway has been found to depend on the 
nature of the nucleophile.1 Thus, based on the pKa of the pronucleophile, Nu–H, 
anionic nucleophiles (Nu–) are divided into two classes: carbon nucleophiles 
derived from pronucleophiles with pKa‘s < 25 are considered stabilized or “soft” 
nucleophiles while those from pronucleophiles with pKa‘s > 25 are categorized as 
unstabilized or “hard” nucleophiles. The difference between these two classes of 
nucleophiles is that soft nucleophiles attack the Pd(π-allyl) moiety externally 
while hard nucleophiles bind to the metal center (via transmetallation) before C–
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C bond formation with the allyl group. Another important distinction between 
these two pathways is that it has proven easier to control reactions of soft 
nucleophiles in asymmetric allylic substitution reactions than hard 
nucleophiles.1,3,7-10 With this in mind, several groups have set out to expand the 
scope of soft nucleophiles in palladium-catalyzed asymmetric allylic alkylation 
chemistry. This effort has resulted in development of successful asymmetric 
allylic substitution reactions with pronucleophiles with pKa‘s > 25 that behave as 
“soft” nucleophiles, thus challenging the boundary “soft” nucleophiles.11-15 
In to contrast palladium catalyzed allylic substitutions, which have been 
extensively used with soft nucleophiles, nickel-based catalysts have generally 
been paired with hard nucleophiles, such as Grignard reagents. 6,16-27 A downside 
to palladium catalysts is their high costs, motivating a shift from palladium to 
more sustainable base metal catalysts.  Thus, substitution of nickel for palladium 
in allylic substitution reactions would be highly desirable, especially if 
enantioselective versions could be achieved. 
Early examples of nickel catalyzed allylic substitution reactions include 
Hiyama and coworkers use of (S,S)-chiraphos (Scheme 2.1A).16  In a cleaver 
application of achiral ligands to optimize enantioselectivity,28 Hoveyda and 
coworkers used the [(S,S)-chiraphos]Ni-based catalyst in the presence of PR3 
and Grignard reagents to develop an enantioselective synthesis of enol ethers 
(Scheme 2.1B).17  Consiglio and coworkers determined that the nucleophilic 
attack occurred at the nickel center (transmetallation) followed by reductive 
elimination to form the product.6,20 They found excellent enantioselectivity can 
be achieved with EtMgBr, but both MeMgBr and (n-Pr)MgBr exhibited significantly 
lower enantioselectivities (Scheme 2.1C).19  This observation highlights the 
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challenges in enantiocontrol via the “hard” nucleophile pathway. Unlike hard 
nucleophiles, soft nucleophiles that exhibit external attack in nickel-catalyzed 
asymmetric allylic alkylations show reduced enantioselection (up to 40% ee,  
Scheme 2.1D). 29 
Our interest in the palladium catalyzed Tsuji-Trost reaction has been in 
expanding the scope of soft nucleophiles and broadening the synthetic utility of 
this reaction.  We recently demonstrated that diarylmethane pronucleophiles 
behave as soft nucleophiles in allylic substitution reactions under basic 
conditions, raising the pKa limit of soft nucleophiles from 25 to at least 32.14  In 
the current study, we asked 1) if diarylmethane pronucleophiles were suitable 
substrates for nickel catalyzed allylic substitution reactions, 2) if they would 
react via the hard or soft nucleophile pathway, and 3) if enantioselective 
reactions would be possible.  Herein, we communicate that these basic 
nucleophiles react via the soft nucleophile pathway and we present promising 
preliminary evidence for development of an asymmetric version of nickel-
catalyzed allylic substitution reactions via the soft nucleophile pathway. 
 
Scheme 2.1. Previous Works On Ni-Catalyzed Asymmetric Allylic Alkylation  
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2.2. Results and Discussion 
Given the success of our (Xantphos)Pd-catalyzed allylic substitution with 
diarylmethane pronucleophiles, we initiated our investigation by simply replacing 
Pd with Ni under the same conditions. 14 Thus, employing Ni(COD)2 and van 
Leeuwen’s Xantphos30 (10 mol % each) with allylOBoc and KN(SiMe3)2, we were 
pleased that 63% yield of the allylated product was obtained (eq 2.1)  
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+ OBoc
 10% Ni(COD)2
10%Xantphos
5 equiv KN(SiMe3)2
solvent, 24 oC, 12 h
1 equiv 3 equiv
63%
O
PPh2 PPh2
Xantphos
(1)
 
During the course of the reaction an insoluble orange precipitate formed 
which we suspected was Ni(Xantphos)2. Therefore, 24 ligands were screened 
under the conditions in eq 2.1 (see Supporting Information) leading to 
determination that DPPF was superior to Xantphos.  We then screened the nickel 
to ligand ratios, with 5 mol % nickel and 10 mol % DPPF we could obtain desired 
product in 72% yield (Table 2.1, entry 3).  Solvents screening showed DME to 
give the best yields.  Testing nickel sources NiCl2 and NiBr2 resulted in decreased 
yields (Table 2.1, entry 8 and 9) Finally, 88% isolated yield was obtained with 
7.5 mol % catalyst loading. (Table 2.1, entry 10) 
 
Table 2.1. Optimization of Allylic Alkylation with Diphenylmethane 1a 
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+ OBoc
 Ni Source
DPPF
5 eq KHMDS
solvent, 12 h, rt
entry Ni Source yieldb (%)
1
2
3
4
5
6
7
solventNi/DPPF (mol %)
5/5Ni(COD)2 DME 39
8
9
Ni(COD)2
Ni(COD)2
Ni(COD)2
Ni(COD)2
NiCl2
NiBr2
5/10
5/10
5/10
5/10
5/10
5/10
CPME
THF
dioxane
DME
DME
2-MeTHF
46
35
<5
<5
52
51
1a
1 eq
2a
3 eq
10 Ni(COD)2 7.5/15 DME 90 (88)c
Ni(COD)2
Ni(COD)2 5/10
5/7.5
DME
DME 46
72
3aa
 
a Reaction conducted on a 0.1 mmol scale. b Yield determined by 1H NMR 
spectroscopy of the crude reaction mixture. c Isolated yield after 
chromatographic purification. 
 
With optimized conditions in Table 2.1 (entry 10), we probed the scope 
of diphenylmethane derivatives (Table 2.2). We investigated 4-halogenated 
diphenylmethanes (Table 2.2, entries 2−4). Fluorine-containing compounds are 
useful because of their bioactivities and applications in material science.31 The 
reaction with 4-fluoro diphenylmethane (4b) as pronucleophile afforded the 
desired 4-fluoro diphenylmethane (1b) afforded the desired product 3ba in 
67% yield (Table 2.2, entry 2). We then applied our reaction conditions to 4-
bromo and 4-chloro diphenylmethanes (1c and 1d) with different selection of 
the base (NaN(SiMe3)2). Oxidative addition of C–X (X = Cl, Br) bonds to the 
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active Ni(0) species could be a potentially competitive reaction pathway. 
Fortunately, Ni-catalyzed allylic alkylation afforded the allylated products 3ca 
and 3da in 98% and 89% yield, respectively (Table 2.2, entries 3 and 4). These 
results suggested that generation of the π-allyl nickel intermediate is faster than 
the oxidative addition of C–X bonds to the Ni(0) species under our reaction 
conditions. 4-methyl diphenylmethane (1e) gave 3ea in 61% yield (Table 2.2, 
entry 5). Sterically hindered substrate 2-methyl diphenylmethane (1f) reacted 
to provide 3fa in 65% yield (Table 2.2, entry 6).  Fluorene derivatives are 
interesting components in material and photochemistry.32 We changed the 
selection of base due to the increased acidity of Fluorene (1g). With 5 equiv 
LiOtBu and 1.2 equiv of 2a, 3ga was provided in 75% yield (Table 2.2, entry 7). 
Unfortunately, 4-methoxy diphenylmethane gave only poor yield after efforts on 
optimization.  
 
Table 2.2. Scope of Diphenylmethane Derivatives in Allylic Alkylation Reactions 
a 
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R OBoc DME, 24 oC, 12 h
7.5 mol % Ni(COD)2
15 mol % DPPF
2a
R
1a-1g 3aa-3ga
Entry Pronucleophiles Products Yield
1 1:5:3 88%
2
F
F
67%
3
Cl Cl
98%
4
5
Br Br
89%NaHMDS
1:4:3
1:5:3
1:5:3
6
61%KHMDS 1:5:3
7
65%KHMDS 1:5:3
NaHMDS
KHMDS
KHMDS
ratio
1:base:2abase
3aa
3ba
3ca
3da
3ea
3fa
75%LiOtBu 1:5:1.23ga
 
a Reaction conducted on a 0.1 mmol scale.  
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After screening the scope of diphenylmethane derivatives, we turned our 
attention to biologically more interesting targets, heterocyclic diarylmethanes 
(Table 2.3).  Pyridine containing diarylmethanes are useful in drug discovery.33 2-
benzylpyridine (4a) afforded 5aa in 91% yield (Table 2.3, entry 1). 4-
benzylpyridine (4b) and 3-benzylpyridine (4c) provided desired products 5ba 
and 5ca in 93% and 91% yield (Table 2.3, entries 2 and 3). Xanthene 
derivatives are building blocks of dyes.32 We applied our reaction condition to 
Xanthene (4d) and obtained 5da in 81% yield (Table 2.3, entry 4). Thiophene 
containing products are important in agrochemicals and pharmaceuticals.34 2-
benzylthiophene (4e) rendered 5ea in 82% yield (Table 2.3, entry 5). Finally, 
3,3’-dipyridylmethane (4f) successfully provided 5fa in 90% (Table 2.3, entry 
6). 
 
Table 2.3. Scope of Heterocyclic Diphenylmethane in Allylic Alkylation 
Reactions a 
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HetArPh + OBoc DME, 24 oC, 12 h
5 mol % Ni(COD)2
10 mol % DPPF
HetArPh
N
N
N
S
O
4a-f 2a 5aa-5fa
Entry Pronucleophiles Base Yieldb (%)
1
2
3
4
5
6
NaN(SiMe3)2
LiN(SiMe3)2
NaN(SiMe3)2
LiN(SiMe3)2
NaN(SiMe3)2
1:2:1.2
1:3:1.2
1:2:1.2
1:3:1.2
1:2:1.2
91
81
93
91
82
N
N
N
S
O
Products
N N
LiN(SiMe3)2 1:3:1.2 90
N N
ratio
4:base:2a
5aa
5da
5ba
5ca
5ea
5fa
 
a Reaction conducted on a 0.1 mmol scale.  
With good to excellent yields demonstrated in Table 2.3, we decided to 
perform one-pot diallylation to construct quaternary carbon center. (Table 4) 
Pyridine-containing compounds such as 2-benzyl, 4-benzyl, or 3-benzyl pyridine 
all gave good yields (6aa – 6ca, 84%, 75%, 78%; Table 2.4, entries 1−3). 
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Xanthene and fluorene showed excellent reactivity of 89% and 90% yields (6da, 
6ea; Table 2.4, entries 4, 5). 2-benzylthiophene provided diallylation product 
6fa in 83% yield under our reaction condition. After demonstrating one-pot 
synthesis to construct quaternary carbon center from secondary diarylmethanes, 
we were also interested in starting from tertiary centers such as triarylmethane 
and alkylated diarylmethane. To our delight, triphenylmethane (7a) gave 8aa in 
90% yield. 2-(1-phenylethyl)pyridine (7b) also underwent allylation to form 8ba 
in 92% yield. Overall, starting from diarylmethanes or tertiary carbon centers 
both gave good to excellent yields. Noteworthy, the yield-per-step was higher 
than 86% in each case. 
 
Table 2.4. Scope of Diallylation of Diarylmethanes, Alkylated Diarylmethane 
and Triphenylmethane a 
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HetArPh + OBoc DME, 24 oC, 12 h
5 mol % Ni(COD)2
10 mol % DPPF
HetArPh
N
N
S
O
4a-f, 7a, 7b 2a
Entry Pronucleophiles Base Yieldb (%)
1
2
3
4
KN(SiMe3)2
NaN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
N
N
S
O
Products
1:5:3 75
841:5:3
891:5:3
1:5:3 83
5
Ph Ph
Ph
KN(SiMe3)2 Ph Ph
1:5:3 90
6
N
CH3
KN(SiMe3)2
N
1:5:3 92
7 Ph
H3C
ratio
4:base:2a
KN(SiMe3)2 1:5:3 90
6aa-6ga, 8aa, 8ba
N
KN(SiMe3)2
N
1:5:3 78
8
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a Reaction conducted on a 0.1 mmol scale.  
After demonstrating diarylmethanes are suitable substrates for nickel 
catalyzed allylic substitution reactions, we turned our attention to the 
mechanistic pathway of the reaction. In order to probe the reaction pathway 
with cyclic electrophile 2c (eq 2.3), we first examined the reactivity of the 
condition on structurally similar electrophile 2b with 4f. Fortunately, the 
reaction condition can be applied to cyclic electrophiles 2b and the product 9fb 
was formed in 91% yield (eq 2.2).  
 
DME, 24 oC, 12 h
5 mol % Ni(COD)2
10 mol % DPPF
N N
OBoc
+
N N
91%
4f
1 equiv
2b
2 equiv
3 equiv NaHMDS
9fb
(2)
 
 
With this promising result, we would pursue the answer to our question: 
Does 3,3’-dipyridylmethane (4f) behave as soft nucleophiles same in Ni-
catalyzed allylic alkylation as in Pd-catalyzed allylic alkylation? We were able to 
answer this question by performing reaction with 3,3’-dipyridylmethane (4f) and 
stereoprobe (2c) to determine whether the reaction proceed as double inversion 
pathway (soft nucleophile) or single inversion pathway (hard nucleophile). After 
analysis of the products,15 we were able to identify the nucleophiles 4f behaves 
as soft nucleophiles, which is identical in both Ni-catalyzed allylic alkylation and 
in Pd-catalyzed allylic alkylation (eq 2.3). 
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 3 equiv NaN(SiMe3)2
DME, 24 oC, 12 h
7.5 mol % Ni(COD)2
15 mol % DPPF
(3)+N N BocO Ph
4f 2c
10:1 cis:trans
N
N
Ph
10fc
87% (10:1 cis:trans)  
More importantly, we would like to know if Ni-catalyzed asymmetric allylic 
alkylation (AAA) could be done with soft nucleophiles in high enantiopurity. To 
our delight, after 252 chiral ligands screened, we were able to identify the right 
ligand SL-J204-1 to perform Ni-catalyzed asymmetric allylic alkylation in 91% 
yield with 92% e.e using optimized reaction conditions (see Supporting 
Information). The nucleophile 4f was proven to be soft nucleophile with SL-
J204-1, which is identical with DPPF as the ligand. 
 
Scheme 2.2. Asymmetric Allylic Alkylation and Mechanistic Study with SL-
J204-1 
 
N N
OBoc
+
N N
*
9fb
91% yield
92% e.e.
4f 2b
 3 equiv NaN(SiMe3)2
DME, 0 oC, 12 h
5 mol % Ni(COD)2
5 mol % Ligand
+
N N BocO Ph
N
N
Ph
10fc
83% (10:1 cis:trans)
4f 2c
10:1 cis:trans
Fe
P
H3C
PCy2
F3C
F3C
SL-J204-1
 3 equiv NaN(SiMe3)2
DME, 0 oC, 12 h
5 mol % Ni(COD)2
5 mol % Ligand
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2.3. SUMMARY AND OUTLOOK 
To sum up, we have developed a racemic version of Ni-catalyzed allylic 
alkylation with diarylmethane derivatives. The protocol is robust with different 
nucleophiles including diphenylmethanes derivatives and heterocyclic 
diarylmethanes. We could also perform an one-pot synthesis from either 
diarylmethanes, alkylated diarylmethane or triarylmethane to construct 
quaternary centers. The method provides a rapid way of expanding the library of 
medicinally interesting targets: allylated diarylmethanes. The same soft 
diarylmethane nucleophiles in Pd-catalyzed allylic alkylation turned out to be soft 
nucleophiles as well as in Ni-catalyzed allylic alkylation. More importantly, the 
first Ni-catalyzed asymmetric allylic alkylation (AAA) of soft nucleophiles with 
high e.e. has been demonstrated. This suggested Ni-catalyzed asymmetric allylic 
alkylation (AAA) could be done not only with hard nucleophiles, but with soft 
nucleophiles as well.  
 
2.4. EXPERIMENTAL SECTION 
General Methods.  All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. The solvent (DME) 
was sparged for 20 min with dry N2 and dried using a commercial two-column solvent 
purification system comprising columns packed with neutral alumina. Unless otherwise 
stated, reagents were commercially available and used as purchased without further 
purification. Chemicals were obtained from Sigma-Aldrich, Acros, TCI America, Strem 
Chemicals or Matrix Scientific, and solvents were purchased from Fisher Scientific. The 
progress of the reactions was monitored by thin-layer chromatography using Whatman 
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Partisil K6F 250 μm precoated 60 Å silica gel plates and visualized by short-wavelength 
ultraviolet light as well as by treatment potassium permanganate (KMnO4) stain or 
iodine. Silica gel (230−400 mesh, Silicycle) was used for flash chromatography. The 1H 
NMR and 13C{1H} NMR spectra were obtained using a Brüker AM-500 Fourier 
transform NMR spectrometer at 500 and 126 MHz, respectively. Chemical shifts are 
reported in units of parts per million (ppm) downfield from tetramethylsilane (TMS), and 
all coupling constants are reported in hertz. The infrared spectra were obtained with KBr 
plates using a Perkin-Elmer Spectrum 100 Series FTIR spectrometer. High-resolution 
mass spectrometry (HRMS) data were obtained on a Waters LC−TOF mass spectrometer 
(model LCT-XE Premier) using chemical ionization (CI) or electrospray ionization (ESI) in 
positive or negative mode, depending on the analyte.  Melting points were determined on 
a Unimelt Thomas-Hoover melting point apparatus and are uncorrected. 
 
Preparation of Diarylmethanes. 
Compounds  4e35, 4f36, 7b37 were prepared according to literature procedures. 
 
Preparation of Allyl ic Electrophiles.  
Compounds 2a38, 2b39, 2c40 were prepared according to literature procedures. 
 
General Procedure A: An oven-dried 10 mL reaction vial equipped with a stir bar was 
charged with KN(SiMe3)2 (100 mg, 0.50 mmol, 5 equiv) under a nitrogen atmosphere. A 
solution (from a stock solution) of Ni(COD)2 (2.06 mg, 0.0075 mmol) and DPPF (8.31 
mg, 0.015 mmol) in 1 mL of dry DME was taken up by syringe and added to the reaction 
vial. After stirring for 5 min at 24 °C, 1a (17 μL, 0.1 mmol, 1 equiv) was added to the 
reaction mixture followed by 2a (51 μL, 0.3 mmol, 3 equiv). Note that the 
diarylmethanes or allyl OBoc in a solid form was added to the reaction vial prior to 
KN(SiMe3)2. The reaction mixture was stirred for 12 h at 24 °C, quenched with two drops 
of H2O, diluted with 3 mL of ethyl acetate, and filtered over a pad of MgSO4 and silica. 
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The pad was rinsed with additional ethyl acetate, and the solution was concentrated in 
vacuo. The crude material was loaded onto a silica gel column and purified by flash 
chromatography eluting with EtOAc/hexanes.  
 
General Procedure B: An oven-dried 10 mL reaction vial equipped with a stir bar was 
charged with NaN(SiMe3)2 (55 mg, 0.30 mmol, 3 equiv) under a nitrogen atmosphere. A 
solution (from a stock solution) of Ni(COD)2 (1.37 mg, 0.005 mmol) and DPPF (5.54 
mg, 0.010 mmol) in 1 mL of dry DME was taken up by syringe and added to the reaction 
vial. After stirring for 5 min at 24 °C, 4a (16 μL, 0.1 mmol, 1 equiv) was added to the 
reaction mixture followed by 2a (20.4 μL, 0.12 mmol, 1.2 equiv). Note that the 
diarylmethanes or allyl OBoc in a solid form was added to the reaction vial prior to 
NaN(SiMe3)2. The reaction mixture was stirred for 12 h at 24 °C, quenched with two 
drops of H2O, diluted with 3 mL of ethyl acetate, and filtered over a pad of MgSO4 and 
silica. The pad was rinsed with additional ethyl acetate, and the solution was 
concentrated in vacuo. The crude material was loaded onto a silica gel column and 
purified by flash chromatography eluting with EtOAc/hexanes.  
 
General Procedure C: An oven-dried 10 mL reaction vial equipped with a stir bar was 
charged with NaN(SiMe3)2 (55 mg, 0.30 mmol, 3 equiv) under a nitrogen atmosphere. A 
solution (from a stock solution) of Ni(COD)2 (1.37 mg, 0.005 mmol) and SL-J204-1 
(3.65 mg, 0.005 mmol) in 1 mL of dry DME was taken up by syringe and added to the 
reaction vial. After stirring for 5 min at 24 °C, 4f (17 mg, 0.1 mmol, 1 equiv) was added 
to the reaction mixture followed by 2b (40 μL, 0.2 mmol, 2 equiv). Note that the 
diarylmethanes or allyl OBoc in a solid form was added to the reaction vial prior to 
NaN(SiMe3)2. The reaction mixture was stirred for 12 h at 0 °C, quenched with two drops 
of H2O, diluted with 3 mL of ethyl acetate, and filtered over a pad of MgSO4 and silica. 
The pad was rinsed with additional ethyl acetate, and the solution was concentrated in 
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vacuo. The crude material was loaded onto a silica gel column and purified by flash 
chromatography eluting with EtOAc/hexanes.  
 
 
but-3-ene-1,1-diyldibenzene (2.3aa): The reaction was 
performed following General Procedure A with 1a (17 μL, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a (51 μL, 0.3 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (18.3 mg, 88% yield) as a colorless oil. Rf = 
0.25 (hexanes); The NMR spectral data match the previously published data.41  
 
1-fluoro-4-(1-phenylbut-3-en-1-yl)benzene (2.3ba): The 
reaction was performed following General Procedure A with 1b (17 
μL, 0.1 mmol), KN(SiMe3)2 (80 mg, 0.40 mmol) and 2a (51 μL, 0.3 
mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with hexanes) to give the product (15.2 mg, 67% yield) as a colorless 
oil. Rf = 0.25 (hexanes); The NMR spectral data match the previously published data.42 
 
 1-chloro-4-(1-phenylbut-3-en-1-yl)benzene (2.3ca): The 
reaction was performed following General Procedure A with 1c 
(18 μL, 0.1 mmol), NaN(SiMe3)2 (91 mg, 0.50 mmol) and 2a (51 
μL, 0.3 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (23.8 mg, 98% 
yield) as a colorless oil. Rf = 0.25 (hexanes); The NMR spectral data match the previously 
published data.41 
 
F
Cl
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1-bromo-4-(1-phenylbut-3-en-1-yl)benzene (2.3da): The 
reaction was performed following General Procedure A with 1d 
(18.5 μL, 0.1 mmol), NaN(SiMe3)2 (91 mg, 0.50 mmol) and 2a 
(51 μL, 0.3 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (25.5 mg, 89% 
yield) as a colorless oil. Rf = 0.25 (hexanes); The NMR spectral data match the previously 
published data.42 
 
1-methyl-4-(1-phenylbut-3-en-1-yl)benzene 
(2.3ea):The reaction was performed following General 
Procedure A with 1e (18.5 μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 
0.50 mmol) and 2a (51 μL, 0.3 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to give the product 
(13.5 mg, 61% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR spectral data 
match the previously published data.41 
 
1-methyl-2-(1-phenylbut-3-en-1-yl)benzene (2.3fa):The 
reaction was performed following General Procedure A with 1f (18.5 
μL, 0.1 mmol), KN(SiMe3)2 (100 mg, 0.50 mmol) and 2a (51 μL, 0.3 
mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with hexanes) to give the product (14.4 mg, 65% yield) as a colorless 
oil. Rf = 0.20 (hexanes); The NMR spectral data match the previously published data.43 
 
 9-allyl-9H-fluorene (2.3ga): The reaction was performed following 
General Procedure A with 1g (16.7 mg, 0.1 mmol), LiOtBu (40 mg, 
0.50 mmol) and 2a (20.4 μL, 0.12 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to 
Br
H3C
CH3
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give the product (15.5 mg, 75% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR 
spectral data match the previously published data.44 
 
2-(1-phenylbut-3-en-1-yl)pyridine (2.5aa): The reaction was 
performed following General Procedure B with 4a (16 μL, 0.1 mmol), 
NaN(SiMe3)2 (36 mg, 0.20 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 10:90) to give the product (19 mg, 91% yield) 
as a yellow oil. Rf = 0.30 (EtOAc:hexanes = 10:90); The NMR spectral data match the 
previously published data.42 
 
4-(1-phenylbut-3-en-1-yl)pyridine (2.5ba): The reaction was 
performed following General Procedure B with 4b (16 μL, 0.1 mmol), 
LiN(SiMe3)2 (34 mg, 0.20 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with hexanes to 
EtOAc:hexanes = 30:70) to give the product (19.5 mg, 93% yield) as a yellow oil. Rf = 
0.30 (EtOAc:hexanes = 40:60); The NMR spectral data match the previously published 
data.42 
 
3-(1-phenylbut-3-en-1-yl)pyridine (2.5ca): The reaction was 
performed following General Procedure B with 4c (17 mg, 0.1 mmol), 
NaN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 30:70) to give the product (19 mg, 91% yield) 
as a yellow oil. Rf = 0.40 (EtOAc:hexanes = 40:60); The NMR spectral data match the 
previously published data.42 
 
N
N
N
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9-allyl-9H-xanthene (2.5da): The reaction was performed 
following General Procedure B with 4d (18.2 mg, 0.1 mmol), 
LiN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (18 mg, 81% yield) as a colorless oil. Rf = 
0.25 (hexanes); The NMR spectral data match the previously published data.45 
 
2-(1-phenylbut-3-en-1-yl)thiophene (2.5ea): The reaction was 
performed following General Procedure B with 4e (16 μL, 0.1 mmol), 
NaN(SiMe3)2 (36 mg, 0.20 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with hexanes) 
to give the product (17.6 mg, 82% yield) as a colorless oil. Rf = 0.20 (hexanes); The 
NMR spectral data match the previously published data.46 
 
3,3'-(but-3-ene-1,1-diyl)dipyridine (2.5fa): The reaction was 
performed following General Procedure B with 4f (17 mg, 0.1 mmol), 
LiN(SiMe3)2 (51 mg, 0.30 mmol) and 2a (20.4 μL, 0.12 mmol). The 
crude material was purified by flash chromatography on silica gel 
(eluted with MeOH:DCM = 2.5:97.5) to give the product (18.9 mg, 90% yield) as a 
yellow oil. Rf = 0.30 (MeOH:DCM = 2.5:97.5); The NMR spectral data match the 
previously published data.42 
 
2-(4-phenylhepta-1,6-dien-4-yl)pyridine (2.6aa): The reaction 
was performed following General Procedure B with 4a (16 μL, 0.1 
mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel (eluted with 
hexanes to EtOAc:hexanes = 5:95) to give the product (21 mg, 84% yield) as a 
O
S
N N
N
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colorless oil. Rf = 0.30 (EtOAc:hexanes = 5:95); The NMR spectral data match the 
previously published data.42 
 
4-(4-phenylhepta-1,6-dien-4-yl)pyridine (2.6ba): The 
reaction was performed following General Procedure B with 4b (16 μL, 
0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 
mmol). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes to EtOAc:hexanes = 40:60) to give the product (18.7 mg, 75% yield) as a 
colorless oil. Rf = 0.25 (EtOAc:hexanes = 40:60); The NMR spectral data match the 
previously published data.42 
 
3-(4-phenylhepta-1,6-dien-4-yl)pyridine (2.6ca): The reaction 
was performed following General Procedure B with 4c (17 mg, 0.1 
mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes to EtOAc:hexanes = 20:80) to give the product (19.5 mg, 78% 
yield) as a colorless oil. Rf = 0.20 (EtOAc:hexanes = 20:80); The NMR spectral data 
match the previously published data.42 
 
9,9-dial lyl-9H-xanthene (2.6da): The reaction was performed 
following General Procedure B with 4d (18.2 mg, 0.1 mmol), 
NaN(SiMe3)2 (91 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (23.3 mg, 89% yield) as a colorless oil. Rf = 0.25 
(hexanes); The NMR spectral data match the previously published data.42 
 
N
O
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9,9-diallyl-9H-fluorene (2.6ea): The reaction was performed 
following General Procedure B with 1g (16.7 mg, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.3 mmol) and 2a (51 μL, 0.3 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with 
hexanes) to give the product (22.2 mg, 90% yield) as a colorless oil. Rf = 0.20 
(hexanes); The NMR spectral data match the previously published data.42 
 
2-(4-phenylhepta-1,6-dien-4-yl)thiophene (2.6fa): The 
reaction was performed following General Procedure B with 4e (16 μL, 
0.1 mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (21.1 mg, 83% yield) as a colorless oil. Rf = 
0.30 (hexanes); The NMR spectral data match the previously published data.42 
 
but-3-ene-1,1,1-triyltribenzene (2.8aa): The reaction was 
performed following General Procedure B with 7a (24.4 mg, 0.1 
mmol), KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). 
The crude material was purified by flash chromatography on silica gel (eluted with 
hexanes) to give the product (25.5 mg, 90% yield) as white solid. Rf = 0.20 (hexanes); 
The NMR spectral data match the previously published data. 42  
 
 
2-(2-phenylpent-4-en-2-yl)pyridine (2.8ba): The reaction was 
performed following General Procedure A with 7b (18 μL, 0.1 mmol), 
KN(SiMe3)2 (100 mg, 0.5 mmol) and 2a (51 μL, 0.3 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with hexanes to 
EtOAc:hexanes = 5:95) to give the product (20.5 mg, 92% yield) as a colorless oil. Rf = 
S
N
H3C
Ph
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0.20 (EtOAc:hexanes = 5:95); The NMR spectral data match the previously published 
data.42 
 
 
3,3'-(cyclohex-2-en-1-ylmethylene)dipyridine (2.9fb) 
(from DPPF): The reaction was performed following General 
Procedure B with 4f (17 mg, 0.1 mmol), NaN(SiMe3)2 (55 mg, 0.3 
mmol) and 2b (40 μL, 0.2 mmol). The crude material was purified by 
flash chromatography on silica gel (eluted with MeOH:DCM = 2.5:97.5) to give the 
product (22.5 mg, 91% yield) as a yellow oil. Rf = 0.25 (MeOH:DCM = 2.5:97.5); The 
NMR spectral data match the previously published data.42 The ee was determined 
by HPLC with a Daicel Chiralpak AD-H column (10% isopropanol in hexanes, 
1 mL/min, 254 nm, major tr= 23.596 min, minor tr = 26.869 min). 
 
 
 
3,3'-(cyclohex-2-en-1-ylmethylene)dipyridine (2.9fb) 
(from SL-J204-1): The reaction was performed following General 
N N
N N
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Procedure C with 4f (17 mg, 0.1 mmol), NaN(SiMe3)2 (55 mg, 0.3 mmol) and 2b (40 μL, 
0.2 mmol). The crude material was purified by flash chromatography on silica gel (eluted 
with MeOH:DCM = 2.5:97.5) to give the product (22.5 mg, 91% yield, 92% e.e.) as a 
yellow oil. Rf = 0.25 (MeOH:DCM = 2.5:97.5); The NMR spectral data match the 
previously published data.42 
The ee was determined by HPLC with a Daicel Chiralpak AD-H column (10% isopropanol 
in hexanes, 1 mL/min, 254 nm, minor tr= 24.848 min, major tr = 26.798 min). 
 
 
 
3,3'-(((1R ,3R)-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-
yl)methylene)dipyridine (2.10fc)(from DPPF): The 
reaction was performed following General Procedure B with 4f 
(17 mg, 0.1 mmol), NaN(SiMe3)2 (55 mg, 0.3 mmol) and 2c (54 
μL, 0.2 mmol). The crude material was purified by flash chromatography on silica gel 
(eluted with MeOH:DCM = 2.5:97.5) to give the product (28.4 mg, 87% yield, 
cis:trans=10:1) as a pale yellow oil. Rf = 0.20 (MeOH:DCM = 2.5:97.5); The NMR spectral 
data match the previously published data.42 
Stereochemistry was assigned by 1H NMR analysis.40 
PhN
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3,3'-(((1R ,3R)-1,2,3,6-tetrahydro-[1,1'-biphenyl]-3-
yl)methylene)dipyridine (2.10fc) (from SL-J204-1): The 
reaction was performed following General Procedure C with 4f 
(17 mg, 0.1 mmol), NaN(SiMe3)2 (55 mg, 0.3 mmol) and 2c (54 
μL, 0.2 mmol). The crude material was purified by flash chromatography on silica gel 
(eluted with MeOH:DCM = 2.5:97.5) to give the product (27.1 mg, 83% yield, 
cis:trans=10:1) as a pale yellow oil. Rf = 0.20 (MeOH:DCM = 2.5:97.5); The NMR spectral 
data match the previously published data.42 
 
Screening Results of Achiral Ligands  
+ OBoc
 10% Ni(COD)2
Ligand screening
5 equiv KN(SiMe3)2
DME, 24 oC, 12 h
1 equiv 3 equiv
Control: Xantphos 
Assay Yield/ Internal Standard
O
PPh2 PPh2
Xantphos: 22 MePhos: 11
P CyCy
Fe
PPh2
PPh2
DPPF: 46
O
H
N
PPh2 PPh2
NiXantphos: 20  
Ligand 
2-(Di-tert-butylphosphino)biphenyl (JohnPhos) 
4-(Di-tert-butylphosphino)-N,N-dimethylaniline (Ataphos) 
2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl (Dave Phos) 
2-Di-tert-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-triisopropyl-1,1'-biphenyl 
(Me4tBuXPhos) 
Dicyclohexyl-[3,6-dimethoxy-2-(2,4,6-triisopropylphenyl)phenyl]phosphane 
(BrettPhos) 
1,1'-Bis(diphenylphosphino)ferrocene (Dppf) 
9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene (XantPhos) 
PhN
N
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2-Dicyclohexylphosphino-2′-methylbiphenyl (MePhos) 
N-(dicyclohexylphosphino)-2-2’-tolylindole (Indole ligand) 
P(O-Tol)3 
PtBu3HBF4 
2-(Dicyclohexylphosphino)-1-phenyl-1H-pyrrole (CataCXium Pcy) 
4,6-Bis(diphenylphosphino)phenoxazine (NIXANTPHOS) 
Di(1-adamantyl)-2-dimethylaminophenylphosphine (Me-Dalphos) 
2-Dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (Sphos) 
Butyldi-1-adamantylphosphine (CataCXium A) 
PCy3HBF4 
2-Di-tert-butylphosphino-3-Methoxy-6-Methyl-2'-4'-6'-triisopropylbiphenyl 
(RockPhos) 
1,2,3,4,5-Pentaphenyl-1'-(di-t-butylphosphino)ferrocene (Qphos) 
PPh3 
1-[2-[Bis(tert-butyl)phosphino]phenyl]-3,5-diphenyl-1H-pyrazole (Trippy Phos) 
2-(Dicyclohexylphosphino)biphenyl (CyJohnPhos) 
2-Dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl  (Xphos) 
Di(1-adamantyl)-2-morpholinophenylphosphine (Mor-DalPhos) 
 
Screening Results of Chiral Ligands 
 
Chiral Ligands P1-96 ligands 
(S,S)-bpm2: (2S,4S)-tBu-(-)-4-(Diphenylphosphino)-2-
(diphenylphosphinomethyl)pyrrolidine carboxylate 
Catasium D: (3S,4S)-(-)-1-Benzyl-3,4-bis(diphenylphosphino)pyrrolidine 
(R,R)-BICP 
SL-T021-2 
(R,R)-SL-M004-1 
SL-W009-1 
SL-W018-1 
(R,R)-SL-W019-1 
SL-W020-1 
(R,R)-SL-W021-1 
SL-T025-2 
(S,S)-DIOP 
(S,S)-SL-M001-1 
(S,S)-SL-M002-1 
(S,S)-SL-M003-1 
(S)-BINAPINE: (3S,3'S,4S,4'S,11bS,11'bS)-(+)-4,4'-Di-t-butyl-4,4',5,5'-tetrahydro-
3,3'-bi-3H-dinaphtho[2,1-c:1',2'-e]phosphepine 
(S,S)-SL-T001-1 
(R,S)-SL-T002-1 
SL-T026-2 
H8-BINAM-P 
SL-J413-1 
SL-J301-1 
s-f-binaphane 
SL-T027-2 
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(S)-CTH-JAFAPHOS 
(R,R)-Me-DuPhos: 1,2-bis((2R,5R)-2,5-dimethylphospholano)benzene 
(R,R)-i-Pr-DUPHOS: (+)-1,2-Bis((2R,5R)-2,5-di-i-propylphospholano)benzene 
(R,R) Et-DuPhos: (-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE 
(R)-Prophos: (R)-(+)-BIS-(1,2-DIPHENYLPHOSPHINO)PROPANE 
SL-W023-1 
SL-W012-1 
SL-J215-2 
SL-J302-1 
SL-J011-1 
SL-J304-1 
SL-J408-1 
SL-J411-2 
SL-J412-1 
SL-W022-1 
SL-F011-2: (Twinphos, analog of Me-BoPhoz) 
SL-F013-2: (Twinphos, analog of P(cyco)-BoPhoz) 
SL-J851-2: (bis SL-J001) 
SL-J852-2: (bis SL-J005) 
SL-J853-2: (bis SL-J013) 
(S,S)-Ph-BPE: (+)-1,2-Bis((2S,5S)-2,5-diphenylphospholano)ethane 
SL-W016-1 
(+)-catASium I: [(1R,2R,3S)-(+)-1,2-Dimethyl-2,3-
bis(diphenylphosphinomethyl)cyclopentyl]methanol 
SL-W017-1 
(S,S)-CHIRAPHOS: (2S,3S)-(-)-Bis(diphenylphosphino)butane 
(R,R)-SL-W002-1 
(S,S)-DIPAMP: (S,S)-(+)-1,2-Bis[(2-methoxyphenyl)(phenyl)phosphino]ethane 
(1S,1'S,2R,2'R)-DuanPhos: (1S,1'S,2R,2'R)-2,2'-Di-tert-butyl-2,3,2',3'-tetrahydro-1H, 
1'H-(1,1')biisophosphindolyl 
(R)-BINAPHANE: (R,R)-(-)-1,2-Bis{(R)-4,5-dihydro-3H-binaphtho[1,2-c:2',1'-
e]phosphepino}benzene 
(S,S,S,S)-Me-Ketalphos 
(S,S,R,R)-TANGPHOS: (1S,1'S,2R,2'R)-(+)-1,1'-Di-t-butyl-[2,2']-diphospholane 
SL-W006-1 
(-)-MOD DIOP 
SL-W003-1 
CTH-(R)-SpiroP: 1R,5R,6R-(+)-1,6-Bis(diphenylphosphinoxy)spiro[4.4]nonane 
SL-W001-1 
CARBOPHOS: METHYL-ALPHA-D-GLUCOPYRANOSIDE-2,6-DIBENZOATE-3,4-DI(BIS(3,5-
DIMETHYLPHENYL)PHOSPHINITE) 
J430-1 
(1S,2S)-(-)-Bis(methylphenylphosphino)benzene 
M009-1 
SL-W008-1 
(S)-Me-f-Ketalphos 
SL-W005-1 
(R,R)-NORPHOS: (2R,3R)-(-)-2,3-BIS(DIPHENYLPHOSPHINO)BICYCLO[2.2.1]HEPT-5-ENE 
catASium D (R):(3R,4R)-(+)-1-BENZYL-3,4-BIS(DIPHENYLPHOSPHINO)PYRROLIDINE 
M012-1: (S,S)-(-)-2,2'-BIS[(R)-(N,N-DIMETHYLAMINO)(PHENYL)METHYL]-1,1'-BIS(DI(2-
METHYLPHENYL)PHOSPHINO)FERROCENE 
CTH-(R)-3,5-xylyl-PHANEPHOS: (R)-(-)-4,12-Bis(di(3,5-xylyl)phosphino)-[2.2]-
paracyclophane 
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(S,S)-BDPP: (2S,4S)-(-)-2,4-BIS(DIPHENYLPHOSPHINO)PENTANE 
Catasium MN An(R) 
Catasium MNN (R) 
Catasium MN MesF (R) 
Catasium MN Mes (R) 
(S,S)-Me-UCAP-DTBM 
(R,R)-QuinoxP*: (R,R)--2,3-Bis(tert-butylmethylphosphino)quinoxaline 
(R,R,R)-Me-KEPHOS 
(S,S,R)-Me-KEPHOS 
SL-J005-1 
SL-J014-1 
SL-J031-1 
SL-J211-1 
SL-J213-1 
SL-J216-1 
SL-J219-1 
SL-J220-1 
SL-J221-1 
SL-J222-1 
SL-J305-1 
SL-J404-1 
SL-J409-1 
SL-J502-1 
SL-J505-1 
SL-J506-1 
 
Chiral Ligands P2-96 ligands 
(R,R)-Me-BPE: (+)-1,2-Bis[(2R,5R)-2,5-dimethylphospholano]ethane 
(R,R)-Et-BPE: (+)-1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane 
(R,R)-iPr-BPE: 1,2-BIS[(2R,5R)-2,5-DIISOPROPYLPHOSPHOLANO]ETHANE 
(R,R)-Me-Ferrolane: 1,1'-BIS[(2R,5R)-2,5-DIMETHYLPHOSPHOLANO]FERROCENE 
(R,R)-Et-Ferrolane: 1,1'-BIS[(2R,5R)-2,5-DIETHYLPHOSPHOLANO]FERROCENE 
(R,R)-iPr-Ferrolane: 1,1'-Bis[(2R,5R)-2,5-diisopropylphospholano]ferrocene 
SL-F131-1 (Trifer): 1,1'-BIS[(R)-[(RP)-2-[(S)-1-
(DIMETHYLAMINO)ETHYL]FERROCENYL]PHENYLPHOSPHINO]FERROCENE 
SL-F356-1 (Chenphos): 1-DICYCLOHEXYLPHOSPHINO-1'-[(R)-[(RP)-2-[(S)-1-
(DIMETHYLAMINO)ETHYL]FERROCENYL]PHENYLPHOSPHINO]FERROCENE 
SL-J681-1: (S, Rp, SSPO)-1-tert.-butylphosphinoyl)-2-[1-
(diphenylphosphino)ethyl]ferrocene 
SL-J688-1: (RP)-1-[(S)-1-(DI-TERT-BUTYLPHOSPHINO)ETHYL]-2-[(S)-
PHENYLPHOSPHINOYL]FERROCENE 
(R)-PhanePhos: (R)-(-)-4,12-BIS(DIPHENYLPHOSPHINO)-[2.2]-PARACYCLOPHANE 
(R)-An-PhanePhos: (R)-4,12-Bis[di(4-methoxyphenyl)phosphino]-[2.2]-paracyclophane 
(1S,1'S)-ethane-1,2-diylbis(tert-butyl(methyl)phosphonium) tetrafluoroborate 
(R,R)-miniPHOS 2HBF4: (1R,1'R)-methylenebis(tert-butyl(methyl)phosphonium) 
tetrafluoroborate 
(R)-di-tert-butyl((tert-butyl(methyl)phosphonio)methyl)phosphonium 
tetrafluoroborate 
(S)-MaxPhos HBF4: (S)-(tert-butylmethylphosphonium)(di-tert-butylphosphino)amine 
tetrafluoroborate 
(R,R)-(+)-1,2-Bis(t-butylmethylphosphino)benzene 
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(R,R)-Nap-DIPAMP: 1,2-bis((R)-naphthalen-1-yl(phenyl)phosphino)ethane 
(R,R)-Tol-DIPAMP: 1,2-bis((R)-phenyl(o-tolyl)phosphino)ethane 
(S,S)-iPr-DIPAMP: 1,2-bis((S)-(2-isopropylphenyl)(phenyl)phosphino)ethane 
(S,S)-Ph2-DIPAMP: 1,2-bis((S)-[1,1'-biphenyl]-2-yl(phenyl)phosphino)ethane 
catASium T1 (R): (1R,AR)-3-DIPHENYLPHOSPHINO-2-(4-DIPHENYLPHOSPHINO-2,5-
DIMETHYL-3-THIENYL)-1,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-ENE 
catASium T2 (R): (1R,4S)-3-[BIS(3,5-DIMETHYLPHENYL)PHOSPHINO]-2-(4-
DIPHENYLPHOSPHINO-2,5-DIMETHYL-3-THIENYL)-1,7,7-
TRIMETHYLBICYCLO[2.2.1]HEPT-2-ENE 
catASium T3 (R): (1R,AR)-3-DIPHENYLPHOSPHINO-2-(4-BIS(3,5-
DIMETHYLPHENYL)PHOSPHINO-2,5-DIMETHYL-3-THIENYL)-1,7,7-
TRIMETHYLBICYCLO[2.2.1]HEPT-2-ENE 
(-)-TMBTP 
(R)-Tol-Binap: (R)-(+)-2,2'-BIS(DI-P-TOLYLPHOSPHINO)-1,1'-BINAPHTHYL 
(R)-Hexaphemp 
(S)-Me-Soniphos: (S)-(-)-6,6'-Bis(diphenylphosphino)-1,1'-biphenyl-2,2'-
diylbis(acetate) 
(R)-Cl,MeO-Biphep: (R)-(+)-5,5'-DICHLORO-6,6'-DIMETHOXY-2,2'-
BIS(DIPHENYLPHOSPHINO)-1,1'-BIPHENYL 
(R)-segphos 
SL-A109-2: (S)-2,2'-Bis(di(3,5-di-tert-butyl-4-methoxyphenyl)phosphino)-6,6'-
dimethoxy-1,1'-biphenyl 
(R)-P-Phos: (R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine 
(R)-DTBM-SEGPHOS 
s-c1-tunaphos 
s-c3-tunaphos 
s-c5-tunaphos 
(S)-Binap: (S)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL 
(R)-xyl-binap: (R)-(+)-2,2'-BIS[DI(3,5-XYLYL)PHOSPHINO]-1,1'-BINAPHTHYL 
(R)-Catasium T2: (1R)-(+)-[Di(3,5-dimethylphenyl)phosphino]-2-(4-diphenylphosphino-
2,5-dimethylthien-3-yl)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ene 
(R)-DM-SEGPHOS 
(R)-Difluorophos: (R)-(-)-5,5'-Bis(diphenylphosphino)-2,2,2',2'-tetrafluoro-4,4'-bi-1,3-
benzodioxole 
SL-A120-2: (S)-2,2'-Bis[bis(3,5-dimethyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl 
(R)-H8-BINAP 
(S)-Xylyl-P-Phos: (S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-
bipyridine 
(S)-cHex-Soniphos: (S)-(-)-6,6'-Bis(diphenylphosphino)-1,1'-biphenyl-2,2'-
diylbis(cyclohexylcarboxylate), 
S-c2-tunaphos 
s-c4-tunaphos 
s-c6-tunaphos 
(R)-MP2-SEGPHOS 
(R)-P3-SEGPHOS 
(+)-Cy-SEGPHOS 
SL-A102-1: (R)-2,2'-Bis(di-p-tolylphosphino)-6,6'-dimethoxy-1,1'-biphenyl 
SL-A107-1: (R)-2,2'-Bis[bis(3,5-diisopropyl-4-dimethylaminophenyl)phosphino]-6,6'-
dimethoxy-1,1'-biphenyl 
SL-A104-1: (R)-2,2'-Bis[bis(3,4,5-trimethoxyphenyl)phosphino]-6,6'-dimethoxy-1,1'-
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biphenyl 
SL-A121-1: (R)-2,2'-Bis[bis(3,5-di-tert-butyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl 
SL-A108-1: (R)-(+)-2,2'-Bis(di-2-furylphosphino)-6,6'-dimethoxy-1,1'-biphenyl 
SL-A116-1: (R)-2,2'-Bis(diisopropylphosphino)-6,6'-dimethoxy-1,1'-biphenyl 
SL-A118-1: (R)-2,2'-Bis(dicyclobutylphosphino)-6,6'-dimethoxy-1,1'-biphenyl 
(R,R)-DACH-Phenyl Trost Ligand 
(R,R)-DACH-Naphthyl Trost Ligand 
(R)-Pfaltz (iPr) 
(R)-Pfaltz (Ph) 
SL-N003-2 ((S)-4-Isopropyl-2-[(S)-2-(diphenylphosphino)ferrocen-1-yl]oxazoline) 
SL-N008-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(3,5.dimethyl-4-
methoxyphenyl)phosphino)ferrocen-1-yl]oxazoline) 
SL-N011-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(1-naphtyl)phosphino)ferrocen-1-
yl]oxazoline) 
SL-N012-2 ((S)-4-Isopropyl-2-[(S)-2-(bis(2-methoxyphenyl)phosphino)ferrocen-1-
yl]oxazoline) 
SL-N004-2 
SL-N007-2 
SL-N013-1 
(S)-Xyl-SDP 
(S)-Tol-SDP 
(S)-SDP 
SL-J001-1: (R)-(-)-1-[(S)-2-
(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDICYLCOHEXYLPHOSPHINE 
SL-J002-1 
SL-J004-1: (R)-(-)-1-[(S)-2-
(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDIPHENYLPHOSPHINE 
SL-J006-1 
SL-J008-1 
SL-J204-1 
SL-J013-1 
SL-J212-1 
SL-J417-1 
SL-J425-1 
SL-J452-1 
SL-J503-1 
SL-J210-1 
SL-J003-1: (R)-(-)-1-[(S)-2-
(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDICYCLOHEXYLPHOSPHINE 
SL-J110-1 
SL-J007-1 
SL-J009-1 
SL-J012-1 
SL-J015-2 
SL-J418-1 
SL-J504-1 
SL-J605-1 
SL-J507-1 
SL-J034-1 
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Chiral Ligands P3-60 ligands 
(R)-MonoPhos: (R)-(-)-[4-N,N-DIMETHYLAMINO]DINAPHTHO[2,1-D:1',2'-
F][1,3,2]DIOXAPHOSPHEPINE 
(S)-N-Me-N-Bn-MonoPhos: (S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-
A']DINAPHTHALEN-4-YL)BENZYL(METHYL)AMINE 
(S)-PipPhos: (S)-(+)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinapthalen-4-
yl)piperidine 
(S)-2,6-Me-MonoPhos: (S)-(+)-(2,6-Dimethyl-3,5-dioxa-4-phospha-cyclohepta[2,1-
a;3,4-a']dinaphthalen-4-yl)dimethylamine 
(S,R)-(a-MeBn)-MonoPhos: (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-
a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]amine 
(S,R,R)-(a-MeBn)2-MonoPhos: (S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-
A;3,4-A']DINAPHTHALEN-4-YL)BIS[(1R)-1-PHENYLETHYL]AMINE, DICHLOROMETHANE 
ADDUCT 
(S,S,S)-(a-MeBn)2-MonoPhos: (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-
a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine 
(S)-H8-MonoPhos: (S)-(+)-(8,9,10,11,12,13,14,15-OCTAHYDRO-3,5-DIOXA-4-
PHOSPHA-CYCLOHEPTA[2,1-A;3,4-A']DINAPHTHALEN-4-YL)DIMETHYLAMINE 
(S)-H8-PipPhos: 1-[(11bS)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepin-4-yl]piperidine 
(R)-BINOL-P-OiPr: (R)-BINAPHTHYLISOPROPYLPHOSPHITE 
(R)-BINOL-P-OiBu: (R)-BINAPHTHYLISOBUTYLPHOSPHITE 
(R,R)-TADDOL-P-NMe2: (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-
[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 
(R)-SIPHOS (11aR)-(+)-10,11,12,13-tetrahydrodiindeno[7,1-de:1',7'-
fg][1,3,2]dioxaphosphocin-5-dimethylamine 
(R)-SIPHOS-PE: (11aR)-(+)-10,11,12,13-tetrahydrodiindeno[7,1-de:1',7'-
fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine 
(R)-ShiP: (11aR)-(+)-10,11,12,13-tetrahydrodiindeno[7,1-de:1',7'-
fg][1,3,2]dioxaphosphocin-5-phenoxy 
(S,S)-Mikami Ligand: 2,10-dimethyl-N,N-bis[(1S)-1-phenylethyl]-12H-
Dibenzo[d,g][1,3,2]dioxaphosphocin-6-amine 
(S,S)-tBu-Mikami Ligand: 4,8-di-tert-butyl-2,10-dimethyl-N,N-bis[(1S)-1-phenylethyl]-
12H-Dibenzo[d,g][1,3,2]dioxaphosphocin-6-amine 
(R)-Quinap: (R)-1-(2-DIPHENYLPHOSPHINO-1-NAPHTHYL)ISOQUINOLINE 
(R)-N-PINAP: (R)-(+)-4-[2-(DIPHENYLPHOSPHINO)-1-NAPHTHALENYL]-N-[(R)-1-
PHENYLETHYL]-1-PHTHALAZINAMINE 
(R)-MOP 
(R,R)-Me-DuPhos Monoxide: (2R,5R)-1-[2-[(2R,5R)-2,5-DIMETHYLPHOSPHOLAN-1-
YL]PHENYL]-2,5-DIMETHYLPHOSPHOLANE 1-OXIDE 
(S,S)-Me-RajPhos: (2S,5S)-(+)-1-(2-(1,3-DIOXOLAN-2-YL)PHENYL)-2,5-
DIMETHYLPHOSPHOLANE 
(S,S)-Et-RajPhos: (2S,5S)-(-)-1-(2-(1,3-DIOXOLAN-2-YL)PHENYL)-2,5-
DIETHYLPHOSPHOLANE 
(S,S,S)-DiazaPhos-PPE: 2,2'-[(1S,3S)-2,3,5,10-tetrahydro-5,10-dioxo-2-phenyl-1H-
[1,2,4]diazaphospholo[1,2b]phthalazine-1,3-diyl]bis[N-(1S)-1-phenylethyl]benzamide 
(S)-BINAP: (S)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL 
(R)-xyl-BINAP: (R)-(+)-2,2'-BIS[DI(3,5-XYLYL)PHOSPHINO]-1,1'-BINAPHTHYL 
(R)-SegPhos: (R)-(+)-5,5'-BIS(DIPHENYLPHOSPHINO)-4,4'-BI-1,3-BENZODIOXOLE 
SL-J002-1 
SL-J212-1 
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SL-J005-1 
SL-J009-1 
SL-J006-2 
SL-J010-1 
SL-W005-2 
(S,S)-Me-DuPhos: (+)-1,2-BIS[(2S,5S)-2,5-DIMETHYLPHOSPHOLANO]BENZENE 
(1S,1'S,2R,2'R)-DuanPhos: (1S,1'S,2R,2'R)-2,2'-Di-tert-butyl-2,3,2',3'-tetrahydro-1H, 
1'H-(1,1')biisophosphindolyl 
SL-J003-2 
SL-W001-1 
SL-W003-1 
SL-W006-1 
(R,R)-QuinoxP*: (R,R)-2,3-Bis(tert-butylmethylphosphino)quinoxaline 
(R,R)-SL-M002-2 (Cy) 
(S,S)-Me-UCAP-DTBM 
(S)-(−)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindene 
SL-T001-1 
(+)-Cy-SEGPHOS 
(S)-BINAPINE: (3S,3'S,4S,4'S,11bS,11'bS)-(+)-4,4'-Di-t-butyl-4,4',5,5'-tetrahydro-
3,3'-bi-3H-dinaphtho[2,1-c:1',2'-e]phosphepine 
(S)-PipPhos: (S)-(+)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinapthalen-4-
yl)piperidine 
K15-0026: (1R,2R)-N,N'-BIS[2-(DIPHENYLPHOSPHINO)BENZYL]CYCLOHEXANE-1,2-
DIAMINE 
K15-0088: (1R,2R)-N,N-Bis(2-(di-p-tolylphosphino)-benzyl)cyclohexane-1,2-diamine 
K15-0090: (1R,2R)-N,N-Bis(2-(bis(3,5-dimethylphenyl)-
phosphino)benzyl)cyclohexane-1,2-diamine 
K15-0020: 2,2'-BIS[(R-1,1'-BINAPHTHYL-2,2'-DIMETHYL)PHOSPHINO]DIETHYLAMINE 
K15-0129: (R)-1-(DIPHENYLPHOSPHINO)-2-AMINO-3-METHYLBUTANE 
K15-0131: (R)-1-(DIPHENYLPHOSPHINO)-2-AMINO-3,3-DIMETHYLBUTANE 
K15-0128: (S)-1-AMINO-8-(DIPHENYLPHOSPHINO)-1,2,3,4-
TETRAHYDRONAPHTHALENE 
K15-0051: 2-[(11BS)-3H-BINAPHTHO[2,1-C:1',2'-E]PHOSPHEPIN-4(5H)-
YL]ETHANAMINE 
K15-0046: (1R,2R)-2-(DIPHENYLPHOSPHINO)-1,2-DIPHENYLETHYLAMINE 
K15-0137: (1R,2R)-2-(DIPHENYLPHOSPHINO)-1-AMINOCYCLOHEXANE 
K15-0100: (1R,2R)-1-[(4S,11BR)-3,5-DIHYDRO-4H-DINAPHTHO[2,1-C:1',2'-
E]PHOSPHEPIN-4-YL]-1-PHENYLPROPAN-2-AMINE 
(1S,2S)-(2-METHYLAMINO-1-PHENYLPROPYL)DIPHENYLPHOSPHINE 
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N N
OBoc
+
N N
*
 3 equiv NaN(SiMe3)2
DME, temp, 12 h
5 mol % Ni(COD)2
 Ligand
entry Ligand e.e.c (%)
1
2
3
4
5
6
7
yieldb (%)Ni/Ligand (mol %)
5/10R,R-Me-DuPhos 57 47
8
9
SL-J507-1
SL-J605-1
SL-J204-1
SL-J204-1
SL-J204-1
SL-J204-1
5/10
5/10
5/10
5/10
5/7.5
5/5
61
51
85
93
92(91)d
80
30
92
73
7
93
92
a Reaction conducted on a 0.1 mmol scale.b Yield determined by 1H NMR spectroscopy of the crude 
reaction mixture.c Crude e.e determined by chiral-HPLC. d Isolated yield.
SL-J203-2
SL-J219-1 5/10
5/10
40
66 70
15
temp(oC)
24
24
0
24
24
0
0
24
24
1 equiv 2 equiv
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Chapter 3 
Palladium-Catalyzed α-Arylation of Aryl Acetic Acid 
Derivatives via Dienolate Intermediates with  
Aryl Chlorides and Bromides 
 
 
 
3.1. INTRODUCTION 
 Transition metal-catalyzed α-arylation of enolates and their derivatives is of 
great importance due to the diversity of compounds that can be accessed.1  In 
1997 pioneering studies on palladium-catalyzed α-arylation of ketones with aryl 
bromides was independently reported by the Miura2, Buchwald3 and Hartwig4 
groups.  Since these seminal works, intensive studies on α-arylation of carbonyl 
compounds have been reported.5,6  To date, however, examples of α-arylation of 
simple carboxylic acids remain scarce.7-9  
 In 2007, Daugulis and co-workers studied the palladium-catalyzed ortho 
arylation of benzoic acids.  They reported a byproduct derived from the α-
arylation of acetic acid with 3,5-dimethyl iodobenzene (Scheme 3.1A).7 The 
scope and mechanism of this reaction were recently investigated by Han and 
Zhao.8  In both cases, the reaction required use of excess acetic acid (3.5 to 
>50 equiv), supra-stoichiometric silver acetate, and gave poor to moderate 
yields (18–68%). 
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 In 2000, Wolfe and co-workers reported reaction of phenyl acetic acid 
dienolate with aryl bromides and iodides in liquid ammonia under near-UV 
irradiation to afford alpha and para arylation products via a proposed SRN1 
process (Scheme 3.1B).10 The inconvenient reaction conditions (NH3(l), hv) 
preclude large-scale applications of this chemistry. 
 
Scheme 3.1. Previous Examples of a-Arylation of Carboxylic Acid Derivatives  
+  CH3COOH  +  AgOAc
Pd(OAc)2 (cat)
130 oC, 7 h
Me
Me I
Me
Me OH
O
52% yield
A.  Daugulis, 2007
Ar
NH3(l), hv, 5 h
B.  Wolfe, 2000
2–3 equiv
OLi
OLi X (1 equiv)
Ar
OH2
O
O
OK
D. This work
OK
OK
H H
KN(SiMe3)2
H
Toluene, 
110 oC, 12 h
Ar X O
OH
Ar
C.  Mori 2014
O
OH
OMgCl
OMgCl
H H
O
OH
Ar
(X=Cl, Br)
X= Br, I
61–77% yield
1) EtMgCl
R R R
RRR
H
2) Pd-cat
Ar–X
Pd(NiXantPhos)
(cat)
OH
OAr
+
 
 
 Mori and co-workers described α-arylation of carboxylic acids in a two-step 
process (Scheme 3.1C). The substrates are first irreversibly deprotonated using 
EtMgCl to generate dienolates followed by palladium-catalyzed α-arylation with 
aryl bromides and iodides.9 
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 Our approach to the α-arylation of carboxylic acids differs from that of Mori 
and coworkers.  We envisioned reversible deprotonation of the substrate in the 
presence of the catalyst, allowing the use of less reactive bases.  Under these 
conditions, the carboxylate would be in equilibrium with the dienolate, as shown 
in Scheme 3.1D.  To develop this approach, a few issues must be considered. 
Prior studies on the generation of dienolates by double deprotonation of 
carboxylic acids11-14 indicate strong bases (e.g. nBuLi, LDA, Grignard reagents) 
are needed to achieve the second deprotonation.   
 Other challenges include control of chemo selectivity, undesired reactivity of 
the aryl acetic acid starting materials and decomposition/further reactions of 
the diaryl acetic acid product.  As noted above, aryl acetic acid derivatives are 
known to undergo palladium-catalyzed ortho arylation via a C–H activation 
pathway.15,16 In this process the carboxylate moiety serves as directing group to 
facilitate the C–H bond cleavage.  For example, Yu and co-workers demonstrated 
that ortho-C–H activation of phenyl acetic acid derivatives by palladium could be 
followed by cross-coupling (Scheme 3.2A).  Furthermore, aryl acetates have 
been reported to be unstable in the presence of palladium catalysts and undergo 
decarboxylative cross-coupling.17-23  This reaction pathway is exemplified by the 
report of Liu and co-workers, who demonstrated diarylmethanes can be formed 
using 2-pyridyl or nitroaryl acetates with aryl halides via palladium-catalyzed 
decarboxylative coupling (Scheme 3.2B).22,23  These studies indicate potential 
side reaction involving intermediates such as those in Scheme 3.1D that may 
compete with the desired α-arylation of dienolates.   
 Despite these issues, our experience with deprotonative cross-coupling 
processes (DCCP) of weakly acidic substrates (pKa > 25) positioned us to pursue 
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the α-arylation of acids.24-31 An important feature of the DCCP is an in situ 
reversible metallation of the substrate via C−H deprotonation under catalytic 
cross-coupling conditions. Herein, we describe a general protocol for the 
palladium-catalyzed α-arylation of carboxylic acids with aryl chlorides and 
bromides involving reversible deprotonation of the carboxylate.  
 
Scheme 3.2. Selectivity in Arylation of Aryl Acetic Acid Derivatives 
O
OH
Ar-X O
OH
R
H Pd
oxidant
Ar
A. Yu 2008-2013
O
OKAr Ar
Pd
Pd
L
L
Ar'Ar-X
O
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B. Liu 2010
- CO2
L L
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Ar= 2-Pyridyl, 2-nitrophenyl, 4-nitrophenyl
Ar Ar'
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3.2. RESULTS AND DISCUSSION 
 
The first step in our reaction development focused on deprotonation of phenyl 
acetic acid to form the dienolate intermediate.  To evaluate bases to 
deprotonate the carboxylate substrate, we employed a benzylation reaction with 
benzyl chloride to trap the dienolate (eq 3.1). 
O
OMPh OMPh
O
OHPh
H H
M-base
H–base
Ph Cl
Ph
80% yield
(1)
1a 1aa1.2 equiv
base = KN(SiMe3)2
2.5 equiv
1 equiv
THF, 80oC
OMO
OHPh
H H
M-base 1)
2) work up
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We chose to use KN(SiMe3)2 as base, because it exhibits good compatibility with 
catalysts, reagents, and products in deprotonative cross-coupling processes.28 
Employing KN(SiMe3)2 at 80 oC (eq. 3.1), the benzylation product 1aa was 
isolated in 80% yield, indicating formation of the dienolate under these 
conditions.  With this result in hand, we chose the NiXantphos/Pd(OAc)2–based 
catalyst due to its ability to arylate weakly acidic substrates, such as 
diphenylmethanes (pKa = 32.332, eq. 3.2).28 
O
H
N
PPh2 PPh2
NiXantphos
Ar' = aryl or heteroaryl
pKa up to 32
3 equiv KN(SiMe3)2
CPME, 24 oC, 12 h
up to 99% yield
Ar'' Br
Ar''
Ar Ar'
+
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
(2)Ar Ar'
H H
 
We examined the α-arylation of phenyl acetic acid 1a (1.2 equiv) with 1-bromo-
4-tert-butylbenzene 2a (limiting reagent) in the presence of KN(SiMe3)2 (2.5 
equiv) and catalytic Pd(OAc)2 (5 mol %) and NiXantphos (7.5 mol %).  These 
studies were initiated with a solvent screen.  The reaction in cyclopentyl methyl 
ether (CPME), an excellent solvent for DCCP’s, failed to afford arylation product 
(Table 3.1, entry 1). Dioxane initially appeared promising, with 56% yield (entry 
2).  Attempts to increase the yield, however, were unsuccessful.  THF, 2-methyl-
THF, and DME (entries 3–5) were examined at 80 oC with DME, giving up to 80% 
yield.  Likewise, toluene at 110 oC afforded the product in 80% yield (entry 6).  
Both THF and DME resulted in generation of 5–10% of an inseparable byproduct 
that was not observed in toluene, making toluene a better choice for further 
optimization. In the reaction in toluene (entry 6), some decomposition of phenyl 
acetic acid was observed, presumably resulting in lower yields.  To address this 
issue, the equivalents of aryl bromide and base were increased to 1.5 and 3, 
 90 
respectively, resulting in 83% yield (entry 7).  Reducing the reaction 
concentration to 0.05 M resulted in > 95% yield by 1H NMR of the crude product 
(entry 8).  Lowering the temperature (entry 9) or catalyst loading (entry 10), 
resulted in lower yields.   
 
Table 3.1. Optimization of Phenyl Acetic Acid a-Arylation a 
entry yieldb (%)
1
2
3
4
5
solvent(1a : base)
1.2 : 2.5 CPME 0
6
7
1.2 : 2.5
1.2 : 2.5
1.2 : 2.5
1.2 : 2.5
1.2 : 2.5
dioxane
2-MeTHF
toluene
DME
75
56
80
20
80
OH
+
KN(SiMe3)2, Temp, 12 h
solvent, concentration
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
1a
O OH
O
Br
tBu
tBu
temp (oC)
110
110
110
80
80
80
conc.
0.1
0.1
0.1
0.1
0.1
0.1
2a (1 equiv.) 3aa
THF
8
1.5 : 3.0 toluene 83110 0.1
9c
1.5 : 3.0 toluene >95 (93)110 0.05
10c,d
1.5 : 3.0 toluene 6580 0.05
1.5 : 3.0 toluene 88 (85)110 0.05
 
a Reaction conducted on a 0.1 mmol scale. b Yield determined by 1H NMR 
spectroscopy of the crude reaction mixture. c Isolated yield after 
chromatographic purification. d 2.5 mol % Pd(OAc)2/3.75 mol % NiXantphos. 
 
 With the optimized conditions of Table 3.1 (entry 8), the scope of aryl 
halides in the α-arylation of phenyl acetic acid was examined (Table 3.2). 1-
Bromo- and 1-chloro-4-tert-butylbenzene gave 3aa in 93 and 84% yield, 
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respectively (entry 1). Substrates with electron donating groups, such as 4-
bromo- and 4-chloroanisole, exhibited good reactivity, generating 87 and 80% 
yield of the arylation products (entry 2).  4-Bromo-N,N-dimethylaniline furnished 
3ac in 86% yield. Aryl bromides and chlorides with electron-withdrawing groups, 
such as 4-F, 4-Cl, and 3-CF3, were all tolerated.  1-Bromo- and 1-chloro-4-
fluorobenzene furnished diaryl acetic acid in 75 and 62% yield, respectively, 
while 1-bromo-4-chlorobenzene underwent coupling to give 3ae in 65% yield. In 
the latter case, no byproducts derived from oxidative addition of the C–Cl bond 
were observed. Aryl bromide bearing a 3-CF3 substituent furnished the product 
in 77% yield. Sterically hindered 2-bromotoluene and 1-bromonaphthalene gave 
3ag and 3ah in 71% and 80% yields, respectively.  In the case of 2-
bromotoluene, both the aryl bromide and base equivalents were increased to 2 
and 4, respectively.  For the more challenging 2-chlorotoluene, 10% Pd(OAc)2 
was required to render 3ag in 63% isolated yield. Heterocyclic N-methyl-5-
bromoindole exhibited good reactivity with phenyl acetic acid to form 3ai in 
82% yield.  The TIPS silyl ether derived from 4-bromophenol was subjected to 
the reaction conditions and afforded 3ai in 53% yield. (Table 2, entry 10) 
Unfortunately, aryl bromides containing ketone, ester or amide groups failed to 
give desired products. 
 
Table 3.2. Scope of Aryl Halides in the a-Arylation of Phenyl Acetic 
Acida,b  
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OH
+
3 equiv KN(SiMe3)2
Toluene, 110 oC, 12 h
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
1a 
1.5 equiv
2a-2i
1 equiv 3aa-3ai
O
Ar-X OH
O
Ar
OH
O1
3aa, 
X=Br, 93%
X=Cl, 84%
OH
O2
OMe
3ab, 
X=Br, 87%
X=Cl, 80%
OH
O3
NMe2
3ac, 
X=Br, 86%
OH
O
4
F
3ad, 
X=Br, 75%
X=Cl, 62%
OH
O
5
Cl
3ae, 
X=Br, 65%
OH
O
6
3ag, 
X=Br, 71%
 X=Cl, 63%d
CH3
OH
O
7
3af, 
X=Br, 77%c
OH
O8
3ah, 
X=Br, 80%
OH
O9
3ai, 
X=Br, 82%
F3C
MeN
OH
O
10
OSi(iPr)3
3aj, 
X=Br, 53%
 
a Reaction conducted on a 0.1 mmol scale at 0.05M. b Isolated yield after 
chromatographic purification. c 2 equiv of 1a and 4 equiv of KN(SiMe3)2. d 10 mol 
% Pd(OAc)2/15 mol % NiXantphos.  
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 The scope of α-arylation with substituted aryl acetic acids was examined 
with 1-bromo-4-tert-butylbenzene 2a (Table 3.3). Electron neutral 2-naphthyl 
acetic acid afforded the coupling product in 73% yield.  Electron donating 4-
methoxy phenyl acetic acid underwent coupling in 86% yield.  Aryl acetic acids 
with withdrawing 4-F, 4-Cl and 3-CF3 groups furnished coupling products in 81, 
58 and 65% yield, respectively. Sterically hindered 2-tolyl acetic acid proved to 
be a challenging substrate with 53% yield obtained despite repeated attempts 
to optimize the reaction. We next examined 3-pyridyl acetic acid in the α-
arylation. With our standard reaction conditions, only decomposition of the acid 
was observed. We then screened bases KN(SiMe3)2 , NaN(SiMe3)2, LiN(SiMe3)2, 
KOtBu, NaOtBu, and LiOtBu and identified NaOtBu as a better option, generating 
70% isolated yield in the coupling (entry 7).  In order to demonstrate scalability 
of the protocol, a gram-scale reaction was performed with 4-methoxy phenyl 
acetic acid (1b) and 4-tert-butyl bromobenzene (2a).  The arylation product 
3ba (1.1 g) was isolated in 74% (Table 3.3, entry 1). 
 
Table 3.3. Scope of a-Arylation with Aryl Acetic Acidsa,b 
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OH
+
3 equiv KN(SiMe3)2
Toluene, 110 oC, 12 h
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
1b-1h 
1.5 equiv
2a
1 equiv
O OH
O
OH
O1
tBu
3ba, 86%(74%c)
OH
O
2
tBu
3ca, 81%d
OH
O
3
tBu
3da, 58%
OH
O
6
3ea, 53%
OH
O
4
3ga, 65%d
OH
O
5
3fa, 73 %
R
tBu
Br
tBu
F
R
3ba-3ha
OH
O
N
3ha, 70 %e
MeO Cl
7
tBu tBu tBu
tBu
CH3
F3C
 
a Reaction conducted on a 0.1 mmol scale at 0.05M. b Isolated yield after 
chromatographic purification. c Reaction conducted on a 5 mmol scale at 0.05M, 
1.1 grams of product was obtained. d 2 equiv of acid and 4 equiv of KN(SiMe3)2.  
e 2 equiv of acid and 6 equiv of NaOtBu. 
 
 After demonstrating the scope of aryl halides and aryl acetic acids, we 
turned our attention to styryl acetic acids (Scheme 3.3). trans-Styryl acetic acid 
4a is an interesting substrate, because it has two sites that can potentially 
undergo arylation. After screening different bases with this substrate, we 
observed that with NaN(SiMe3)2, only one regioisomeric arylation product was 
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obtained. It appears that the initially formed product undergoes isomerization of 
the double bond to form the more conjugated product 4ap in 70% isolated 
yield.  This product could also be envisioned to arise from a Heck reaction. We 
are unaware, however, of literature precedence involving trans-styryl acetic 
acids undergoing Heck-type reactions.  
 It is noteworthy that the structure of 4ap is related to Amitriptyline, a 
medication that has been used in the treatment of migraines,33,34 diabetic 
neuropathy,35 postherpetic neuralgia,36 and chronic lower back pain.35,37 In 
addition, Brown and co-workers reported an analog of Amitriptyline, 
diphenylamine DHP-362, which exhibits higher potency as a sodium channel 
blocker.38 The synthesis of DHP-362 is only two steps away from 4ap. We next 
examined the arylation of trans-styryl acetic acid 4a with different aryl 
bromides. Both 4-tert-Bu and 4-F groups underwent reaction with excellent 
regioselectivity and afforded E/Z-mixtures in 71–78% yield.39  
Scheme 3.3. Arylation of trans-Styryl Acetic Acid 4a 
Amitriptyline
N
DHP-362
N
OH
O Ar
O OH
4a
3 equiv NaN(SiMe3)2
Toluene, 80 oC, 12 h
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
1 equiv ArBr
Ar = Ph, 4ap,  70%
Ar = 4-tBu-C6H4, 4aa, 78% (E:Z = 1.4:1)
Ar = 4-F-C6H4,  4ad,  71% (E:Z = 1:1)
1.5 equiv
 
 
3.3. SUMMARY AND OUTLOOK 
 
 In summary, we have developed a general method for palladium-catalyzed α-
arylation of aryl acetic acids with aryl bromides and chlorides.  The reaction also 
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affords product with trans-styryl acetic acid, which provides intermediates in 
route to biologically active compounds. We anticipate that this protocol will be 
an important complement to the existing arsenal of palladium-catalyzed a-
arylation reactions.  
 
3.4. EXPERIMENTAL SECTION 
 
General Methods.  All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. Toluene (anhydrous, 
99.8%) was purchased from Sigma-Aldrich, THF was sparged for 20 min with dry N2 and 
dried using a commercial two-column solvent purification system comprising columns 
packed with neutral alumina. Unless otherwise stated, reagents were commercially 
available and used as purchased without further purification. Chemicals were obtained 
from Sigma-Aldrich, Acros, TCI America, Strem Chemicals or Matrix Scientific, and 
solvents were purchased from Fisher Scientific. The progress of the reactions was 
monitored by thin-layer chromatography using Whatman Partisil K6F 250 μm precoated 
60 Å silica gel plates and visualized by short-wavelength ultraviolet light as well as by 
treatment potassium permanganate (KMnO4) stain or iodine. Silica gel (230−400 mesh, 
Silicycle) was used for flash chromatography. The 1H NMR and 13C{1H} NMR spectra 
were obtained using a Brüker AM-500 Fourier transform NMR spectrometer at 500 and 
126 MHz, respectively. Chemical shifts are reported in units of parts per million (ppm) 
downfield from tetramethylsilane (TMS), and all coupling constants are reported in hertz. 
The infrared spectra were obtained with KBr plates using a Perkin-Elmer Spectrum 100 
Series FTIR spectrometer. High-resolution mass spectrometry (HRMS) data were 
obtained on a Waters LC−TOF mass spectrometer (model LCT-XE Premier) using 
chemical ionization (CI) or electrospray ionization (ESI) in positive or negative mode, 
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depending on the analyte.  Melting points were determined on a Unimelt Thomas-Hoover 
melting point apparatus and are uncorrected. Compounds 2i was prepared according 
to literature procedures.40  It is noteworthy that the acidic proton of the acid 
products is not observed under the 1H NMR conditions used in our protocol 
(except in one case).  The acid is clearly visible in the IR and 13C{1H} NMR, and 
high resolution MS spectra.   
 
General Procedure: Palladium-Catalyzed Alpha Arylation with Phenyl Acetic Acids. An 
oven-dried 10 mL reaction vial equipped with a stir bar was charged with KN(SiMe3)2 (60 
mg, 0.30 mmol, 3 equiv) under a nitrogen atmosphere. A solution (from a stock 
solution) of Pd(OAc)2 (1.12 mg, 0.0050 mmol) and NiXantphos (4.14 mg, 0.0075 
mmol) in 2 mL of dry toluene was taken up by syringe and added to the reaction vial. 
After stirring for 5 min at 24 °C, phenyl acetic acid 1a (20.42 mg, 0.15 mmol, 1.5 
equiv) was added to the reaction mixture followed by 2a (18 μL, 0.1 mmol, 1 equiv). 
The reaction mixture was stirred for 12 h at 110 °C, quenched with two drops of H2O, 
diluted with 3 mL of 15% MeOH/DCM solution and filtered over a pad of MgSO4 and 
silica. The pad was rinsed with additional 15% MeOH/DCM solution, and the solution was 
concentrated in vacuo. The crude material was loaded onto a silica gel column and 
purified by flash chromatography eluting with MeOH/DCM.  
 
 
2,3-Diphenylpropanoic acid (3.1aa): An oven-dried 10 mL 
reaction vial equipped with a stir bar was charged with 1a (16.3 mg, 
0.12 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol, 3 equiv) under a nitrogen 
atmosphere. THF (2 mL) was added followed by benzyl chloride (11.5 
μL, 0.1 mmol). The reaction mixture was stirred for 12 h at 110 °C, quenched with two 
drops of H2O, diluted with 3 mL of 15% MeOH/DCM solution and filtered over a pad of 
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MgSO4 and silica. The pad was rinsed with additional 15% MeOH/DCM solution, and the 
solution was concentrated in vacuo. The crude material was purified by flash 
chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 
2.5:97.5) to give the product (18 mg, 80% yield) as a colorless oil. Rf = 0.40 
(MeOH:DCM = 5:95). The spectroscopic data match the previously reported data.41 
 
2-(4-(tert-Butyl)phenyl)-2-phenylacetic acid (3.3aa): The 
reaction was performed following the General Procedure with 1a (20.4 
mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-bromo-4-
(tert-butyl)benzene (18 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM 
= 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (25 mg, 93% yield) as a 
yellow oil. Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.35-7.24 (m, 
9H), 5.01 (s, 1H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.6, 150.6, 138.3, 
135.1, 128.91, 128.84, 128.5, 127.6, 125.8, 56.8, 34.7, 31.5; IR (thin film): 3060 
3029, 2963 (br),, 2904, 2708, 1708, 1600, 1514, 1496, 1454, 1408, 1364, 1307, 
1285, 1269, 1215, 1174, 1108, 1019, 934, 821, 700 cm–1; HRMS calc’d for C18H20O2+ 
268.1463, observed 268.1459 [MH]+. 
2-(4-(tert-Butyl)phenyl)-2-phenylacetic acid (3.3aa) (from 1-
chloro-4-(tert-butyl)benzene): The reaction was performed following 
the General Procedure with 1a (20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 
mg, 0.30 mmol) and 1-chloro-4-(tert-butyl)benzene (17 μL, 0.1 
mmol). The crude material was purified by flash chromatography on 
silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the 
product (22.5 mg, 84% yield) as a yellow oil. Rf = 0.40 (MeOH:DCM = 5:95). The 
spectroscopic data match the previously reported data. 
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2-(4-Methoxyphenyl)-2-phenylacetic acid (3.3ab): The 
reaction was performed following the the General Procedure with 1a 
(20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-bromo-
4-methoxybenzene (12.5 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM 
= 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (21 mg, 87% yield) as a 
colorless oil. Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.31-7.22 (m, 
7H), 6.85 (d, J = 8.5, 2H), 4.98 (s, 1H), 3.77 (s, 3H); 13C {1H} NMR (126 MHz, CDCl3): δ 
178.6, 158.9, 138.3, 130.1, 129.8, 128.66, 128.57, 127.4, 114.1, 56.2, 55.3; IR (thin 
film): 3029 (br), 1707, 1610, 1584, 1512, 1494, 1454, 1408,  1303, 1251, 1179, 
1032, 823, 699 cm–1; HRMS calc’d for C15H14O3+ 242.0943, observed 242.0937 [M]+. 
 
2-(4-Methoxyphenyl)-2-phenylacetic acid (3.3ab) (from 1-
chloro-4-methoxybenzene): The reaction was performed following the 
General Procedure with 1a (20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 
0.30 mmol) and 1-chloro-4-methoxybenzene (12.5 μL, 0.1 mmol). 
The crude material was purified by flash chromatography on silica gel 
(eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (19.5 
mg, 80% yield) as a colorless oil. Rf = 0.40 (MeOH:DCM = 5:95). The spectroscopic data 
match the previously reported data. 
 
2-(4-(Dimethylamino)phenyl)-2-phenylacetic acid (3.3ac): 
The reaction was performed following the General Procedure with 1a 
(20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 4-bromo-
N,N-dimethylaniline (20 mg, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM 
= 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (22 mg, 86% yield) as a 
yellow oil. Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.32-7.22 (m, 
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5H), 7.19-7.17 (m, 2H), 6.70-6.68 (m, 2H), 4.94 (s, 1H), 2.91 (s, 6H); 13C {1H} NMR 
(126 MHz, CDCl3): δ 178.9, 149.9, 138.8, 129.4, 128.60, 128.55, 127.2, 126.0, 
112.9, 56.2, 40.7; IR (thin film): 3059, 3027 , 2920 (br), 2803, 1953, 1719, 1612, 
1565, 1521, 1495, 1453, 1351,  1282, 1196, 1165, 1032, 947, 909, 813, 728, 700 
cm–1; HRMS calc’d for C16H18NO2+ 256.1338, observed 256.1338 [M+H]+. 
 
2-(4-Fluorophenyl)-2-phenylacetic acid (3.3ad): The reaction 
was performed following the General Procedure with 1a (20.4 mg, 
0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-bromo-4-
fluorobenzene (11 μL, 0.1 mmol). The crude material was purified by 
flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 
to MeOH:DCM = 2.5:97.5) to give the product (17.3 mg, 75% yield) as a yellow solid (m. 
p. = 106-108 °C). Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.34-7.26 
(m, 7H), 7.00 (t, J = 8.6, 2H), 5.01 (s, 1H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.3, 
162.1 (J = 247 Hz), 137.7, 133.67 (J = 3.8 Hz), 130.36 (J = 7.6 Hz), 128.8, 128.5, 
127.7, 115.56 (J = 21.4 Hz), 56.2; IR (thin film): 2923 (br),  1704, 1602, 1508, 1454, 
1284, 1223, 1159, 804, 720, 695 cm–1; HRMS calc’d for C14H10F- 229.0665, observed 
229.0672 [M-H]-. 
 
 
2-(4-Fluorophenyl)-2-phenylacetic acid (3.3ad) (from 1-
chloro-4-fluorobenzene): The reaction was performed following the 
General Procedure with 1a (20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 
0.30 mmol) and 1-chloro-4-fluorobenzene (11 μL, 0.1 mmol). The 
crude material was purified by flash chromatography on silica gel 
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(eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (14.3 
mg, 62% yield) as a yellow solid (m. p. = 106-108 °C). Rf = 0.40 (MeOH:DCM = 5:95). 
The spectroscopic data match the previously reported data.  
 
2-(4-Chlorophenyl)-2-phenylacetic acid (3.3ae): The reaction 
was performed following the General Procedure with 1a (20.4 mg, 
0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-bromo-4-
chlorobenzene (19.14 mg, 0.1 mmol). The crude material was purified 
by flash chromatography on silica gel (eluted with MeOH:DCM = 
0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (16 mg, 65% yield) as a yellow 
oil. Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.36-7.25 (m, 9H), 5.02 
(s, 1H); 13C {1H} NMR (126 MHz, CDCl3): δ 177.9, 137.5, 136.4, 133.5, 130, 128.8, 
(128.8), 128.6, 127.8, 56.3; IR (thin film): 3029 (br), 1708, 1491, 1454, 1402, 1276, 
1213, 1091, 1015, 814, 699 cm–1; HRMS calc’d for C13H10Cl 201.0471, observed 
201.0479 [M-COOH]. 
 
2-Phenyl-2-(3-(trif luoromethyl)phenyl)acetic acid (3.3af): 
The reaction was performed following the General Procedure with 1a 
(27.2 mg, 0.2 mmol), KN(SiMe3)2 (80 mg, 0.40 mmol) and 1-bromo-
3-(trifluoromethyl)benzene (14 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (21.5 mg, 77% yield) as a yellow oil. Rf = 
0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.61-7.31 (m, 9H), 5.10 (s, 1H); 
13C {1H} NMR (126 MHz, CDCl3): δ 177.7, 138.9, 137.1, 132.2, 131 (J = 32 Hz), 129.2, 
129, 128.6, 127.9, 125.55  (J = 3.8 Hz), 124.48 (J = 3.8 Hz), 123.96 (J = 272.8 Hz), 
56.7; IR (thin film): 3031 (br), 1712, 1600, 1496, 1450, 1412, 1330, 1215, 1165, 
1125, 1098, 1077, 1032, 1003, 917, 801, 730, 700 cm–1; HRMS calc’d for C30H21O4F6- 
559.1344, observed 559.1343 [2M-H]-. 
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2-Phenyl-2-(o-tolyl)acetic acid (3.3ag): The reaction was 
performed following the General Procedure with 1a (20.4 mg, 0.15 
mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-bromo-2-
methylbenzene (12.5 μL, 0.1 mmol). The crude material was purified 
by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 
2.5:97.5) to give the product (16 mg, 71% yield) as a yellow solid (m. p. = 87-89 °C) . 
Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.34-7.19 (m, 9H), 5.25 (s, 
1H), 2.31 (s, 3H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.3, 137.3, 136.5, 136.3, 130.8, 
129.0, 128.6, 128.2, 127.61, 127.44, 126.3, 53.6, 19.9; IR (thin film): 3027 (br), 
1707, 1602, 1495, 1453, 1409, 1280, 1217, 1031, 935, 747, 726, 698 cm–1; HRMS 
calc’d for C15H14O2 226.0994, observed 226.0984 [M]+. 
 
 
2-Phenyl-2-(o-tolyl)acetic acid (3.3ag) (from 1-chloro-2-
methylbenzene) : The reaction was performed following the General 
Procedure (10% Pd(OAc)2 2.24 mg and 15% NiXantphos 8.27 mg in 
2mL dry toluene) with 1a (20.4 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 
0.30 mmol) and 1-chloro-2-methylbenzene (12 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (14.3 mg, 63% yield) as a yellow solid (m. p. 
= 87-89 °C) . Rf = 0.40 (MeOH:DCM = 5:95). The spectroscopic data match the 
previously reported data.  
 
2-(Naphthalen-1-yl)-2-phenylacetic acid (3.3ah): The reaction 
was performed following the General Procedure with 1a (20.4 mg, 
0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 1-
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bromonaphthalene (14 μL, 0.1 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 
2.5:97.5) to give the product (21 mg, 80% yield) as a brown solid (m. p. = 128-129 
°C) . Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 8.02-8.00 (m, 1H), 
7.89-7.87 (m, 1H), 7.82 (d, J = 7.9, 1H), 7.51-7.29 (m, 9H), 5.82 (s, 1H); 13C {1H} 
NMR (126 MHz, CDCl3): δ 178.4, 137.3, 134.0, 133.8, 131.6, 129.05, 129.03, 128.8, 
128.5, 127.6, 126.7, 126.4, 125.8, 125.4, 123.2, 53.5; IR (thin film): 3428 (br), 2077, 
1706, 1599, 1510, 1495, 1453, 1397, 1270, 1215, 1031, 907, 790, 775, 730, 700 
cm–1; HRMS calc’d for C18H14O2Na 285.0891, observed 285.0902 [M+Na]+. 
 
2-(1-Methyl-1H-indol-5-yl)-2-phenylacetic acid (3.3ai): The 
reaction was performed following the General Procedure with 1a (20.4 
mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 5-bromo-1-
methyl-indole (21 mg, 0.1 mmol). The crude material was purified by 
flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 
to MeOH:DCM = 2.5:97.5) to give the product (21.8 mg, 82% yield) as a yellow solid (m. 
p. = 136-138 °C) . Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.58-
7.57 (m, 1H), 7.36-7.24 (m, 6H), 7.18 (dd, J = 8.5, 1.8, 1H), 7.02 (d, J = 3.1, 1H), 
6.43 (dt, J = 3.1, 0.4, 1H), 5.16 (s, 1H), 3.75 (s, 3H); 13C {1H} NMR (126 MHz, CDCl3): δ 
179.3, 138.9, 136.0, 129.4, 128.86, 128.68, 128.55, 128.46, 127.1, 122.4, 120.9, 
109.4, 101.1, 57.0, 32.8; IR (thin film): 3027 (br), 1703, 1511, 1493, 1449, 1421, 
1339, 1246, 1079, 909, 795, 700 cm–1; HRMS calc’d for C17H16NO2 266.1181, 
observed 266.1171 [MH]+. 
 
2-(4-(tert-Butyl)phenyl)-2-(4-methoxyphenyl)acetic 
acid (3.3ba): The reaction was performed following the General 
Procedure with  2-(4-methoxyphenyl)acetic acid (25 mg, 0.15 
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mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 2a (18 μL, 0.1 mmol). The crude material 
was purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (25.7 mg, 86% yield) as a yellow oil. Rf = 
0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.33 (d, J = 8.2, 2H), 7.26-7.22 
(m, 4H), 6.85 (d, J = 8.3, 2H), 4.95 (s, 1H), 3.77 (d, J = 0.7, 3H), 1.29 (d, J = 0.7, 9H); 
13C {1H} NMR (126 MHz, CDCl3): δ 179.1, 158.9, 150.3, 135.2, 130.3, 129.8, 128.2, 
125.6, 114.0, 55.8, 55.3, 34.5, 31.4; IR (thin film): 3418 (br), 2962, 2835, 1707, 
1611, 1584, 1511, 1463, 1441, 1406, 1363, 1303, 1251, 1215, 1179, 1109, 1035, 
826 cm–1; HRMS calc’d for C19H22O3Na+ 321.1467, observed 321.1467 [M+Na]+. 
 
2-(4-(tert-Butyl)phenyl)-2-(4-fluorophenyl)acetic acid 
(3.3ca): The reaction was performed following the General 
Procedure with 2-(4-fluorophenyl)acetic acid (30.8 mg, 0.2 
mmol), KN(SiMe3)2 (80 mg, 0.40 mmol) and 2a (18 μL, 0.1 
mmol). The crude material was purified by flash chromatography 
on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the 
product (23.2 mg, 81% yield) as a yellow oil. Rf = 0.40 (MeOH:DCM = 5:95); 1H NMR 
(500 MHz, CDCl3): δ 7.35-7.34 (m, 2H), 7.30 (dd, J = 8.8, 5.3, 2H), 7.23-7.22 (m, 2H), 
7.00 (t, J = 8.7, 2H), 4.98 (s, 1H), 1.29 (d, J = 7.5, 9H); 13C {1H} NMR (126 MHz, 
CDCl3): δ 178.5, 162.1 (J = 247 Hz), 150.6, 134.7, 133.84 (J = 3.4 Hz), 130.35 (J = 
8.2 Hz), 128.2, 125.7, 115.5 (J = 21.3 Hz), 55.8, 34.5 31.3; IR (thin film): 2963 (br), 
1709, 1603, 1508, 1405, 1364, 1269, 1225, 1159, 1017, 828 cm–1; HRMS calc’d for 
C17H20O- 241.1392, observed 241.0714 [M-COOH]-. 
 
2-(4-(tert-Butyl)phenyl)-2-(4-chlorophenyl)acetic acid 
(3.3da): The reaction was performed following the General 
Procedure with  2-(4-chlorophenyl)acetic acid (25.6 mg, 0.15 
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mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 2a (18 μL, 0.1 mmol). The crude material 
was purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (17.6 mg, 58% yield) as a yellow oil. Rf = 
0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.31-7.17 (m, 8H), 4.93 (s, 1H), 
1.26 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.5, 150.7, 136.6, 134.4, 133.5, 
130.1, 128.8, 128.2, 125.8, 56.0, 34.5, 31.3; IR (thin film): 2963 (br), 1709, 1491, 
1402, 1364, 1269, 1215, 1091, 1015, 909, 824, 734, 682 cm–1; HRMS calc’d for 
C18H19O2Cl- 302.1074, observed 302.1103 [M-COOH]-. 
 
2-(4-(tert-Butyl)phenyl)-2-(o-tolyl)acetic acid (3.3ea): 
The reaction was performed following the General Procedure with  
2-(o-tolyl)acetic acid (22.5 mg, 0.15 mmol), KN(SiMe3)2 (60 mg, 
0.30 mmol) and 2a (18 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (15 mg, 53% yield) as a yellow paste. Rf = 
0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.32 (d, J = 8.5, 3H), 7.18-7.17 
(m, 5H), 5.20 (s, 1H), 2.31 (s, 3H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 
178.9, 150.2, 136.5, 134.2, 130.7, 128.6, 128.2, 127.5, 126.3, 125.6, 53.1, 34.5, 
31.4, 19.9; IR (thin film): 2963 (br), 1707, 1462, 1408, 1363, 1269, 1217, 1019, 910, 
823, 730, 668 cm–1; HRMS calc’d for C38H43O4- 563.3161, observed 563.3167 [2M-H]-. 
 
 
2-(4-(tert-Butyl)phenyl)-2-(naphthalen-2-yl)acetic acid 
(3.3fa): The reaction was performed following the General 
Procedure with  2-(naphthalen-2-yl)acetic acid (28 mg, 0.15 
mmol), KN(SiMe3)2 (60 mg, 0.30 mmol) and 2a (18 μL, 0.1 
mmol). The crude material was purified by flash chromatography 
on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the 
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product (23.3 mg, 73% yield) as a off-white solid (m.p. = 172-174 °C). Rf = 0.40 
(MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.80-7.77 (m, 4H), 7.46-7.43 (m, 3H), 
7.35-7.32 (m, 2H), 7.30-7.28 (m, 2H), 5.18 (s, 1H), 1.28 (s, 9H); 13C {1H} NMR (126 
MHz, CDCl3): δ 178.8, 150.5, 135.5, 134.8, 133.4, 132.6, 128.4, 128.0, 127.64, 
127.45, 126.8, 126.26, 126.13, (126.13), 125.7, 56.7, 34.5, 31.4; IR (thin film): 
2962 (br), 1707, 1600, 1508, 1407, 1364, 1270, 1215, 1018, 909, 815, 748, 701 
cm–1; HRMS calc’d for C44H45O4+ 637.3318, observed 637.33034 [2M+H]+. 
 
2-(4-(tert-Butyl)phenyl)-2-(3-
(trif luoromethyl)phenyl)acetic acid (3.3ga): The reaction 
was performed following the General Procedure with 2-(3-
(trifluoromethyl)phenyl)acetic acid (40.8 mg, 0.2 mmol), 
KN(SiMe3)2 (80 mg, 0.40 mmol) and 2a (18 μL, 0.1 mmol). The crude material was 
purified by flash chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to 
MeOH:DCM = 2.5:97.5) to give the product (21.9 mg, 65% yield) as a yellow oil. Rf = 
0.40 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): δ 7.62 (s, 1H), 7.54 (t, J = 7.2, 
2H), 7.44 (t, J = 7.8, 1H), 7.37-7.35 (m, 2H), 7.26-7.23 (m, 2H), 5.05 (s, 1H), 1.30 (s, 
9H); 13C {1H} NMR (126 MHz, CDCl3): δ 177.9, 150.8, 139, 134, 132.2, 131 (J = 32 Hz), 
129.1, 128.1, 125.9,  125.4  (J = 3.9 Hz), 124.4 (J = 3.9 Hz), 123.99 (J = 272.8 Hz), 
56.3, 34.5, 31.3; IR (thin film): 2965 (br), 1711, 1515, 1450, 1408, 1365, 1330, 
1215, 1165, 1128, 1097, 1076, 1019, 917, 828, 800, 701, 658 cm–1; HRMS calc’d for 
C38H37O4F6 672.2674, observed 672.0913 [2M]. 
 
2-(4-(tert-Butyl)phenyl)-2-(pyridin-3-yl)acetic acid 
(3.3ha): The reaction was performed following the General 
Procedure with  2-(pyridin-3-yl)acetic acid (34.7 mg, 0.2 mmol), 
NaOtBu (59 mg, 0.60 mmol) and 2a (18 μL, 0.1 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with MeOH:DCM 
OH
O
tBu
F3C
OH
O
N
tBu
 107 
= 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (18.9 mg, 53% yield) as a 
white solid (m.p. = 75-76 °C). Rf = 0.30 (MeOH:DCM = 5:95); 1H NMR (500 MHz, CDCl3): 
δ 9.36 (s, 1H), 8.68-8.67 (m, 1H), 8.48-8.46 (m, 1H), 7.82-7.78 (m, 1H), 7.36-7.22 
(m, 4H), 5.05-5.01 (m, 1H), 1.34-1.24 (m, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 
174.7, 150.4, 147.8, 145.8, 138.6, 136.8, 134.9, 128.2, 125.8, 124.1, 55.0, 34.5, 
31.3; IR (thin film in Mesitylene): 3016 (br), 2917 (br), 2860, 2729,  1757, 1711, 
1607, 1471, 1374, , 1165, 1037, 928, 880, 835, 687, 668 cm–1; HRMS calc’d for 
C17H20NO2- 210.1494, observed 210.1499 [M+H]+. 
 
4,4-Diphenylbut-3-enoic acid (3.4ap): The reaction was 
performed following the General Procedure trans-styrylacetic acid 
(24.3 mg, 0.15 mmol), NaN(SiMe3)2 (55 mg, 0.30 mmol) and phenyl 
bromide (10.5 μL, 0.1 mmol). The crude material was purified by flash 
chromatography on silica gel (eluted with MeOH:DCM = 0.5:99.5 to MeOH:DCM = 
2.5:97.5) to give the product (16.7 mg, 70% yield) as a yellow oil. Rf = 0.40 
(MeOH:DCM = 5:95). The spectroscopic data match the previously reported data.42 
 
4-(4-(tert-Butyl)phenyl)-4-phenylbut-3-enoic acid 
(3.4aa): The reaction was performed following the General 
Procedure trans-styrylacetic acid (24.3 mg, 0.15 mmol), 
NaN(SiMe3)2 (55 mg, 0.30 mmol) and 2a (18 μL, 0.1 mmol). The 
crude material was purified by flash chromatography on silica gel (eluted with MeOH:DCM 
= 0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (23 mg, 78% yield) as a 
yellow oil. Rf = 0.40 (MeOH:DCM = 5:95). The two geometric isomers are not separable. 
1H NMR (500 MHz, CDCl3): δ 7.41-7.10 (m, 9H), 6.25-6.18 (m, 1H), 3.26-3.18 (m, 2H), 
1.35-1.28 (m, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.12, 178.03, 150.58, 150.39, 
145.2, 145.0, 142.1, 139.2, 138.8, 135.9, 129.7, 129.4, 128.4, 128.1, 127.58, 
127.44, 127.0, (127.0), 125.29, 125.10, 119.3, 118.7, 35.23, 35.15, 34.63, 34.52, 
OHO
OHO
tBu
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31.41, 31.32; IR (thin film): 3421 (br), 2962, 1705, 1512, 1493, 1461, 1444, 1408, 
1362, 1269, 1217, 1109, 1073, 1017, 910, 832, 760, 733, 702, 650 cm–1; HRMS 
calc’d for C20H23O2+ 295.1698, observed 295.1698 [M+H]+. 
 
4-(4-Fluorophenyl)-4-phenylbut-3-enoic acid (3.4ad): The 
reaction was performed following the General Procedure trans-
styrylacetic acid (24.3 mg, 0.15 mmol), NaN(SiMe3)2 (55 mg, 0.30 
mmol) and 1-chloro-4-fluorobenzene (11 μL, 0.1 mmol). The crude 
material was purified by flash chromatography on silica gel (eluted with MeOH:DCM = 
0.5:99.5 to MeOH:DCM = 2.5:97.5) to give the product (18.2 mg, 71% yield) as a 
yellow oil.  Rf = 0.40 (MeOH:DCM = 5:95). The two geometric isomers are not separable. 
1H NMR (500 MHz, CDCl3): δ 7.39-6.92 (m, 18H), 6.21 (t, J = 7.4, 1H), 6.15 (t, J = 7.4, 
1H), 3.18 (dd, J = 7.4, 3.5, 4H); 13C {1H} NMR (126 MHz, CDCl3): δ 178.1, 178, 162.4 
(J = 247 Hz), 162.2 (J = 247 Hz), 144.4, 144.3, 141.6, 138.9, 137.94 (J = 3.5 Hz), 
137.92 (J = 3.5 Hz), 131.45 (J = 8.2 Hz), 129.7 (129.7), 129.07 (J = 8.2 Hz), 128.6, 
128.3, 127.7, 127.4, 119.7, 119.3, 115.35 (J = 21.4 Hz), 115.18 (J = 21.4 Hz), 35.2, 
35.1; IR (thin film): 3425 (br), 1651, 1507, 1410, 1223 cm–1; HRMS calc’d for 
C32H25O4F2- 511.1721, observed 511.1738 [2M-H]-. 
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Chapter 4 
New Strategy in C–H Functionalizations with Bimetall ic 
Catalysts 
 
4.1. INTRODUCTION 
  Aromatic hydrocarbons are inexpensive and abundant components of 
petroleum distillates and have been employed as solvents and reagents on 
laboratory and industrial scales.  They are common starting materials for the 
preparation of more functionalized and higher value small molecules with 
applications in synthesis,1 materials science,2,3 and pharmaceutical chemistry.4-6  
Inspired by the challenge of conversion of simple aromatic hydrocarbons into 
valuable synthetic buildings blocks, chemists have focused on transition metal 
promoted C–H functionalizations of simple aromatic hydrocarbons. 
  Among catalysts that activate C–H bonds, several different modes of C–H 
bond cleavage have been documented.  Most common are direct oxidative 
addition of C–H bonds and concerted metallation deprotonation processes. 7-10 
These processes can be difficult to optimize, because the demands on the 
catalyst are quite stringent.  Furthermore, the arene substrates usually posses 
multiple types of C–H’s, giving rise to selectivity problems.11  Both reactivity and 
selectivity issues can be addressed by outfitting substrates with directing 
groups that bear Lewis basic centers that can bind to the catalyst and position 
it in the proximity C–H bond of interest.12-19 
  Strategies mentioned above focus sorely on the position or reactivity of 
transition metal. Main group metal, on the other hand, is often considered 
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innocent or is involved only in transmetallation step.  For example, well known 
reactions such as Suzuki-Miyaura, Negishi, Kumada-Corriu, and Stille cross-
coupling reactions share the same common mechanism with main group metal 
(M) serving as a transmetallation partner. (Figure 4.1A) However, with unique 
bimetallic system such as TM-NIXANTPHOS, main group metal is involved in the 
whole catalytic cycle.20 (Figure 4.1B) This system prompted us to pursue a new 
kind of strategy: activation of inert molecules using main group metal.  
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Figure 4.1 Traditional Catalytic Cycle and Heterobimetallic Catalytic Cycle 
 
  We have been interested in the introduction of methods to functionalize 
benzylic C–H’s of arenes and heteroarenes. 21-30 A well-known method to activate 
benzylic positions is by coordination of the arene to a metal in an η-6-fashion.  
Previously we demonstrated the utility of this activation mode in the palladium 
catalyzed arylation of toluene derivatives and benzylic ethers and amines.  This 
method was also applied to the catalytic enantioselective arylation of benzylic 
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amines to afford diarylmethylamine derivatives, which are important 
pharmacophores.26,31 (Scheme 4.1A) 
 
[Cr]Cr(CO)3
Z Z
R
R'
[Cr]
Z
R
Ar'BrArBr
PdCl2(PPh3)2
LiN(SiMe3)2
Z = H, Ar, OR,NMe2, CH3 Z = H, OR, CH3
A. Cr Complex Benzylic Activation
B. Deprotonatable Ligand-M-Complex Benzylic Activation
1. No Cr Needed
2. Different M, different activation pattern
3. No preformed complex neededN O
PPh2
PPh2
Pd
M
CH2
M= Counter cation of the base  
Scheme 4.1 Activation of Benzylic C-H Bond with Cr and Main Group Metal  
 
  We hypothesized that use of bimetallic catalysts for C–H functionalization 
reactions could provide unique system to incorporate the activation of benzylic 
C–H with the main group metal from the counter cation of the base.  The design 
was envisioned to benefit from cooperativity between the main group metal on 
the deprotonatable ligand and transition metal in the bimetallic catalysts 
(Scheme 4.1B).  
  Our previous study revealed a heterobimetallic Pd/M catalyst (M=Li, Na, 
K) with deprotonatable ligand NIXANTPHOS framework that demonstrates 
enhanced activity in the oxidative addition of aryl chlorides.20 (Figure 4.2)  
Importantly, the (NIXANTPHOS)Pd complex’s N–H must be deprotonated to 
generate the active bimetallic catalyst that achieves the room temperature 
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oxidative addition of aryl chlorides. This result partially supports the hypothesis 
of cooperativity between the main group metal on deprotonatable ligand and 
transition metal in the bimetallic catalysts. 
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Figure 4.2. Oxidative addition of aryl chlorides by deprotonated 
(NIXANTPHOS)Pd(0) in the presence of base. 
  In this study, we focuses on the benzylic C–H activation of toluene 
derivatives via η6 interaction between the π – electron of aromatic ring and the 
main group metal carried on the ligand. Noteworthy, no other metal specie 
needed in the reaction than just the counter cation of the base and the Pd to 
functionalize toluene derivatives. A variety of diarylmethanes can be prepared 
from readily commercially available toluene derivatives, which mostly serve as 
solvents in lab or industrial use, in good to excellent yields. A novel strategy of 
C–H functionalization is proposed: With deprotonatable ligand, main group metal 
can be carried through the entire catalytic cycle and furthermore play an 
important role in the activation. This cooperativity between the main group 
metal and transition metal provides a new possibility in ligand designing and 
reveals the interesting feature of the main group metal.   
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4.2.  RESULTS AND DISCUSSION 
 
  The journey began with an interesting result observed in our study on α – 
arylation of acetic acid derivatives. With phenyl acetic acid and aryl bromides 
under standard condition, desired α – arylation product was obtained in 93% 
yield. However, an unknown byproduct was isolated if no phenyl acetic acid 
added to the reaction and was later on identified as diarylmethane. (Scheme 
4.2) 
 
Scheme 4.2. Start Point of Pd-Catalyzed Arylation of Toluene. 
OH
+
3 equiv KN(SiMe3)2
Toluene, 110 oC, 12 h
5 mol % Pd(OAc)2
7.5 mol % NiXantphosO
3 equiv KN(SiMe3)2
Toluene, 110 oC, 12 h
5 mol % Pd(OAc)2
7.5 mol % NiXantphos
No Acid
93%
Br
tBu tBu
O OH
tBu
HH
+
Br
tBu
80%  
  This interesting result urged us to discover the origin of the product to 
the arylation of toluene in the reaction. Based on our experience on the arylation 
with relatively high pka substrates (29 – 35.1), our hypothesis would be the 
toluene specie got deprotonated to form nucleophile and later transmetallated 
onto Pd to finish the cross coupling cycle. Another possible reaction pathway is 
through radical process, which the requirement for Pd or ligand is not necessary. 
Control experiments without Pd or ligand gave no desired product, which 
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suggested a traditional Pd catalyzed reaction mechanism is involved. (Scheme 
4.3) 
Scheme 4.3. Control Experiments of Pd-Catalyzed Arylation of Toluene. 
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No LigandBr
tBu
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No Pd
7.5 mol % NiXantphos
3 equiv KN(SiMe3)2
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No Pd
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tBu
No Reaction
 
 
  However, the traditional protocol of deprotonating toluene requires much 
stronger base than K[N(SiMe3)2], it is unlikely that toluene can be deprotonated 
only with [N(SiMe3)2]- anion since the pka of the two conjugate acid is in a great 
difference (26 vs 43). To account for this unusual reactivity, we hypothesized 
the counter cation of the base must not be innocent in the reaction. The 
hypothesis is especially reasonable with deprotonatable ligand NIXANTPHOS 
since the main group metal is carried through the catalytic cycle. In order to 
prove our hypothesis, we took a closer look to [N(SiMe3)2]- with different 
counter cation and found out both K[N(SiMe3)2] and Na[N(SiMe3)2] gave 
conversion of desired product. Lithium led to Buchwald-Hartwig type reaction 
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product with [N(SiMe3)2]- anion as nucleophile instead  of benzyl anion. (Scheme 
4.4) We also did a ligand screening to investigate the necessity of the 
deprotonatable ligand NIXANTPHOS. Not surprisingly, NIXANTPHOS was the only 
hit out of 48 common ligands selection that gave the desired product. (See 
Supporting Information) 
 
Scheme 4.4. Effects on Different Cation of Base in Pd-Catalyzed Arylation of 
Toluene. 
1.5 eq KN(SiMe3)2, 
110oC, 12 h
Toluene, 0.05M
5 mol % Pd(OAc)2
7.5 mol % NiXantphosBr
tBu tBu
80%
1.5 eq LiN(SiMe3)2, 
110oC, 12 h
Toluene, 0.05M
5 mol % Pd(OAc)2
7.5 mol % NiXantphosBr
tBu
N
tBu
TMS
TMS
67 %
1.5 eq NaN(SiMe3)2, 
110oC, 12 h
Toluene, 0.05M
5 mol % Pd(OAc)2
7.5 mol % NiXantphosBr
tBu tBu
58%
 
  To this point, it’s been proven that NIXANTPHOS is required in the 
reaction and the main group is not innocent. To proceed, we decided to optimize 
the reaction condition before further exploring more details in mechanism. With 
efforts on the optimization, the key factors are the Pd source, temperature and 
concentration. We were able to get desired product in 93% isolated yield with 
2.5% Pd loading. (Table 4.1) 
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Table 4.1. Optimization of Pd-Catalyzed Arylation of Toluene. 
entry yieldb (%)
1
2
3
4
5
ligand %
base 
equiv
3 7.5% 80
6
7
1.5
1.5
1.5
1.5
1.5
7.5%
7.5%
No additional
7.5%
68
81
83
84
95
+
KN(SiMe3)2, Temp, 12 h
concentration
Pd source
NiXantphosBr
tBu
Pd source
5% Pd(OAc)2
5% Pd(OAc)2
5% Pd PreCat
5% Pd(OAc)2
5% Pd(OAc)2
5% Pd(OAc)2
conc.
0.05
0.05
0.1
0.033
0.033
0.025
1a (1 equiv.)
7.5%
8
1.5 No additional 715% Pd PreCat 0.033
9
1.5 No additional 05% Pd PreCat 0.033
10
1.2 No additional 655% Pd PreCat 0.033
1.5 No additional 932.5% Pd PreCat 0.033
CH3
tBu
temp (oC)
110
110
110
110
110
110
80
24
110
110
11 1.5 No additional 751% Pd PreCat 0.033110  
a Reaction conducted on a 0.1 mmol scale b Yield determined by 1H NMR 
spectroscopy of the crude reaction mixture. 
  
 With the optimized reaction condition, we decided to investigate the cation 
effect with additives. In previous initial results, both K[N(SiMe3)2] and 
Na[N(SiMe3)2] gave desired product, but K[N(SiMe3)2] in better yield. It’s worth 
knowing whether this difference came from the kinetic behavior of the base (i.e. 
K[N(SiMe3)2] is more reactive than Na[N(SiMe3)2] and Li[N(SiMe3)2]), or the 
counter cation of the base was playing a role in the reaction. To tackle this 
question, we designed the experiment with additives that are capable of caging 
the counter cation of the base (12-crown-4 for Li, 15-crown-5 and 18-crown-6 
for K) and, theoretically, increasing the reactivity of the bases. However, cases 
with potassium cation caged by 15-crown-5 or 18-crown-6 showed no reactivity 
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as well as all lithium cases. This result suggested the potassium cation was 
playing an important role other than just an innocent counter cation in the 
reaction. (Table 4.2) 
 
 Table 4.2. Effect of Crown Ethers in Pd-Catalyzed Arylation of Toluene. 
entry yieldb (%)
1
2
3
4
5
equiv.
93
6
7
1.5
1.5
5.0
3.0
20
64
10
35
>5
+
1.5 eq base, 110 oC, 
12 h, 0.033 M, additives
2.5 mol % Buchwald 3rd
PreCat./NiXantphosBr
tBu
additives
18-Crown-6
18-Crown-6
15-Crown-5
18-Crown-6
15-Crown-5
15-Crown-5
2a (1 equiv.)
3.0
8
10.0 >515-Crown-5
9
>512-Crown-4
10
>512-Crown-4
3.0 >512-Crown-4
CH3
tBu
base
KN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
KN(SiMe3)2
LiN(SiMe3)2
LiN(SiMe3)2
LiN(SiMe3)2
1.5
none
none
 
a Reaction conducted on a 0.1 mmol scale b Yield determined by 1H NMR 
spectroscopy of the crude reaction mixture. 
 
  With all the evidence above, it’s now clear that deprotonatable ligand 
NIXANTPHOS as well potassium cation are required. To better understand the 
system, we came up with a model to explain the unique reactivity for the 
catalyst. It’s well known that Cr and other metals can form η6 complex with 
toluene to activate benzylic protons. Potassium, on the other hand, is well 
known to have η6 interaction with benzene ring in the crystal forms. However, 
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activation of benzylic protons using potassium η6 interaction is not documented. 
Herein we proposed a heterobimetallic model with potassium attaching to the 
deprotonated ligand NIXANTPHOS as an active catalyst to perform arylation of 
toluene derivatives. The benzylic protons of toluene are activated due to η6 
interaction between potassium and benzene ring. We believe this model 
explained the role of potassium in the activation of toluene and the inhibited 
reactivity by addition of 15-crown-5 or 18-crown-6. Once the potassium cation 
is caged with crown ether, the η6 interaction of potassium and benzene ring is 
inhibited, therefore shut down the activation. (Figure 4.3) Meanwhile, we believe 
the deprotonatable ligand NIXANTPHOS also has incremental effect to the 
reactivity due to the localization of potassium by the ligand. It is likely that the 
localization of potassium helped the transmetallation of deprotonated benzyl 
anion.  
 
N O
PPh2
PPh2
Pd
K
CH2
"turned on"
O O OOO
O O OOO
K
"shut down"  
Figure 4.3. Proposed Activation Pattern of Potassium.  
 
  In order to demonstrate the utility of the protocol, we synthesized a 
series of diarylmethanes from simple toluene with different aryl bromides. (Table 
4.3) Aryl bromides bearing electron donating groups such as tert-butyl, methoxy 
group and N,N-dimethyl group worked in excellent yields (3aa-3ac, 90-95%). 
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Steric hindered 2-methyl-bromobenzene and 1-bromonaphathalene also gave 
desired product in excellent yield (3ad, 3ae; 92% and 90%). We next explored 
interesting aryl bromide bearing silyl-ether, the protocol successfully gave cross 
coupled product 3af in 80% yield. Heterocycle-containing diarylmethanes are 
valuable targets because of their uses in pharmaceuticals. We were able to 
produce an indole-containing diarylmethane 3ag from corresponding aryl 
bromides in excellent yield (95%). Overall, the protocol is robust for different 
kind of aryl bromides with Pd loading as low as 2.5%.  
 
Table 4.3. Scope of Aryl Bromides in Pd-Catalyzed Arylation of Toluene. 
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ArAr Br
3aa, 93%
OMe NMe2
CH3
MeN
OSi(iPr)3
3af, 80%b3ad, 92% 3ae, 90%
3ag, 95%b
3ab, 80%b 3ac, 95%b
1.5 eq KN(SiMe3)2, Toluene
0.0333M, 110 oC, 12 h
2.5 mol % Buchwald 3rd
preCat./NiXantphos
1a-1g 3aa-3ag
 
a Reaction conducted on a 0.1 mmol scale b 5 mol % Catalyst was used.  
 
  Next, we set the goal in arylation of toluene derivatives. Xylenes, for 
instance, are major toluene derivatives that are obtained from petroleum. 
Different xylenes exhibited different reactivity under the reaction condition. For 
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example, ortho-xylene (2b) reacted with 4-tert-butyl bromobenzene to form 
desired product 4ba in 99% yield. The yield dropped with meta-xylene (2c) and 
para-xylene (2d) to 80% and 64%. Mesitylene (2e) can also be subjected to the 
reaction condition to form the product 4ea in 63% yield. Both toluene 
derivatives with electron donating (2f) and electron withdrawing group (2g, 
2h) on the ortho-position gave excellent yields (4fa-4ha; 90%, 85% and 81%). 
Noteworthy, no byproduct derived from the oxidative addition of 2-
chlorotoluene (2h) was found. 3-fluorotoluene (2i) and 3-chlorotoluene (2j) 
also provided cross-coupled products 4ia and 4ja in 78% and 74% yields. One 
important example is ethyl benzene (2k), the arylation happened at the benzylic 
position where the most acidic protons locate and gave the branched product 
4ka in 75% yield. The result is particularly interesting because it generated a 
chiral center, which made asymmetric transformation possible. Overall, common 
toluene derivatives were well tolerated under the reaction condition. However, 
the protocol came with limitations such as the lack of para substituted examples 
but para-xylene (4da). Benzene with propyl or high carbon number side chains 
also failed to give desired products.    
 
Table 4.4. Scope of Toluene Derivative in Pd-Catalyzed Arylation of Toluene.a 
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1.5 eq KN(SiMe3)2, 
0.0333M, 110 oC, 12 h
2.5 mol % Buchwald 3rd
preCat./NiXantphos
Ar CH3
1
 4ba, 99%
Br
tBu
+
CH3
tBu
2 3
 4ca, 80%
tBu
4
tBu
4fa, 90%
tBu
H3C
OMe
9
tBu
10
4ja, 74%
tBu
4ea, 63%
H3C CH3
5
4ka, 75%
tBu
6
4ga, 85%
tBu
7
tBu
Cl
4ha, 81%
F
8
F Cl
4ia, 78%
4da, 64%
tBu
CH3
1a2b-2k 4ba-4ka
Ar
tBu
 
a Reaction conducted on a 0.1 mmol scale  
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4.3. SUMMARY AND OUTLOOK 
  In summary, we have developed a method to directly functionalize 
toluene derivatives with aryl bromides to generate diarylmethanes, all of which 
are important building blocks in drug discovery. The mechanistic insight provides 
a novel point of view for the role of main group metal in the catalytic cycle. By 
devising the deprotonatable ligand with main group metal, new strategy of C–H 
functionalization can be revealed.  
 
4.4. EXPERIMENTAL SECTION 
 
General Methods.  All reactions were performed under nitrogen using oven-dried 
glassware and standard Schlenk or vacuum line techniques. Air- and moisture-sensitive 
solutions were handled under nitrogen and transferred via syringe. Unless otherwise 
stated, reagents were commercially available and used as purchased without further 
purification. Chemicals were obtained from Sigma-Aldrich, Acros, TCI America, Strem 
Chemicals or Matrix Scientific, and solvents were purchased from Fisher Scientific. The 
progress of the reactions was monitored by thin-layer chromatography using Whatman 
Partisil K6F 250 μm precoated 60 Å silica gel plates and visualized by short-wavelength 
ultraviolet light as well as by treatment potassium permanganate (KMnO4) stain or 
iodine. Silica gel (230−400 mesh, Silicycle) was used for flash chromatography. The 1H 
NMR and 13C{1H} NMR spectra were obtained using a Brüker AM-500 Fourier 
transform NMR spectrometer at 500 and 126 MHz, respectively. Chemical shifts are 
reported in units of parts per million (ppm) downfield from tetramethylsilane (TMS), and 
all coupling constants are reported in hertz. The infrared spectra were obtained with KBr 
plates using a Perkin-Elmer Spectrum 100 Series FTIR spectrometer. High-resolution 
mass spectrometry (HRMS) data were obtained on a Waters LC−TOF mass spectrometer 
(model LCT-XE Premier) using chemical ionization (CI) or electrospray ionization (ESI) in 
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positive or negative mode, depending on the analyte.  Melting points were determined on 
a Unimelt Thomas-Hoover melting point apparatus and are uncorrected. 
 
Preparation of Electrophile. 
Compounds 1g32 were prepared according to literature procedures. 
General Procedure A: An oven-dried 10 mL reaction vial equipped with a stir bar was 
charged with Pd Buchwald’s 3rd generation precatalyst (2.33 mg, 0.0025 mmol, 2.5 mol 
%),  KN(SiMe3)2 (30 mg, 0.15 mmol, 1.5 equiv) under a nitrogen atmosphere. 3 mL of 
dry toluene was taken up by syringe and added to the reaction vial. 1a (18 μL, 0.1 
mmol, 1 equiv) was added to the reaction mixture Note that the ArBr in a solid form was 
added to the reaction vial prior to KN(SiMe3)2. The reaction mixture was stirred for 12 h 
at 110 °C, quenched with two drops of H2O, diluted with 3 mL of ethyl acetate, and 
filtered over a pad of MgSO4 and silica. The pad was rinsed with additional ethyl acetate, 
and the solution was concentrated in vacuo. The crude material was loaded onto a silica 
gel column and purified by flash chromatography eluting with EtOAc/hexanes.  
 
General Procedure B: An oven-dried 10 mL reaction vial equipped with a stir bar was 
charged with Pd Buchwald’s 3rd generation precatalyst (2.33 mg, 0.0025 mmol, 2.5 mol 
%),  KN(SiMe3)2 (30 mg, 0.15 mmol, 1.5 equiv) under a nitrogen atmosphere. 3 mL of 
2b was taken up by syringe and added to the reaction vial. 1a (18 μL, 0.1 mmol, 1 
equiv) was added to the reaction mixture Note that the ArBr in a solid form was added 
to the reaction vial prior to KN(SiMe3)2. The reaction mixture was stirred for 12 h at 110 
°C, quenched with two drops of H2O, diluted with 3 mL of ethyl acetate, and filtered over 
a pad of MgSO4 and silica. The pad was rinsed with additional ethyl acetate, and the 
solution was concentrated in vacuo. The crude material was loaded onto a silica gel 
column and purified by flash chromatography eluting with EtOAc/hexanes.  
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1-benzyl-4-(tert-butyl)benzene (3aa): The reaction was 
performed following General Procedure A with 1a (18 μL, 0.1 
mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to give the product 
(20.8 mg, 93% yield) as a colorless oil. Rf = 0.4 (hexanes); The NMR spectral data match 
the previously published data.33  
 
1-benzyl-4-methoxybenzene (3ab): The reaction was 
performed following General Procedure A with 1b (12.5 μL, 0.1 
mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The crude material was 
purified by flash chromatography on silica gel (eluted with hexanes) to give the product 
(15.9 mg, 80% yield) as a colorless oil. Rf = 0.4 (hexanes); The NMR spectral data match 
the previously published data.34  
 
4-benzyl-N,N-dimethylanil ine (3ac): The reaction was 
performed following General Procedure A with 1c (20.2 mg, 
0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The crude material 
was purified by flash chromatography on silica gel (eluted with EtOAc:hexanes = 5:95) 
to give the product (20 mg, 95% yield) as a colorless oil. Rf = 0.25 (EtOAc:hexanes = 
5:95); The NMR spectral data match the previously published data.34 
 
1-benzyl-2-methylbenzene (3ad): The reaction was performed 
following General Procedure A with 1d (12 μL, 0.1 mmol), KN(SiMe3)2 
(30 mg, 0.15 mmol) and toluene 2a (3mL). The crude material was purified by flash 
chromatography on silica gel (eluted with hexanes) to give the product (16.8 mg, 92% 
yield) as a colorless oil. Rf = 0.4 (hexanes); The NMR spectral data match the previously 
published data.35 
 
tBu
OMe
NMe2
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1-benzylnaphthalene (3ae): The reaction was performed 
following General Procedure A with 1e (20.7 mg, 0.1 mmol), 
KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The crude 
material was purified by flash chromatography on silica gel (eluted with hexanes) to give 
the product (19.6 mg, 90% yield) as a colorless oil. Rf = 0.20 (hexanes); The NMR 
spectral data match the previously published data.36 
 
 (4-benzylphenoxy)tri isopropylsi lane (3af): The 
reaction was performed following General Procedure A with 
1f (28.5 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The 
crude material was purified by flash chromatography on silica gel (eluted with hexanes) 
to give the product (27.2 mg, 80% yield) as a colorless oil. Rf = 0.30 (hexanes); 1H NMR 
(500 MHz; CDCl3): δ 7.28 (t, J = 7.6, 2H), 7.21-7.16 (m, 3H), 7.03 (d, J = 8.2, 2H), 
6.81 (d, J = 8.3, 2H), 3.92 (s, 2H), 1.28-1.22 (m, 3H), 1.10 (d, J = 7.4, 18H); 13C {1H} 
NMR (126 MHz, CDCl3): δ 154.5, 141.9, 133.6, 130.0, 129.1, 128.6, 126.1, 120.0, 
41.3, 18.2, 12.9 ppm; IR (thin film): 3028, 2944, 1608, 1508, 1494, 1463, 1384, 
1367, 1264, 1169, 1099, 916, 883, 686 cm–1; HRMS calc’d for C22H32OSi+ 340.2222, 
observed 340.2219 [MH]+ 
 
5-benzyl-1-methyl-1H-indole (3ag): The reaction was 
performed following General Procedure A with 1g (21 mg, 0.1 
mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and toluene 2a (3mL). The crude material was 
purified by flash chromatography on silica gel (eluted with EtOAc:hexanes = 5:95) to 
give the product (21 mg, 95% yield) as a colorless oil. Rf = 0.40 (eluted with 
EtOAc:hexanes = 5:95); 1H NMR (500 MHz; CDCl3): δ 7.43 (t, J = 0.7, 1H), 7.27-7.20 
(m, 5H), 7.18-7.15 (m, 1H), 7.05 (dd, J = 8.4, 1.6, 1H), 6.99 (d, J = 3.1, 1H), 6.40 (d, 
J = 3.1, 1H), 4.08 (s, 2H), 3.73 (s, 3H); 13C {1H} NMR (126 MHz, CDCl3): δ 142.6, 135.7, 
132.2, 129.19, 129.10, 128.9, 128.5, 126.0, 123.2, 121.0, 109.4, 100.8, 42.2, 33.1 
OSi(iPr)3
N
Me
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ppm; IR (thin film): 3024, 2903, 1658, 1601, 1512, 1492, 1448, 1421, 1339, 1303, 
1244, 1154, 1079, 785, 718, 699 cm–1; HRMS calc’d for C16H15N+ 222.1282, observed 
222.1251 [MH]+ 
 
1-(4-(tert-butyl)benzyl)-2-methylbenzene (4ba): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2b 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (23.8 mg, 99% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.29-7.27 (m, 2H), 7.13 (dq, J = 12.8, 4.0, 4H), 
7.05 (d, J = 8.0, 2H), 3.95 (s, 2H), 2.25 (s, 3H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, 
CDCl3): δ 148.7, 139.2, 137.3, 136.6, 130.3, 130.0, 128.4, 126.4, 126.0, 125.3, 38.9, 
34.4, 31.4, 19.8 ppm; IR (thin film): 3020, 2904, 1909, 1603, 1514, 1492, 1462, 
1411, 1392, 1378, 1363, 1268, 1201, 1108, 1050, 916, 805, 720 cm–1; HRMS calc’d 
for C18H22+ 238.1722, observed 238.1721 [M]+ 
 
1-(4-(tert-butyl)benzyl)-3-methylbenzene (4ca): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2c 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (19 mg, 80% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.28-7.25 (m, 2H), 7.14 (t, J = 7.5, 1H), 7.10-
7.08 (m, 2H), 6.99-6.96 (m, 3H), 3.87 (s, 2H), 2.28 (s, 3H), 1.27 (s, 9H); 13C {1H} NMR 
(126 MHz, CDCl3): δ 148.8, 141.2, 138.3, 138.0, 129.8, 128.51, 128.37, 126.8, 
126.1, 125.4, 41.5, 34.4, 31.5, 21.5 ppm; IR (thin film): 3023, 2961, 1906, 1606, 
1514, 1488, 1460, 1411, 1392, 1376, 1363, 1268, 1202, 1109, 1090, 932, 807, 
700 cm–1; HRMS calc’d for C18H22+ 238.1722, observed 238.1713 [M]+ 
 
tBu
tBu
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1-(4-(tert-butyl)benzyl)-4-methylbenzene (4da): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2d (3mL). The crude material 
was purified by flash chromatography on silica gel (eluted with hexanes) to give the 
product (15.3 mg, 64% yield) as a colorless oil. Rf = 0.40 (hexanes); 1H NMR (500 MHz; 
CDCl3): δ 7.30-7.28 (m, 2H), 7.12-7.09 (m, 6H), 3.91 (s, 2H), 2.31 (d, J = 1.2, 3H), 
1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 148.7, 138.42, 138.27, 135.5, 129.1, 
128.9, 128.4, 125.3, 41.0, 34.4, 31.4, 21.1; IR (thin film): 3020, 2962, 1512, 1463, 
1411, 1362, 1268, 1202, 1108, 1020, 846, 811, 721 cm–1; HRMS calc’d for C18H22+ 
238.1722, observed 238.1724 [M]+ 
 
1-(4-(tert-butyl)benzyl)-3,5-dimethylbenzene (4ea): 
The reaction was performed following General Procedure B 
with 1a (18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) 
and 2e (3mL). The crude material was purified by flash chromatography on silica gel 
(eluted with hexanes) to give the product (15.9 mg, 63% yield) as a colorless oil. Rf = 
0.40 (hexanes); 1H NMR (500 MHz; CDCl3): δ 7.29 (d, J = 8.3, 2H), 7.11 (d, J = 8.4, 2H), 
6.82 (s, 3H), 3.86 (s, 2H), 2.26 (s, 6H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 
148.7, 141.2, 138.4, 137.9, 128.5, 127.7, 126.9, 125.4, 41.4, 34.4, 31.5, 21.3; IR 
(thin film): 3015, 2962, 1603, 1514, 1463, 1411, 1362, 1268, 1202, 1109, 1018, 
855, 826, 701 cm–1; HRMS calc’d for C19H24+ 252.1878, observed 252.1870 [M]+ 
 
1-(4-(tert-butyl)benzyl)-2-methoxybenzene (4fa): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2f 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (22.9 mg, 90% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.29-7.27 (m, 2H), 7.18 (td, J = 7.8, 1.6, 1H), 
tBu
tBu
tBu
OMe
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7.15-7.13 (m, 2H), 7.08-7.06 (m, 1H), 6.88-6.85 (m, 2H), 3.94 (s, 2H), 3.81 (s, 3H), 
1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 157.4, 148.5, 138.0, 130.4, 129.9, 
128.6, 127.3, 125.2, 120.5, 110.4, 55.4, 35.3, 34.4, 31.5; IR (thin film): 3015, 2962, 
1603, 1514, 1463, 1411, 1362, 1268, 1202, 1109, 1018, 855, 826, 701 cm–1; HRMS 
calc’d for C18H22O+ 254.1671, observed 254.1665 [M]+ 
 
1-(4-(tert-butyl)benzyl)-2-fluorobenzene (4ga): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2g 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (20.6 mg, 85% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.31-7.29 (m, 2H), 7.20-7.13 (m, 4H), 7.06-
7.00 (m, 2H), 3.97 (s, 2H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 161.0 (d, 
JC–F = 245.7 Hz), 149.0, 136.8, 131.1 (d, JC–F = 5.0 Hz), 128.2, 127.8 (d, JC–F = 8.8 
Hz), 125.4, 125.3, 124.0 (d, JC–F = 3.8 Hz), 115.3 (d, JC–F = 22.7 Hz), 34.4, 34.2 (d, 
JC–F = 2.5 Hz), 31.4; IR (thin film): 3014, 2962, 1584, 1515, 1491, 1455, 1412, 1363, 
1268, 1230, 1203, 1118, 1091, 1019, 916, 833, 805, 754 cm–1; HRMS calc’d for 
C17H19F+ 242.1471, observed 242.1481 [M]+ 
 
1-(4-(tert-butyl)benzyl)-2-chlorobenzene (4ha): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2h 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (21 mg, 81% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.36-7.35 (m, 1H), 7.31-7.29 (m, 2H), 7.16-
7.11 (m, 5H), 4.07 (s, 2H), 1.30 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 149.1, 
138.9, 136.5, 134.3, 131.1, 129.5, 128.6, 127.6, 126.9, 125.4, 38.7, 34.4, 31.5; IR 
(thin film): 3057, 2962, 1570, 1514, 1470, 1442, 1411, 1363, 1268, 1201, 1109, 
tBu
F
tBu
Cl
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1050, 1038, 914, 841, 801, 754, 719 cm–1; HRMS calc’d for C17H19Cl+ 258.1175, 
observed 258.1169 [M]+ 
 
1-(4-(tert-butyl)benzyl)-3-fluorobenzene (4ia): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2i 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (18.9 mg, 78% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.32-7.30 (m, 2H), 7.24-7.22 (m, 1H), 7.10 (d, 
J = 8.1, 2H), 6.98 (d, J = 7.5, 1H), 6.88 (dt, J = 5.8, 2.8, 2H), 3.93 (s, 2H), 1.30 (s, 
9H); 13C {1H} NMR (126 MHz, CDCl3): δ 163.0 (d, JC–F = 245.7 Hz), 149.2, 143.9 (d, 
JC–F = 7.5 Hz), 137.2, 129.8 (d, JC–F = 8.8 Hz), 128.5, 125.5, 124.6 (d, JC–F = 2.5 
Hz), 115.8 (d, JC–F = 21.4 Hz), 112.9 (d, JC–F = 20.1 Hz), 41.1 (d, JC–F = 1.2 Hz), 
34.4, 31.4; IR (thin film): 3025, 2963, 1733, 1612, 1589, 1515, 1486, 1448, 1411, 
1363, 1267, 1249, 1202, 1135, 1109, 1018, 942, 835, 813, 756 cm–1; HRMS calc’d 
for C17H19F+ 242.1471, observed 242.1470 [M]+ 
 
1-(4-(tert-butyl)benzyl)-3-chlorobenzene (4ja): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2j 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (19.1 mg, 74% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.32-7.30 (m, 2H), 7.21-7.15 (m, 3H), 7.10-
7.06 (m, 3H), 3.91 (s, 2H), 1.30 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 149.2, 
143.4, 137.2, 134.2, 129.7, 129.1, 128.5, 127.2, 126.3, 125.5, 41.1, 34.4, 31.4; IR 
(thin film): 2962, 1573, 1514, 1475, 1429, 1411, 1363, 1200, 1109, 1091, 1077, 
1018, 925, 868, 804, 745, 697 cm–1; HRMS calc’d for C17H19Cl+ 258.1175, observed 
258.1183 [M]+ 
tBu
F
tBu
Cl
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1-(tert-butyl)-4-(1-phenylethyl)benzene (4ka): The 
reaction was performed following General Procedure B with 1a 
(18 μL, 0.1 mmol), KN(SiMe3)2 (30 mg, 0.15 mmol) and 2k 
(3mL). The crude material was purified by flash chromatography on silica gel (eluted 
with hexanes) to give the product (17.9 mg, 75% yield) as a colorless oil. Rf = 0.40 
(hexanes); 1H NMR (500 MHz; CDCl3): δ 7.30-7.22 (m, 6H), 7.18-7.14 (m, 3H), 4.12 (q, 
J = 7.2, 1H), 1.63 (d, J = 7.2, 3H), 1.29 (s, 9H); 13C {1H} NMR (126 MHz, CDCl3): δ 
148.7, 146.6, 143.3, 128.4, 127.7, 127.2, 126.0, 125.2, 44.4, 34.4, 31.4, 21.9; IR 
(thin film): 3025, 2964, 1600, 1514, 1492, 1451, 1409, 1363, 1268, 1201, 1111, 
1016, 835, 779, 754, 699 cm–1; HRMS calc’d for C18H22+ 238.1722, observed 
238.1717  [M]+ 
 
Ligands Screening Results 
 
 
Experiments were set up inside a glovebox under a nitrogen atmosphere. Two 24-well 
aluminum block containing 1 mL glass vials was predosed with Buchwald type precatalyst 
dimer (0.5 μmol) and the phosphine ligands (2 μmol for monodentate ligands and 1 μmol 
for bidentate ligands) in THF. The solvent was removed to dryness using a GeneVac and 
4-tert-butylbromobenzene (10 μmol) wes dosed into each reaction vial as a solution in 
Toluene (50 μL, 0.2 M). KN(SiMe3)2 (15 μmol) in Toluene (50 μL, 0.2 M) was added. 
Total reaction scale is 100 μL, 0.1 M. The 24-well plate was then sealed and stirred for 
12 h at 110oC. 
 
Work up:  
Upon opening the plate to air, 500 μL of a solution of Biphenyl (used as internal standard 
to measure HPLC yields) in acetonitrile (0.002 mol/L) was added into each vial. The 
plate was covered again and the vials stirred for 10 min. to ensure good homogenization. 
tBu
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Into a separate 96-well LC block was added 700 μL of acetonitrile, followed by 25 μL of 
the diluted reaction mixtures. The LC block was then sealed with a silicon-rubber storage 
mat and mounted on an automated HPLC instrument for analysis. 
 
 
 
 
Error! Objects cannot be created from editing field codes. 
Entry Ligand  Prod/I
S  
1 9,9–Dimethyl–4,5–bis(diphenylphosphino)xanthene (Xantphos) 0.00 
2 (Oxydi-2,1-phenylene)bis[dicyclohexyl] phosphine (DCE phos) 0.00 
3 4,6–Bis(diphenylphosphino)phenoxazine (NiXantPhos) 0.71 
4 Rac-(1,1′-Binaphthalene-2,2’-diyl)bis(diphenylphosphine) 0.25 
5 Dicyclohexyl–[3,6–dimethoxy–2–(2,4,6–
triisopropylphenyl)phenyl]phosphane (Brettphos) 
0.00 
6 2-Dicyclohexylphosphino-2’,6’-bis(N,N-dimethylamino)biphenyl (Cphos) 0.00 
7  2-Dicyclohexylphosphino-2’,6’-dimethoxybiphenyl (Sphos) 0.00 
8 Di-tert-butyl(2’,4’,6’-triisopropyl-3-methoxy-6-methyl-[1,1′-biphenyl]-2-
yl)phosphine (Rockphos) 
0.00 
9 N–phenyl–2–(dicyclohexylphosphino)pyrrole (cataCXium PCy)  0.00 
10 Di–t–butyl–(1–phenylindol–2–yl)phosphane (cataCXium PIntB) 0.00 
11 Butyldi–1–adamantylphosphine (CataCXium A) 0.00 
12 Dicyclohexyl–(1–phenylindol–2–yl)phosphane (cataCXium PInCy)  0.00 
13 Benzyldi–1–adamantylphosphine (cataCXium ABn)  0.00 
14 N–phenyl–2–(di–t–butylphosphino)pyrrole (CataXCium PtB) 0.10 
15 1–(2,4,6–Trimethylphenyl)–2–(dicyclohexylphosphino)imidazole(CataXCium 
PICy) 
0.00 
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16 2-(Di-tert-butylphosphino)-2’,4’,6’- triisopropyl-3,6-dimethoxy-1,1′-
biphenyl 
0.00 
17  2-Di-tert-butylphosphino-2’-methylbiphenyl (t-Butyl MePhos) 0.00 
18 rac-2-(Di-tert-butylphosphino)-1,1’-binaphthyl 0.14 
19 5-(Di-tert-butylphosphino)-1’, 3’,  5’-triphenyl-1’H-[1,4]bipyrazole 0.00 
20 (dicyclohexylphosphanyl)-2-(o-tolyl)-1H-indole 0.11 
21 Tri(o–tolyl)phosphine 0.00 
22 Triphenyl phosphine 0.00 
23 1-[2-[Bis(tert-butyl)phosphino]phenyl]-3,5-diphenyl-1H-pyrazole 0.00 
24 Di(1-adamantyl)-2-morpholinophenylphosphine 0.00 
25 Di(1-adamantyl)-2-dimethylaminophenylphosphine 0.35 
26 1,1'-bis(dicyclohexylphosphino)ferrocene 0.11 
27 1,1’-Bis(diisopropylphosphino)ferrocene 0.11 
28 1,2,3,4,5-Pentaphenyl-1'-(di-tert-butylphosphino)ferrocene 0.00 
29 1,1'-Bis(diphenylphosphino)ferrocene 0.00 
30 1,1'-Bis(di-tert-butylphosphino)ferrocene 0.00 
31 (4-(N,N-Dimethylamino)phenyl)di-tert-butyl phosphine 0.00 
32 Tris(2,4,6-trimethylphenyl)phosphine 0.33 
33 2'-(Dicyclohexylphosphino)acetophenone ethylene ketal 0.00 
34 Dicyclohexyl(4-(N,N-dimethylamino)phenyl)phosphine 0.24 
35 Tri-tert-butylphosphonium tetrafluoroborate 0.10 
36 Di–tert–butyl(neopentyl)phosphine  0.10 
37 Tricyclohexylphosphine tetrafluoroborate 0.12 
38 2-(Dicyclohexylphosphino)biphenyl 0.00 
39 2–Di–tert–butylphosphino–2’,4',6’ –triisopropylbiphenyl 0.13 
40 2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl 0.00 
41 (2-Biphenyl)di-tert-butylphosphine 0.00 
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42 2-Di-tert-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-triisopropyl-1,1'-
biphenyl 
0.00 
43 2-Dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl 0.15 
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Appendix A1. NMR Spectra Relevant to Chapter 1 
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Figure A1.1 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3aa in CDCl3 
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Figure A1.2 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3ba in CDCl3 
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Figure A1.3 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3ca in CDCl3 
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Figure A1.4 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3da in CDCl3 
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Figure A1.5 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3ea in CDCl3 
O
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Figure A1.6 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3fa in CDCl3 
 
S
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Figure A1.7 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.3ga in CDCl3 
 
N N
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Figure A1.8 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5aa in CDCl3 
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Figure A1.9 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5ba in CDCl3 
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Figure A1.10 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5ca in CDCl3 
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Figure A1.11 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5da in CDCl3 
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Figure A1.12 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5ea in CDCl3 
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Figure A1.13 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5fa in CDCl3 
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Figure A1.14 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5ga in CDCl3 
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Figure A1.15 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.5ha in CDCl3 
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Figure A1.16 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.6ba in CDCl3 
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Figure A1.17 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.6da in CDCl3 
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Figure A1.18 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.7ea in CDCl3 
 
 159 
 
 
Figure A1.19 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.6fa in CDCl3 
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Figure A1.20 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.6aa in CDCl3 
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Figure A1.21 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.6ca in CDCl3 
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Figure A1.22 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.8aa in CDCl3 
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Figure A1.23 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.9aa in CDCl3 
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Figure A1.24 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10a in CDCl3 
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Figure A1.25 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10b in CDCl3 
N N
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Figure A1.26 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10c in CDCl3 
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Figure A1.27 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10d in CDCl3 
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Figure A1.28 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10e in CDCl3 
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Figure A1.29 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10f in CDCl3 
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Figure A1.30 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10g in CDCl3 
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Figure A1.31 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.10h in CDCl3 
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Figure A1.32 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.11a in CDCl3 
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Figure A1.33 500 MHz 1H and 125 MHz 13C{1H} NMR of 1.11b in CDCl3 
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Figure A2.1 500 MHz 1H NMR of 2.3aa in CDCl3 
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Figure A2.2 125 MHz 13C{1H} NMR of 2.3aa in CDCl3 
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Figure A2.3 500 MHz 1H NMR of 2.3ba in CDCl3 
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Figure A2.4 125 MHz 13C{1H} NMR of 2.3ba in CDCl3 
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Figure A2.5 500 MHz 1H NMR of 2.3ca in CDCl3 
 
 180 
Figure A2.6 125 MHz 13C{1H} NMR of 2.3ca in CDCl3 
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Figure A2.7 500 MHz 1H NMR of 2.3da in CDCl3 
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Figure A2.8 125 MHz 13C{1H} NMR of 2.3da in CDCl3 
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Figure A2.9 500 MHz 1H NMR of 2.3ea in CDCl3 
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Figure A2.10 125 MHz 13C{1H} NMR of 2.3ea in CDCl3 
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Figure A2.11 500 MHz 1H NMR of 2.3fa in CDCl3 
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Figure A2.12 125 MHz 13C{1H} NMR of 2.3fa in CDCl3 
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Figure A2.13 500 MHz 1H NMR of 2.3ga in CDCl3 
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Figure A2.14 125 MHz 13C{1H} NMR of 2.3ga in CDCl3 
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Figure A2.15 500 MHz 1H NMR of 2.5aa in CDCl3 
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F igure A2.16 125 MHz 13C{1H} NMR of 2.5aa in CDCl3 
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Figure A2.17 500 MHz 1H NMR of 2.5ba in CDCl3 
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Figure A2.18 125 MHz 13C{1H} NMR of 2.5ba in CDCl3 
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Figure A2.19 500 MHz 1H NMR of 2.5ca in CDCl3 
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Figure A2.20 125 MHz 13C{1H} NMR of 2.5ca in CDCl3 
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Figure A2.21 500 MHz 1H NMR of 2.5da in CDCl3 
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Figure A2.22 125 MHz 13C{1H} NMR of 2.5da in CDCl3 
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Figure A2.23 500 MHz 1H NMR of 2.5ea in CDCl3 
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Figure A2.24 125 MHz 13C{1H} NMR of 2.5ea in CDCl3 
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Figure A2.25 500 MHz 1H NMR of 2.5fa in CDCl3 
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Figure A2.26 125 MHz 13C{1H} NMR of 2.5fa in CDCl3 
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Figure A2.27 500 MHz 1H NMR of 2.6aa in CDCl3 
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Figure A2.28 125 MHz 13C{1H} NMR of 2.6aa in CDCl3 
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Figure A2.29 500 MHz 1H NMR of 2.6ba in CDCl3 
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Figure A2.30 125 MHz 13C{1H} NMR of 2.6ba in CDCl3 
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Figure A2.31 500 MHz 1H NMR of 2.6ca in CDCl3 
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Figure A2.32 125 MHz 13C{1H} NMR of 2.6ca in CDCl3 
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Figure A2.33 500 MHz 1H NMR of 2.6da in CDCl3 
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Figure A2.34 125 MHz 13C{1H} NMR of 2.6da in CDCl3 
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Figure A2.35 500 MHz 1H NMR of 2.6ea in CDCl3 
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Figure A2.36 125 MHz 13C{1H} NMR of 2.6ea in CDCl3 
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Figure A2.37 500 MHz 1H NMR of 2.6fa in CDCl3 
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Figure A2.38 125 MHz 13C{1H} NMR of 2.6fa in CDCl3 
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Figure A2.39 500 MHz 1H NMR of 2.8aa in CDCl3 
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Figure A2.40 125 MHz 13C{1H} NMR of 2.8aa in CDCl3 
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Figure A2.41 500 MHz 1H NMR of 2.8ba in CDCl3 
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Figure A2.42 125 MHz 13C{1H} NMR of 2.8ba in CDCl3 
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Figure A2.43 500 MHz 1H NMR of 2.9fb in CDCl3 
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Figure A2.44 125 MHz 13C{1H} NMR of 2.9fb in CDCl3 
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Figure A2.45 500 MHz 1H NMR of 2.10fc in CDCl3 
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Figure A2.46 125 MHz 13C{1H} NMR of 2.10fc in CDCl3 
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Figure A3.1 500 MHz 1H NMR of 3.1aa in CDCl3 
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 Figure A3.2 125 MHz 13C{1H} NMR of 3.1aa in CDCl3 
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Figure A3.3 500 MHz 1H NMR of 3.3aa in CDCl3 
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Figure A3.4 125 MHz 13C{1H} NMR of 3.3aa in CDCl3 
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Figure A3.5 500 MHz 1H NMR of 3.3ab in CDCl3 
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Figure A3.6 125 MHz 13C{1H} NMR of 3.3ab in CDCl3 
 
 
 228 
Figure A3.7 500 MHz 1H NMR of 3.3ac in CDCl3 
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Figure A3.8 125 MHz 13C{1H} NMR of 3.3ac in CDCl3 
 
 
 230 
Figure A3.9 500 MHz 1H NMR of 3.3ad in CDCl3 
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Figure A3.10 125 MHz 13C{1H} NMR of 3.3ad in CDCl3 
 
 
 232 
Figure A3.11 500 MHz 1H NMR of 3.3ae in CDCl3 
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Figure A3.12 125 MHz 13C{1H} NMR of 3.3ae in CDCl3 
 
 
 234 
Figure A3.13 500 MHz 1H NMR of 3.3af in CDCl3 
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Figure A3.14 125 MHz 13C{1H} NMR of 3.3af in CDCl3 
 
 
 236 
Figure A3.15 500 MHz 1H NMR of 3.3ag in CDCl3 
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Figure A3.16 125 MHz 13C{1H} NMR of 3.3ag in CDCl3 
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Figure A3.17 500 MHz 1H NMR of 3.3ah in CDCl3 
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Figure A3.18 125 MHz 13C{1H} NMR of 3.3ah in CDCl3 
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Figure A3.19 500 MHz 1H NMR of 3.3ai in CDCl3 
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Figure A3.20 125 MHz 13C{1H} NMR of 3.3ai in CDCl3 
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Figure A3.21 500 MHz 1H NMR of 3.3ba in CDCl3 
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Figure A3.22 125 MHz 13C{1H} NMR of 3.3ba in CDCl3 
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Figure A3.23 500 MHz 1H NMR of 3.3ca in CDCl3 
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Figure A3.24 125 MHz 13C{1H} NMR of 3.3ca in CDCl3 
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Figure A3.25 500 MHz NMR of 3.3da in CDCl3 
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Figure A3.26 125 MHz 13C{1H} NMR of 3.3da in CDCl3 
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Figure A3.27 500 MHz 1H NMR of 3.3ea in CDCl3 
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Figure A3.28 125 MHz 13C{1H} NMR of 3.3ea in CDCl3 
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Figure A3.29 500 MHz 1H NMR of 3.3fa in CDCl3 
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Figure A3.30 125 MHz 13C{1H} NMR of 3.3fa in CDCl3 
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Figure A3.31 500 MHz 1H NMR of 3.3ga in CDCl3 
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Figure A3.32 125 MHz 13C{1H} NMR of 3.3ga in CDCl3 
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Figure A3.33 500 MHz 1H NMR of 3.3ha in CDCl3 
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Figure A3.34 125 MHz 13C{1H} NMR of 3.3ha in CDCl3 
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Figure A3.35 500 MHz 1H NMR of 3.4ap in CDCl3 
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Figure A3.36 125 MHz 13C{1H} NMR of 3.4ap in CDCl3 
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Figure A3.37 500 MHz 1H NMR of 3.4aa in CDCl3 
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Figure A3.38 125 MHz 13C{1H} NMR of 3.4aa in CDCl3 
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Figure A3.39 500 MHz 1H NMR of 3.4ad in CDCl3 
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Figure A3.40 125 MHz 13C{1H} NMR of 3.4ad in CDCl3 
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Figure A4.1 500 MHz 1H NMR of 4.3aa in CDCl3 
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Figure A4.2 125 MHz 13C{1H} NMR of 4.3aa in CDCl3 
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Figure A4.3 500 MHz 1H NMR of 4.3ab in CDCl3 
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Figure A4.4 125 MHz 13C{1H} NMR of 4.3ab in CDCl3 
 
 
 267 
Figure A4.5 500 MHz 1H NMR of 4.3ac in CDCl3 
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Figure A4.6 125 MHz 13C{1H} NMR of 4.3ac in CDCl3 
 
 
 269 
Figure A4.7 500 MHz 1H NMR of 4.3ad in CDCl3 
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Figure A4.8 125 MHz 13C{1H} NMR of 4.3ad in CDCl3 
 
 
 271 
Figure A4. 500 MHz 1H NMR of 4.3ae in CDCl3 
 
 
 272 
Figure A4.10 125 MHz 13C{1H} NMR of 4.3ae in CDCl3 
 
 
 273 
Figure A4.11 500 MHz 1H NMR of 4.3af in CDCl3 
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Figure A4.12 125 MHz 13C{1H} NMR of 4.3af in CDCl3 
 
 
 275 
Figure A4.13 500 MHz 1H NMR of 4.3ag in CDCl3 
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Figure A4.14 125 MHz 13C{1H} NMR of 4.3ag in CDCl3 
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Figure A4.15 500 MHz 1H NMR of 4.4ba in CDCl3 
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Figure A4.16 125 MHz 13C{1H} NMR of 4.4ba in CDCl3 
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Figure A4.17 500 MHz 1H NMR of 4.4ca in CDCl3 
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Figure A4.18 125 MHz 13C{1H} NMR of 4.4ca in CDCl3 
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Figure A4.19 500 MHz 1H NMR of 4.4da in CDCl3 
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Figure A4.20 125 MHz 13C{1H} NMR of 4.4da in CDCl3 
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Figure A4.21 500 MHz 1H NMR of 4.4ea in CDCl3 
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Figure A4.22 125 MHz 13C{1H} NMR of 4.4ea in CDCl3 
 285 
 
Figure A4.23 500 MHz 1H NMR of 4.4fa in CDCl3 
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Figure A4.24 125 MHz 13C{1H} NMR of 4.4fa in CDCl3 
 287 
 
Figure A4.25 500 MHz 1H NMR of 4.4ga in CDCl3 
 288 
 
Figure A4.26 125 MHz 13C{1H} NMR of 4.4ga in CDCl3 
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Figure A4.27 500 MHz 1H NMR of 4.4ha in CDCl3 
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Figure A4.28 125 MHz 13C{1H} NMR of 4.4ha in CDCl3 
 291 
 
Figure A4.29 500 MHz 1H NMR of 4.4ia in CDCl3 
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Figure A4.30 125 MHz 13C{1H} NMR of 4.4ia in CDCl3 
 293 
 
Figure A4.31 500 MHz 1H NMR of 4.4ja in CDCl3 
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Figure A4.32 125 MHz 13C{1H} NMR of 4.4ja in CDCl3 
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Figure A4.33 500 MHz 1H NMR of 4.4ka in CDCl3 
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Figure A4.34 125 MHz 13C{1H} NMR of 4.4ka in CDCl3 
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 X-ray Structure Determination  
 
ph
ph ph
 
Compound 11b, C25H24, crystallizes in the monoclinic space group P21/c 
(systematic absences 0k0: k=odd and h0l: l=odd) with a=18.8031(14)Å, 
b=5.8211(5)Å, c=17.3207(13)Å, b=103.022(4)°, V=1847.1(3)Å3, Z=4, and 
dcalc=1.167 g/cm3 . X-ray intensity data were collected on a Bruker APEXII CCD area 
detector employing graphite-monochromated Mo-Ka radiation (l=0.71073 Å) at a 
temperature of 143(1)K. Preliminary indexing was performed from a series of thirty-six 
0.5° rotation frames with exposures of 10 seconds. A total of 2591 frames were 
collected with a crystal to detector distance of 37.6 mm, rotation widths of 0.5° and 
exposures of 30 seconds:  
 
scan type 2q w f c frames 
f -15.50 258.48 8.28 19.46 739 
w -18.00 243.20 310.97 36.30 208 
f -23.00 315.83 12.48 28.88 346 
f -13.00 335.42 31.84 64.29 739 
f 19.50 59.55 348.71 -26.26 559 
 Rotation frames were integrated using SAINTi, producing a listing of unaveraged 
F2 and s(F2) values which were then passed to the SHELXTL ii  program package for 
further processing and structure solution. A total of 38765 reflections were measured 
over the ranges 2.22 £ q £ 25.42°, -22 £ h £ 22, -7 £ k £ 7, -14 £ l £ 20 yielding 
3315 unique reflections (Rint = 0.0633). The intensity data were corrected for Lorentz 
and polarization effects and for absorption using SADABS iii  (minimum and maximum 
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transmission 0.6194, 0.7452). 
The structure was solved by direct methods (SHELXS-97iv). Refinement was by 
full-matrix least squares based on F2 using SHELXL-97.v All reflections were used during 
refinement. The weighting scheme used was w=1/[s2(Fo2 )+ (0.0781P)2 + 1.2783P] 
where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using a riding model.  Refinement converged to 
R1=0.0597 and wR2=0.1474 for 2336 observed reflections for which F > 4s(F) and 
R1=0.0922 and wR2=0.1680 and GOF =1.029 for all 3315 unique, non-zero reflections 
and 226 variables.vi The maximum D/s in the final cycle of least squares was 0.000 and 
the two most prominent peaks in the final difference Fourier were +0.647 and -0.268 
e/Å3. 
Table S1. lists cell information, data collection parameters, and refinement data. 
Final positional and equivalent isotropic thermal parameters are given in Tables S2. and 
S3.  Anisotropic thermal parameters are in Table S4.  Tables S5. and S6. list bond 
distances and bond angles.  Figure 1. is an ORTEPvii representation of the molecule with 
30% probability thermal ellipsoids displayed. 
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Figure S1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table S1.  Summary of Structure Determination of Compound 11b 
Empirical formula  C25H24 
Formula weight  324.44 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P21/c      
Cell constants:   
a  18.8031(14) Å 
b  5.8211(5) Å 
c  17.3207(13) Å 
b 103.022(4)° 
Volume 1847.1(3) Å3 
Z 4 
Density (calculated) 1.167 Mg/m3 
Absorption coefficient 0.066 mm-1 
F(000) 696 
Crystal size 0.38 x 0.08 x 0.02 mm3 
Theta range for data collection 2.22 to 25.42° 
Index ranges -22 £ h £ 22, -7 £ k £ 7, -14 £ l £ 20 
Reflections collected 38765 
Independent reflections 3315 [R(int) = 0.0633] 
Completeness to theta = 25.42° 97.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6194 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3315 / 0 / 226 
Goodness-of-fit on F2 1.029 
Final R indices [I>2sigma(I)] R1 = 0.0597, wR2 = 0.1474 
R indices (all data) R1 = 0.0922, wR2 = 0.1680 
Largest diff. peak and hole 0.647 and -0.268 e.Å-3 
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Table S2. Refined Positional Parameters for Compound 11b 
  Atom x y z Ueq, Å2 
C1 0.25836(12) 0.5999(5) 0.37321(14) 0.0373(6) 
C2 0.32754(12) 0.6628(4) 0.34482(13) 0.0323(5) 
C3 0.39163(13) 0.7204(5) 0.41133(15) 0.0392(6) 
C4 0.37472(13) 0.9183(5) 0.46128(15) 0.0394(6) 
C5 0.30031(13) 0.8965(5) 0.47782(15) 0.0419(7) 
C6 0.24952(13) 0.7568(4) 0.43987(14) 0.0364(6) 
C7 0.19031(13) 0.5970(4) 0.30647(15) 0.0378(6) 
C8 0.19607(12) 0.4448(4) 0.23636(14) 0.0331(6) 
C9 0.22874(13) 0.2295(4) 0.24320(14) 0.0354(6) 
C10 0.23135(13) 0.1019(4) 0.17631(16) 0.0392(6) 
C11 0.20071(14) 0.1864(5) 0.10251(16) 0.0450(7) 
C12 0.16823(14) 0.3986(5) 0.09499(16) 0.0463(7) 
C13 0.16575(13) 0.5275(4) 0.16086(16) 0.0398(6) 
C14 0.12092(12) 0.5408(4) 0.33504(14) 0.0324(6) 
C15 0.06520(14) 0.7006(5) 0.32197(16) 0.0449(7) 
C16 0.00226(15) 0.6631(6) 0.34928(19) 0.0568(8) 
C17 -0.00550(14) 0.4669(6) 0.38946(17) 0.0525(8) 
C18 0.04834(15) 0.3032(5) 0.40079(17) 0.0497(7) 
C19 0.11123(13) 0.3392(5) 0.37348(16) 0.0413(6) 
C20 0.46183(12) 0.7607(4) 0.38311(13) 0.0326(6) 
C21 0.51697(13) 0.6006(4) 0.39917(13) 0.0344(6) 
C22 0.58197(13) 0.6338(4) 0.37662(14) 0.0368(6) 
C23 0.59312(12) 0.8305(4) 0.33675(14) 0.0348(6) 
C24 0.53837(13) 0.9925(4) 0.31791(13) 0.0358(6) 
C25 0.47286(13) 0.9589(4) 0.34133(14) 0.0358(6) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos g+2U13aa*cc*cos b+2U23bb*cc*cosa] 
 
Table S3. Positional Parameters for Hydrogens in Compound 11b 
  Atom x y z Uiso, Å2 
H1 0.2652 0.4438 0.3948 0.045 
H2a 0.3407 0.5349 0.3149 0.039 
H2b 0.3170 0.7935 0.3094 0.039 
H3 0.4002 0.5856 0.4461 0.047 
H4a 0.4109 0.9223 0.5110 0.047 
H4b 0.3778 1.0618 0.4338 0.047 
H5 0.2893 0.9879 0.5176 0.050 
H6 0.2051 0.7542 0.4550 0.044 
H7 0.1841 0.7543 0.2859 0.045 
H9 0.2491 0.1703 0.2932 0.042 
H10 0.2539 -0.0412 0.1816 0.047 
H11 0.2019 0.1001 0.0576 0.054 
H12 0.1477 0.4560 0.0448 0.056 
H13 0.1436 0.6713 0.1548 0.048 
H15 0.0699 0.8350 0.2945 0.054 
H16 -0.0348 0.7723 0.3401 0.068 
H17 -0.0471 0.4441 0.4091 0.063 
H18 0.0426 0.1673 0.4269 0.060 
H19 0.1472 0.2266 0.3811 0.050 
H21 0.5102 0.4666 0.4259 0.041 
H22 0.6184 0.5230 0.3884 0.044 
H23 0.6374 0.8541 0.3226 0.042 
H24 0.5451 1.1236 0.2897 0.043 
H25 0.4362 1.0689 0.3291 0.043 
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Table S4.   Refined Thermal Parameters (U's) for Compound 11b 
 
  Atom U11 U22 U33 U23 U13 U12 
C1 0.0308(13) 0.0504(15) 0.0339(14) -0.0132(11) 0.0139(10) -0.0064(11) 
C2 0.0319(12) 0.0391(13) 0.0278(13) -0.0056(10) 0.0107(10) -0.0005(10) 
C3 0.0346(13) 0.0546(16) 0.0317(14) -0.0105(11) 0.0143(11) -0.0058(12) 
C4 0.0321(13) 0.0528(16) 0.0357(14) -0.0171(12) 0.0128(10) -0.0058(11) 
C5 0.0348(13) 0.0594(17) 0.0358(15) -0.0215(12) 0.0168(11) -0.0019(12) 
C6 0.0294(12) 0.0522(15) 0.0317(14) -0.0090(11) 0.0156(10) 0.0002(11) 
C7 0.0393(14) 0.0399(14) 0.0377(15) -0.0058(11) 0.0163(11) -0.0040(11) 
C8 0.0271(12) 0.0393(13) 0.0373(14) -0.0090(11) 0.0168(10) -0.0114(10) 
C9 0.0353(13) 0.0433(14) 0.0307(14) -0.0011(11) 0.0142(10) -0.0074(11) 
C10 0.0408(14) 0.0358(14) 0.0468(17) -0.0084(12) 0.0220(12) -0.0072(11) 
C11 0.0466(15) 0.0586(18) 0.0369(16) -0.0155(13) 0.0241(12) -0.0196(14) 
C12 0.0449(15) 0.0647(19) 0.0308(15) 0.0031(13) 0.0116(11) -0.0188(14) 
C13 0.0325(13) 0.0413(14) 0.0462(16) 0.0038(12) 0.0103(11) -0.0060(11) 
C14 0.0283(12) 0.0413(14) 0.0291(13) -0.0093(10) 0.0096(10) -0.0014(10) 
C15 0.0487(15) 0.0437(15) 0.0438(16) -0.0022(12) 0.0137(12) 0.0059(12) 
C16 0.0355(15) 0.074(2) 0.061(2) -0.0176(17) 0.0107(13) 0.0166(15) 
C17 0.0318(14) 0.085(2) 0.0463(17) -0.0207(16) 0.0206(12) -0.0116(14) 
C18 0.0496(16) 0.0591(18) 0.0433(17) 0.0001(13) 0.0165(13) -0.0145(14) 
C19 0.0330(13) 0.0474(15) 0.0431(16) -0.0003(12) 0.0078(11) 0.0051(12) 
C20 0.0306(12) 0.0468(14) 0.0215(12) -0.0102(10) 0.0081(9) -0.0086(11) 
C21 0.0405(13) 0.0392(13) 0.0248(13) -0.0018(10) 0.0101(10) -0.0039(11) 
C22 0.0342(13) 0.0457(15) 0.0303(14) -0.0016(11) 0.0072(10) 0.0075(11) 
C23 0.0271(12) 0.0536(15) 0.0262(13) -0.0058(11) 0.0112(10) -0.0033(11) 
C24 0.0446(14) 0.0418(14) 0.0228(13) 0.0014(10) 0.0111(10) -0.0026(11) 
C25 0.0313(12) 0.0464(15) 0.0283(13) -0.0071(11) 0.0036(10) 0.0085(11) 
The form of the anisotropic displacement parameter is: 
exp[-2p2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table S5. Bond Distances in Compound 11b, Å 
 
C1-C6  1.510(3) C1-C7  1.519(3) C1-C2  1.535(3) 
C2-C3  1.505(3) C3-C4  1.517(3) C3-C20  1.525(3) 
C4-C5  1.495(3) C5-C6  1.312(3) C7-C8  1.527(3) 
C7-C14  1.531(3) C8-C9  1.389(3) C8-C13  1.390(4) 
C9-C10  1.386(3) C10-C11  1.370(4) C11-C12  1.372(4) 
C12-C13  1.375(4) C14-C15  1.381(3) C14-C19  1.382(4) 
C15-C16  1.387(4) C16-C17  1.362(4) C17-C18  1.372(4) 
C18-C19  1.385(4) C20-C21  1.375(3) C20-C25  1.402(4) 
C21-C22  1.378(3) C22-C23  1.378(3) C23-C24  1.380(3) 
C24-C25  1.395(3)     
 
 
 
 
Table S6. Bond Angles in Compound 11b, ° 
 
C6-C1-C7 111.7(2) C6-C1-C2 110.34(19) C7-C1-C2 112.8(2) 
C3-C2-C1 113.46(19) C2-C3-C4 111.8(2) C2-C3-C20 112.98(19) 
C4-C3-C20 112.0(2) C5-C4-C3 111.7(2) C6-C5-C4 124.3(2) 
C5-C6-C1 124.4(2) C1-C7-C8 114.4(2) C1-C7-C14 112.9(2) 
C8-C7-C14 110.59(19) C9-C8-C13 118.2(2) C9-C8-C7 124.4(2) 
C13-C8-C7 117.4(2) C10-C9-C8 120.7(2) C11-C10-
C9 
120.1(2) 
C10-C11-
C12 
119.8(2) C11-C12-
C13 
120.7(3) C12-C13-
C8 
120.5(2) 
C15-C14-
C19 
118.3(2) C15-C14-
C7 
118.3(2) C19-C14-
C7 
123.5(2) 
C14-C15-
C16 
120.8(3) C17-C16-
C15 
120.3(3) C16-C17-
C18 
119.7(2) 
C17-C18-
C19 
120.4(3) C14-C19-
C18 
120.6(2) C21-C20-
C25 
118.0(2) 
C21-C20-
C3 
119.9(2) C25-C20-
C3 
122.1(2) C20-C21-
C22 
121.6(2) 
C23-C22-
C21 
120.2(2) C22-C23-
C24 
119.8(2) C23-C24-
C25 
119.7(2) 
C24-C25-
C20 
120.6(2)     
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6R1 = Σ||Fo| - |Fc|| / Σ |Fo| 
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